Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • USE OF CITRULLINE FOR THE TREATMENT AND PREVENTION OF ISCHEMIA-REPERFUSION SYNDROME

USE OF CITRULLINE FOR THE TREATMENT AND PREVENTION OF ISCHEMIA-REPERFUSION SYNDROME

Номер патента: FR2937550B1
Опубликовано: 10-12-2010
Автор(ы): Bandt Jean Pascal Jean Pierre Michel De, Christophe Moinard, Luc Cynober
Принадлежит: Universite Paris Descartes Paris 5

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Use of L-citrulline to prevent and treat ischemia-reperfusion syndrome in a tissue comprising liver, brain, intestine, kidney and lung, where ischemia-reperfusion syndrome is related to warm ischemia and cold ischemia

Номер патента: FR2937550A1. Автор: Christophe Moinard,Luc Cynober,Bandt Jean Pascal Jean Pierre Michel De. Владелец: Universite Paris Descartes Paris 5. Дата публикации: 2010-04-30.

Arginine and/or citrulline for use in the treatment and/or prevention of osteoarthritis

Номер патента: WO2014203200A1. Автор: Giuseppe Colombo,Walter Pascale. Владелец: ITALFARMACO SPA. Дата публикации: 2014-12-24.

The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)

Номер патента: AU2019359549A1. Автор: Donald Johns,Judit SOVAGO. Владелец: NOVARTIS AG. Дата публикации: 2021-03-25.

Arginine and/or citrulline for use in the treatment and/or prevention of osteoarthritis

Номер патента: EP3010496A1. Автор: Giuseppe Colombo,Walter Pascale. Владелец: ITALFARMACO SPA. Дата публикации: 2016-04-27.

Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs

Номер патента: AU4950296A. Автор: Paul Leonard Greenhaff,Dumitru Constantin-Teodosiu,Simon Martin Poucher,James Archibald Timmons. Владелец: Zeneca Ltd. Дата публикации: 1996-10-02.

The use of a h3r inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (pd)

Номер патента: CA3112298A1. Автор: Donald Johns,Judit SOVAGO. Владелец: NOVARTIS AG. Дата публикации: 2020-04-16.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US11759442B2. Автор: Ira C. Spector,Mark A. Feitelson,Alla Arzumanyan. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2023-09-19.

Methods for the treatment of pancreatitis and prevention of pancreatic cancer

Номер патента: AU2021275052A1. Автор: I-Lin Ho,Andrea Viale,Alessandro CARUGO,Edoardo DEL POGGETTO. Владелец: University of Texas System. Дата публикации: 2022-12-15.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US20180214399A1. Автор: Feitelson Mark A.,Spector Ira C.,Arzumanyan Alla. Владелец: . Дата публикации: 2018-08-02.

Methods for inhibition of BNIP3 and prevention and treatment of ischemia reperfusion injury by tetra-O-methyl nordihydroguaiaretic acid

Номер патента: US09456995B2. Автор: Ru Chih Huang,Kotohiko Kimura. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2016-10-04.

Use of an anti-atherothrombotic compound for the production of medicaments for use in the treatment of vascular disorders.

Номер патента: MX2007004108A. Автор: Tony Verbeuren,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2009-02-16.

USE OF AN ANTI-ATEROTROMBOTIC COMPOUND FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF VASCULAR DISORDERS

Номер патента: UY30263A1. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2007-05-31.

Use of an anti-atherothrombotic compound for the manufacture of drugs for the treatment of cerebrovascular disorders

Номер патента: DK1842537T3. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Cordoue Agnes De,Laurence Lerond,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2010-04-12.

Use of pharmaceutical compositions and compounds for the preparation of a medicament for the treatment of diseases

Номер патента: CN116270589A. Автор: 堵银道. Владелец: Beijing Aomi Jiade Pharmaceutical Technology Co ltd. Дата публикации: 2023-06-23.

USE OF AN ANTI-ATEROTROMBOTIC COMPOUND FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF VASCULAR DISORDERS

Номер патента: CO5820217A1. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2007-11-30.

USE OF BACLOFENE FOR OBTAINING MEDICINES FOR THE TREATMENT OF CHICKEN ANGINA.

Номер патента: FR2662354A1. Автор: Bousquet Pascal Pierre. Владелец: ADIR SARL. Дата публикации: 1991-11-29.

Use of Baclofen to Obtain Medication for the Treatment of Angina

Номер патента: CA2043033A1. Автор: Pascal-Pierre Bousquet. Владелец: ADIR SARL. Дата публикации: 1991-11-24.

Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Номер патента: WO2019215470A1. Автор: Philippe Pierre,Jessica PEREGO,Evelina GATTI. Владелец: Université D'aix Marseille. Дата публикации: 2019-11-14.

Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Номер патента: EP3790539A1. Автор: Philippe Pierre,Jessica PEREGO,Evelina GATTI. Владелец: Aix Marseille Universite. Дата публикации: 2021-03-17.

Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Номер патента: CA2189762C. Автор: Jes Olesen. Владелец: APS KBUS 17 NR 1797. Дата публикации: 2009-01-13.

Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Номер патента: WO2004032914A3. Автор: Jean-Claude Caron. Владелец: Jean-Claude Caron. Дата публикации: 2004-06-10.

Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function

Номер патента: EP1596850A1. Автор: Jose Esteve-Soler,Javier Angulo-Frutos,Inigo S Enz De Tejada-Gorman. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2005-11-23.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: EP1601352A2. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2005-12-07.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: AU2004218938A1. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2004-09-23.

Use of a fibrate and orlistat for the treatment of obesity

Номер патента: IL170519A0. Автор: . Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-10-05.

Use of a fibrate and orlistat for the treatment of obesity

Номер патента: US20070078179A1. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2007-04-05.

Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Номер патента: US09573882B2. Автор: Ivars Kalvins,Maija Dambrova,Edgars Liepins,Einars Loza,Osvalds Pugovics,Reinis Vilskersts,Janis Kuka,Solveiga Grinberga. Владелец: Grindeks Jsc. Дата публикации: 2017-02-21.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: EP1620084A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: Newron Pharmaceuticals SpA. Дата публикации: 2006-02-01.

Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Номер патента: WO1994017795A1. Автор: Jean-Bernard Ducep,Nikolaus Seiler,Karin C. Jund. Владелец: Merrell Dow Pharmaceuticals Inc.. Дата публикации: 1994-08-18.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: WO2004098585A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: NEWRON PHARMACEUTICALS S.P.A.. Дата публикации: 2004-11-18.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US11065217B2. Автор: Ira C. Spector,Mark A. Feitelson,Alla Arzumanyan. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2021-07-20.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: JP2022179617A. Автор: Arzumanyan Alla,シー．スペクター イラ,C Spector Ira,エー．フェイテルソン マーク,A Feitelson Mark,アーズマーニャン アラ. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2022-12-02.

USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS

Номер патента: FR2849598A1. Автор: Gérard Moinet,Micheline Kergoat,Dominique Marais,Valerie Autier,Catherine Kargar,De Vacqueur Annick Arbellot. Владелец: Merck Sante SAS. Дата публикации: 2004-07-09.

USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS

Номер патента: FR2849598B1. Автор: Gérard Moinet,Micheline Kergoat,Dominique Marais,Valerie Autier,Catherine Kargar,De Vacqueur Annick Arbellot. Владелец: Merck Sante SAS. Дата публикации: 2006-09-22.

The use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders

Номер патента: CN102834002A. Автор: 蔡立慧,管吉松,斯蒂芬·J·哈格蒂,爱德华·赫尔森,弗洛伦斯·瓦格纳,约翰内斯·格雷夫. Владелец: Broad Institute Inc. Дата публикации: 2012-12-19.

The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders

Номер патента: CA2779497A1. Автор: Li-Huei Tsai,Edward Holson,Stephen J. Haggarty,Florence Wagner,Ji-Song Guan,Johannes Graeff. Владелец: Broad Institute Inc. Дата публикации: 2011-05-05.

USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES

Номер патента: FR2849599B1. Автор: Gérard Moinet,Micheline Kergoat,Dominique Marais,Valerie Autier,De Vacqueur Annick Arbellot. Владелец: Merck Sante SAS. Дата публикации: 2006-12-29.

Use of c1 inhibitor for the prevention of ischemia-reperfusion injury

Номер патента: CA2632400C. Автор: Frank Pieper,Maurice Mannesse,Johannes Henricus Nuijens,Maria Grazia De Simoni,Gijsbertus Johannes Ziere. Владелец: Pharming Intellectual Property BV. Дата публикации: 2016-06-07.

Use of opioids or opioid mimetics for the treatment of resistant cancer patients

Номер патента: CA2732497C. Автор: Erich Miltner,Claudia Friesen,Andreas Alt. Владелец: Universitaet Ulm. Дата публикации: 2017-01-17.

Use of odc inhibitors, dacarbazine, and interferon in the treatment of malignant melanoma

Номер патента: AU1502388A. Автор: Sai P. Sunkara. Владелец: Merrell Dow Pharmaceuticals Inc. Дата публикации: 1988-10-27.

Use of ODC inhibitors, dacarbazine, and interferon in the¹treatment of malignant melanoma

Номер патента: IE881221L. Автор: Sai P Sunkara. Владелец: Desmond Joseph Crosdale. Дата публикации: 1988-10-23.

Use of ODC inhibitors, dacarbazine, and interferon in the treatment of malignant melanoma

Номер патента: IE61498B1. Автор: Sai P Sunkara. Владелец: Merrell Dow Pharma. Дата публикации: 1994-11-02.

Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject

Номер патента: US12083128B2. Автор: Tamara VRABEC. Владелец: Individual. Дата публикации: 2024-09-10.

Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject

Номер патента: CA3001464A1. Автор: Tamara VRABEC. Владелец: Individual. Дата публикации: 2017-04-13.

USE OF ELIPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE PREVENTION OF NEUROPATHIES INDUCED BY CANCER AGENTS

Номер патента: FR2722987B1. Автор: Jesus Benavides,Pascal George,Delphine Lekieffre,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1997-05-16.

USE OF ELIPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE PREVENTION OF NEUROPATHIES INDUCED BY CANCER AGENTS

Номер патента: FR2722987A1. Автор: Jesus Benavides,Pascal George,Delphine Lekieffre,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-02-02.

Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome

Номер патента: WO2020113340A1. Автор: Lyne Gagnon,Pierre Laurin,Frank CESARI. Владелец: Liminal Biosciences Limited. Дата публикации: 2020-06-11.

Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome

Номер патента: EP3890717A1. Автор: Lyne Gagnon,Pierre Laurin,Frank CESARI. Владелец: Liminal Biosciences Ltd. Дата публикации: 2021-10-13.

Use of phospholipid emulsion containing effective amount of dihydroquercetin for treating ischemia-reperfusion syndrome in patients with ischemic organ and extremity injuries

Номер патента: RU2766681C1. Автор: Антон Владимирович Евтеев,Сергей Антонович Евтеев. Владелец: Антон Владимирович Евтеев. Дата публикации: 2022-03-15.

Methods for inhibition of bnip3 and prevention and treatment of ischemia reperfusion injury by tetra-o-methyl nordihydroguaiaretic acid

Номер патента: CN104603094A. Автор: R·C·黄,木村琴彦. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2015-05-06.

Methods for inhibition of bnip3 and prevention and treatment of ischemia reperfusion injury by tetra-o-methyl nordihydroguaiaretic acid

Номер патента: WO2014015136A3. Автор: Ru Chih Huang,Kotohiko Kimura. Владелец: THE JOHNS HOPKINS UNIVERSITY. Дата публикации: 2014-03-13.

Methods for inhibition of bnip3 and prevention and treatment of ischemia reperfusion injury by tetra-o-methyl nordihydroguaiaretic acid

Номер патента: WO2014015136A2. Автор: Ru Chih Huang,Kotohiko Kimura. Владелец: THE JOHNS HOPKINS UNIVERSITY. Дата публикации: 2014-01-23.

Glutaric acid compounds for the treatment of ischemia-reperfusion injury

Номер патента: CN109417016B. Автор: 殷翔,黄菁,傅旭东,曼苏雷·埃格巴利,李敬远,卡伦·罗伊,劳伦特·韦尔涅. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2022-06-03.

For treating the glutaric acid compound of ischemia reperfusion injury

Номер патента: CN109417016A. Автор: 殷翔,黄菁,傅旭东,曼苏雷·埃格巴利,李敬远,卡伦·罗伊,劳伦特·韦尔涅. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2019-03-01.

(+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder

Номер патента: AU2018242134B2. Автор: Andrew John Duffield,Anant Pandya. Владелец: ADEPTIO PHARMACEUTICALS Ltd. Дата публикации: 2023-09-28.

Use of 5,10-methylene tetrahydrofolate for the treatment of cancer

Номер патента: WO2005097086A3. Автор: Mark J Cantwell,Joan M Robbins. Владелец: Joan M Robbins. Дата публикации: 2006-05-18.

Use of compositions comprising sesquiterpene derivatives for the treatment of cancer

Номер патента: EP1372677B1. Автор: Jean-Claude Madelmont,André Pichette,Jean Legault. Владелец: FPL Pharma Inc. Дата публикации: 2008-04-30.

Use of senicapoc for treatment of stroke

Номер патента: US20230045322A1. Автор: Thomas Moeller,Roland STAAL,Jonathan Weinstein. Владелец: Paracelsus Neuroscience Ii LLC. Дата публикации: 2023-02-09.

Use of chemical compounds for the treatment of aids

Номер патента: WO2009063412A1. Автор: Xavier Morelli,Yves Collette. Владелец: Institut National de la Sante et de la Recherche Medicale (INSERM). Дата публикации: 2009-05-22.

Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof

Номер патента: EP2556833A4. Автор: Sousa Buck Hudson De,Nunes Marielza Andrade. Владелец: Fundação Arnaldo Vieira De Carvalho. Дата публикации: 2013-09-04.

Use of 2-amino-N-(1,2-diphenyl-1-methylethyl)-acetamide (ie remacemide) in treating Parkinsons disease

Номер патента: NZ299042A. Автор: Peter Johnson,Barry Ernest Watkins,Eric William Harris. Владелец: Astra AB. Дата публикации: 2000-07-28.

Treatment of ischemia-reperfusion injury

Номер патента: WO2010129954A1. Автор: Charles D. Smith,Zhi Zhong,Lynn W. Maines. Владелец: APOGEE BIOTECHNOLOGY CORPORATION. Дата публикации: 2010-11-11.

Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Номер патента: AU5614394A. Автор: Jean-Bernard Ducep,Nikolaus Seiler,Karin C Jund. Владелец: Merrell Dow Pharmaceuticals Inc. Дата публикации: 1994-08-29.

Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Номер патента: AU2003293295A8. Автор: Jean-Claude Caron. Владелец: Galderma Research and Development SNC. Дата публикации: 2004-05-04.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: ZA200507227B. Автор: Edgar Alan. Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-11-29.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: HK1083767A1. Автор: Edgar Alan. Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-07-14.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US20220142978A1. Автор: Feitelson Mark A.,Spector Ira C.,Arzumanyan Alla. Владелец: . Дата публикации: 2022-05-12.

"USES OF AT LEAST ONE COMPOUND FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOLOGICAL AFFECTIONS"

Номер патента: BRPI0719467A2. Автор: Irina Safonova,Cecile Cousin,Leila Zarif. Владелец: Galderma Res & Dev. Дата публикации: 2014-10-29.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: CA2524593A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: Emanuela Izzo. Дата публикации: 2004-11-18.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: AU2004237401A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: Newron Pharmaceuticals SpA. Дата публикации: 2004-11-18.

Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine

Номер патента: HUT73173A. Автор: Jean-Bernard Ducep,Nikolaus Seiler,Karin C Jund. Владелец: Merrell Dow Pharma. Дата публикации: 1996-06-28.

USE OF 3-BEZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF NETWORK DISEASES

Номер патента: DE60120990T2. Автор: A. Daniel Arlington GAMACHE,Gustav Cleburne GRAFF,M. John Burleson YANNI,A. Michael Arlington KAPIN. Владелец: Alcon Inc. Дата публикации: 2007-03-15.

Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function

Номер патента: EP1565174A1. Автор: Jose Esteve-Soler,Inigo Saenz De Tejada-Gorman,Javier Angulo-Frutos. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2005-08-24.

USE OF 3-BEZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF NETWORK DISEASES

Номер патента: DE60120990D1. Автор: Gustav Graff,A Kapin,A Gamache,M Yanni. Владелец: Alcon Inc. Дата публикации: 2006-08-03.

Use of P2Y purinoreceptor antagonist for the treatment of ischemia reperfusion

Номер патента: US6559148B1. Автор: Giorgio Bernardi,Giuseppe Sancesario,Cinzia Volonte′. Владелец: Consiglio Nazionale delle Richerche CNR. Дата публикации: 2003-05-06.

Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases

Номер патента: AU3252699A. Автор: Clemens Erdelmeier,Michael Noldner,Shyam Sunder Chatterjee. Владелец: Dr Willmar Schwabe GmbH and Co KG. Дата публикации: 1999-08-30.

Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases

Номер патента: WO2006094627A3. Автор: Cristina Alonso-Alija,Jang Gupta,Berthold Hinzen. Владелец: Berthold Hinzen. Дата публикации: 2006-12-07.

Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse

Номер патента: EP1848448B8. Автор: Nataliya Dyachyk. Владелец: Parmeggiani Francesco. Дата публикации: 2010-09-15.

Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of chlamydia pneumoniae infections

Номер патента: US20030100614A1. Автор: Giovanni Colombo,Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Maria Gismondo. Владелец: Zambon Group SpA. Дата публикации: 2003-05-29.

Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections

Номер патента: US6833389B2. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon Group SpA. Дата публикации: 2004-12-21.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: US20220241223A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2022-08-04.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: AU2020294943A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2022-01-20.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: WO2020254632A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Centre Hospitalier Universitaire D'angers. Дата публикации: 2020-12-24.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: CA3143608A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2020-12-24.

Use of n-(aryl-propionuyl)-sulfonamides for the treatment of spinal cord injury

Номер патента: ZA200608517B. Автор: Riccardo Bertini,Fransesco Colotta. Владелец: Dompe Pha Ma S P A. Дата публикации: 2008-04-30.

Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs

Номер патента: CA2023630C. Автор: Adrian Llewellyn Harris,Lauri Veikko Matti Kangas,Michael William Degregorio. Владелец: Orion Yhtyma Oy. Дата публикации: 2002-02-19.

Use of Alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex I deficiencies

Номер патента: AU2021313398A1. Автор: Stéphane Azoulay,Vincent Procaccio,Carole SELLEM,Agnès DELAHODDE,Aurélie RENAUD,Déborah TRIBOUILLARD-TANVIER. Владелец: Universite Cote dAzur. Дата публикации: 2023-02-23.

Use of alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex i deficiencies

Номер патента: US20230310348A1. Автор: Stéphane Azoulay,Vincent Procaccio,Carole SELLEM,Agnès DELAHODDE,Aurélie RENAUD,Déborah TRIBOUILLARD-TANVIER. Владелец: Universite Cote dAzur. Дата публикации: 2023-10-05.

Use of a polyamine-poor composition for the production of a medical human food

Номер патента: CA2533690C. Автор: Guy Simonnet,Jacques-Philippe Moulinoux. Владелец: Universite Victor Segalen Bordeaux 2. Дата публикации: 2013-06-11.

Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function

Номер патента: US6147112A. Автор: Jose Esteve-Soler. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2000-11-14.

Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse

Номер патента: EP1848448A1. Автор: Nataliya Dyachyk. Владелец: IFB Srl. Дата публикации: 2007-10-31.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20230255951A1. Автор: John D. Minna,Amit Das,Maithili P. DALVI,Elisabeth D. MARTINEZ,Juan BAYO-FINA. Владелец: University of Texas System. Дата публикации: 2023-08-17.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20190151296A1. Автор: Amit Das,John D Minna,Juan BAYO-FINA,Maithili P DALVI,Elisabeth D MARTINEZ. Владелец: University of Texas System. Дата публикации: 2019-05-23.

Use of c1 inhibitor for the prevention of ischemia-reperfusion injury

Номер патента: WO2007073186A3. Автор: Frank Pieper,Maurice Mannesse,Johannes Henricus Nuijens,Gijsbertus Johannes Ziere,Simoni Maria Grazia De. Владелец: Simoni Maria Grazia De. Дата публикации: 2007-08-09.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: US20240207302A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Individual. Дата публикации: 2024-06-27.

Dosage form for intra-articular injection comprising colchicine and an anesthesic agent in the treatment of crystal-and non-crystal associated acute inflammatory arthritis

Номер патента: EP4406531A1. Автор: designation of the inventor has not yet been filed The. Владелец: Pk Med Sas. Дата публикации: 2024-07-31.

Use of dpiv and apn inhibitors for the treatment of dermatalogical diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts

Номер патента: US20070042938A1. Автор: Siegfried Ansorge,Klaus Neubert,Robert Vetter,Burkhart Schraven,Uwe Lendeckel,Dirk Reinhold,Harald Gollnick,Jürgen FAUST,Anja Thielitz. Владелец: INSTITUTE fur MEDIZINTECHONOLOGIE MAGDEBUR IMTM GmbH. Дата публикации: 2007-02-22.

USE OF OPIOIDS OR OPIOID MIMETICS FOR THE TREATMENT OF PATIENTS WITH SUSTAINABLE MALIGNANT TUMOR

Номер патента: RU2011107280A. Автор: Эрих МИЛТНЕР,Клаудиа ФРИЗЕН,Андреас АЛЬТ,Эрих МИЛТНЕР (DE),Клаудиа ФРИЗЕН (DE),Андреас АЛЬТ (DE). Владелец: Универзитет Ульм (De). Дата публикации: 2012-09-10.

Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders

Номер патента: CA2448025C. Автор: Norbert Mueller. Владелец: Individual. Дата публикации: 2011-07-05.

Uses of DPP IV inhibitors

Номер патента: US11291668B2. Автор: Michael Mark,Frank Himmelsbach,Klaus Dugi. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2022-04-05.

Use of anti-her2 antibody-drug conjugate in the treatment of urothelial carcinoma

Номер патента: RU2750817C1. Автор: Цзяньминь ФАН. Владелец: Ремеджен, Лтд. Дата публикации: 2021-07-05.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: WO2018000057A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio De Mesquita Filho. Дата публикации: 2018-01-04.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: EP4314001A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Individual. Дата публикации: 2024-02-07.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: WO2022204770A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Souza Thiago Moreno Lopes E. Дата публикации: 2022-10-06.

Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2

Номер патента: CA2428176C. Автор: Alberto Mantovani,Marco Presta,Marco Rusnati,Barbara Bottazzi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2013-02-05.

Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome

Номер патента: US6599927B2. Автор: Jan Trofast,Per Lindberg,Joan Piñas-Massó,Jordi Serra-Carreras. Владелец: AstraZeneca AB. Дата публикации: 2003-07-29.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression

Номер патента: WO2007095606A1. Автор: Virginia L. Smith-Swintosky. Владелец: Janssen Pharmaceutica, N.V.. Дата публикации: 2007-08-23.

Dosage form for intra-articular injection comprising colchicine and an anesthesic agent in the treatment of crystal-and non-crystal associated acute inflammatory arthritis

Номер патента: EP4360619A1. Автор: designation of the inventor has not yet been filed The. Владелец: Pk Med Sas. Дата публикации: 2024-05-01.

Dosage form for intra-articular injection comprising colchicine and an anesthesic agent in the treatment of crystal-and non-crystal associated acute inflammatory arthritis

Номер патента: WO2024089046A1. Автор: Philippe Pouletty,Gauthier Pouliquen,Charles Sanson,Farah Marzouki. Владелец: Pk Med. Дата публикации: 2024-05-02.

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

Номер патента: CA2235350A1. Автор: Rima Kaddurah-Daouk,Ghaleb Daouk,M. Flint Beal. Владелец: Library Pharma, Inc.. Дата публикации: 1996-05-17.

USE OF PROLACTINE MODULATORS AND DIET FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF FATIBLE ADJUSTMENT

Номер патента: DE69534084D1. Автор: H Meier,H Cincotta. Владелец: Pliva dd. Дата публикации: 2005-04-21.

USE OF PROLACTINAL MODULATORS AND DIET FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF FAT ADJUSTMENT

Номер патента: DE69534084T2. Автор: H. Anthony CINCOTTA,H. Albert MEIER. Владелец: Pliva dd. Дата публикации: 2006-02-09.

The use of a h3r inverse agonist for the treatment of shift work disorder

Номер патента: CA3059131A1. Автор: Donald Johns,Judit SOVAGO,Klaus KUCHER. Владелец: NOVARTIS AG. Дата публикации: 2018-10-25.

Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease

Номер патента: US20130338165A1. Автор: David A. Baker,Michael NEARY,Daniel G. Lawton,Chad Beyer. Владелец: Promentis Pharmaceuticals Inc. Дата публикации: 2013-12-19.

Use of eribulin and histone deacetylase inhibitors in the treatment of cancer

Номер патента: WO2018016563A1. Автор: Bruce A. Littlefield,Gary HENDLER. Владелец: Eisai R&D Management Co., Ltd.. Дата публикации: 2018-01-25.

Use of eribulin and histone deacetylase inhibitors in the treatment of cancer

Номер патента: EP3487492A1. Автор: Bruce A. Littlefield,Gary HENDLER. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2019-05-29.

Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease

Номер патента: US20130338165A1. Автор: Baker David A.,Neary Michael,Lawton Daniel G.,Beyer Chad. Владелец: . Дата публикации: 2013-12-19.

USE OF A HISTONE DEACETYLASE INHIBITOR FOR THE TREATMENT OF MUSCLE DYSTROPHIES

Номер патента: FR2847817B1. Автор: La Porte Sabine De,Maurice Israel,Vincent Voisin,Hafedh Haddad. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2006-11-10.

USE OF (2S) -2-AMINOPENTANEDIOIC ACID FOR THE TREATMENT OF SEBORRHEA

Номер патента: FR2996127B1. Автор: Nathalie Castex-Rizzi,Corinne Dechelette,Laetitia Bonzom. Владелец: Pierre Fabre Dermo Cosmetique SA. Дата публикации: 2015-07-24.

USE OF A HISTONE DEACETYLASE INHIBITOR FOR THE TREATMENT OF MUSCULAR DYSTROPHIA

Номер патента: FR2847817A1. Автор: La Porte Sabine De,Maurice Israel,Vincent Voisin,Hafedh Haddad. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2004-06-04.

Use of isoxazole and crotonamide derivatives for the modulation of apoptosis

Номер патента: CA2212207C. Автор: Stefan Müllner,Claudia Dax. Владелец: Hoechst AG. Дата публикации: 2008-12-30.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: US20190160085A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio de Mesquita Filho UNESP. Дата публикации: 2019-05-30.

Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis

Номер патента: CA2912453A1. Автор: Franck Mouthon,Matthieu Charveriat. Владелец: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA. Дата публикации: 2014-11-20.

Novel aminothiol reduction of ischemia-reperfusion-induced cell death

Номер патента: CA3092596C. Автор: William E. Fahl,Ningfeng LI. Владелец: Obvia Pharmaceuticals Ltd. Дата публикации: 2024-05-21.

Use of AMPK Inducers and Metformin for the Treatment of Fibromyalgia

Номер патента: US20150272911A1. Автор: Mario David Cordero Morales,Pedro BULLÓN FERNÁNDEZ,Elisabet ALCOCER GÓMEZ. Владелец: Universidad de Sevilla. Дата публикации: 2015-10-01.

Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Номер патента: EP1594456A1. Автор: Alfred Marchal. Владелец: Auriga International SA. Дата публикации: 2005-11-16.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: CA2353553C. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2011-05-17.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: AU766216B2. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2003-10-09.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: AU766216C. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2004-11-11.

Method for the treatment of cerebral ischaemia and use of erythropodietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: NZ541591A. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Christoph Gleiter. Дата публикации: 2007-08-31.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder

Номер патента: WO2007095609A2. Автор: Virginia L. Smith-Swintosky. Владелец: Janssen Pharmaceutica, N.V.. Дата публикации: 2007-08-23.

The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders

Номер патента: CA2251197C. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 2004-07-27.

Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence

Номер патента: US5610174A. Автор: Charles Gluchowski,Carlos C. Forray,Theresa A. Branchek,Douglas A. Craig. Владелец: Synaptic Pharmaceutical Corp. Дата публикации: 1997-03-11.

Topical use of valproic acid for the prevention or treatment of skin disorders

Номер патента: EP2039355A2. Автор: Pier Giuseppe Pelicci,Donatella Paolino,Sergio Chimenti,Antonio Costanzo,Steven Paul Department of Dermatology Nistico,Saverio Minucci. Владелец: Topotarget Germany Ag. Дата публикации: 2009-03-25.

Use of glepp-1 inhibitor for the manufacture of a medicament for treatment of an autoimmune and/or inflammatory disorder

Номер патента: IL188735A. Автор: Catherine Jorand-Lebrun,Agnès Bombrun,Rob Hooft Van Huijsduijnen,Pierre-Alain Vitte,Patrick Gerber. Владелец: Patrick Gerber. Дата публикации: 2012-07-31.

Method for the treatment of heart disease in mammals

Номер патента: AU2018253371B2. Автор: Jerome Guyonnet,Estelle Ayme-Dietrich,Roland Lawson,Luc Maroteaux,Laurent Monassier. Владелец: Ceva Sante Animale SA. Дата публикации: 2023-10-19.

Phytochemical-antibiotic combination for the treatment of a bacterial infection

Номер патента: US20210060049A1. Автор: Jian Yang,Meena Kishor Sakharkar. Владелец: UNIVERSITY OF SASKATCHEWAN. Дата публикации: 2021-03-04.

Compositions for the prevention and treatment of acute renal injury

Номер патента: US20210330649A1. Автор: Lars Otto Uttenthal. Владелец: Aki Therapeutics Aps. Дата публикации: 2021-10-28.

Compositions for the prevention and treatment of acute renal injury

Номер патента: EP3641798A1. Автор: Lars Otto Uttenthal. Владелец: Aki Therapeutics Aps. Дата публикации: 2020-04-29.

Methods and systems for use of photolyzable nitric oxide donors

Номер патента: US8980332B2. Автор: Roderick A. Hyde,Muriel Y. Ishikawa,Lowell L. Wood, JR.. Владелец: Invention Science Fund I LLC. Дата публикации: 2015-03-17.

THE USE OF A H3R INVERSE AGONIST FOR THE TREATMENT OF SHIFT WORK DISORDER

Номер патента: US20200121679A1. Автор: Johns Donald,KUCHER Klaus,SOVAGO Judit. Владелец: . Дата публикации: 2020-04-23.

Use of aminoguanidine or aminoguanidine analogs for the treatment of diseases of the nervous system

Номер патента: US20030018082A1. Автор: Rima Kaddurah-Daouk. Владелец: Rima Kaddurah-Daouk. Дата публикации: 2003-01-23.

The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions

Номер патента: CA2515424A1. Автор: Michael A. Zeligs. Владелец: Individual. Дата публикации: 2004-08-26.

Methods of treating and preventing coronavirus infection and disrupting coronavirus replication

Номер патента: WO2022023960A1. Автор: Horacio Emilio PÉREZ-SÁNCHEZ,José Pedro CERÓN-CARRASCO,Jorge DE LA PEÑA GARCÍA,Alfonso PÉREZ-GARRIDO,Antonio Jesús BANEGAS LUNA. Владелец: Fundación Universitaria San Antonio (Ucam). Дата публикации: 2022-02-03.

Use of an acetylsalicylic acid salt for the treatment of viral infections

Номер патента: DE102008004386A1. Автор: Gerhard Dr. Scheuch,Stephan Prof. Dr. Ludwig,Oliver Dr. Planz. Владелец: ACTIVAERO GMBH. Дата публикации: 2009-07-23.

Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases

Номер патента: WO2008020032A1. Автор: Pedro CUEVAS SÁNCHEZ,Guillermo GIMÉNEZ GALLEGO,Iñigo SÁENZ DE TEJADA GORMAN,Javier Angulo Frutos,Serafín VALVERDE LÓPEZ,Antonio Romero Garrido,Rosa María LOZANO PUERTO. Владелец: Action Medicines, S.L.. Дата публикации: 2008-02-21.

Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain

Номер патента: PT2054045E. Автор: Pedro CUEVAS SÁNCHEZ,Guillermo GIMÉNEZ GALLEGO,Iñigo SÁENZ DE TEJADA GORMAN,Javier Angulo Frutos,Antonio Romero Garrido,Rosa María LOZANO PUERTO. Владелец: Action Medicines SL. Дата публикации: 2011-08-31.

USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF DIABETES COMPLICATIONS

Номер патента: FR2956976B1. Автор: Iliev Ilian PETROV,Piero RUGGENENTI,Giuseppe Remuzzi,Bruno Pietro Imbimbo,Giuseppe Lauria. Владелец: Chiesi Farmaceutici SpA. Дата публикации: 2012-08-17.

USE OF ALKALINE EARTH METAL SALT FOR THE TREATMENT OF PRURITUS AND EYE OR PALPEBRAL DYSESTHESIA

Номер патента: FR2732598B1. Автор: Lionel Breton,Lacharriere Olivier De. Владелец: LOreal SA. Дата публикации: 1997-05-09.

USE OF ALKALINE EARTH METAL SALT FOR THE TREATMENT OF PRURITUS AND EYE OR PALPEBRAL DYSESTHESIA

Номер патента: FR2732598A1. Автор: Lionel Breton,Lacharriere Olivier De. Владелец: LOreal SA. Дата публикации: 1996-10-11.

Use of an acetylsalicylic acid salt for the treatment of viral infections

Номер патента: EP2249866B1. Автор: Gerhard Scheuch,Oliver Planz,Stephan Ludwig. Владелец: ACTIVAERO GMBH. Дата публикации: 2012-08-15.

Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases

Номер патента: WO2008020032A8. Автор: Sànchez Pedro Cuevas,Gallego Guillermo Gimenez,Frutos Javier Angulo,Lopez Serafin Valverde,Garrido Antonio Romero,De Tejada Gorman Inigo Saenz,Puerto Rosa Maria Lozano. Владелец: Puerto Rosa Maria Lozano. Дата публикации: 2008-04-17.

Use of tri-substituted glycerol compounds for the treatment of hematological malignancies

Номер патента: EP2117555A1. Автор: Wolfgang Richter,Lutz Weber,Axel Rolf Zander,Francis Ayuk Ayuketang. Владелец: Universitatsklinikum Hamburg Eppendorf. Дата публикации: 2009-11-18.

Combination therapy for the treatment of ischemia-reperfusion injury

Номер патента: CA2920735A1. Автор: D. Travis Wilson. Владелец: Stealth Biotherapeutics Corp. Дата публикации: 2015-02-19.

Use of a drug with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject

Номер патента: CN116211871A. Автор: 塔玛拉·弗拉贝克. Владелец: Ta MalaFulabeike. Дата публикации: 2023-06-06.

Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension

Номер патента: CA2741706A1. Автор: Eva-Maria Becker,Stefan Schaefer,Hubert Truebel,Katja Schaefer,Juergen Kohlmeyer. Владелец: Bayer Schering Pharma AG. Дата публикации: 2010-05-06.

Use of cabergoline in the treatment of restless legs syndrome

Номер патента: US6114326A. Автор: Peter Schueler. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2000-09-05.

Use of p38 inhibitors for the treatment of smoke inhalation

Номер патента: WO2002032862A3. Автор: Don E Griswold,David C Underwood. Владелец: David C Underwood. Дата публикации: 2002-08-22.

METHODS FOR INHIBITION OF BNIP3 AND PREVENTION AND TREATMENT OF ISCHEMIA REPERFUSION INJURY BY TETRA-O-METHYL NORDIHYDROGUAIARETIC ACID

Номер патента: US20150209304A1. Автор: Kimura Kotohiko,Huang Ru Chih. Владелец: . Дата публикации: 2015-07-30.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Номер патента: AU8106794A. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: SmithKline Beecham Ltd. Дата публикации: 1995-05-29.

Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Номер патента: AU6739690A. Автор: Ernest Marshall,Helga Stolze,R. Douglas Thornes,Kurt ZÄNKER. Владелец: Schaper und Bruemmer GmbH and Co KG. Дата публикации: 1991-06-26.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: ZA202304512B. Автор: Erwan BEAUCHAMP,Luc G Berthiaume. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-01-31.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: US20240350481A1. Автор: Luc G. Berthiaume,Erwan BEAUCHAMP. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-10-24.

Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.

Номер патента: MY111755A. Автор: Gianni Luca,Merlini Giampaolo. Владелец: Istituto Naz Per Lo Studio E La Cura Dei. Дата публикации: 2000-12-30.

Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract

Номер патента: WO2001010423A3. Автор: Wolfgang Mueller,Lothar Faerber,Christian Stratz. Владелец: Christian Stratz. Дата публикации: 2001-09-07.

Use of 10-hydroxy-2-decenoic acid in the treatment of autism spectrum disorders

Номер патента: CA2951288C. Автор: Steve Cheung,Wah Chin BOON. Владелец: Individual. Дата публикации: 2024-01-02.

Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions

Номер патента: WO2010127878A2. Автор: Armin Schneider,Rico Laage,Anja Moraru,Carola Krüger. Владелец: SYGNIS BIOSCIENCE GmbH & Co. KG. Дата публикации: 2010-11-11.

Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions

Номер патента: WO2006030322A3. Автор: Edwin A Kroeger. Владелец: Edwin A Kroeger. Дата публикации: 2006-06-29.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Номер патента: CA2176392C. Автор: Richard Anthony Vere Hodge. Владелец: SmithKline Beecham Ltd. Дата публикации: 2005-11-08.

Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors

Номер патента: CA2624795A1. Автор: Wei Zheng,Philip E. Brandish,Andrew Pike,Alister Campbell,Nicholas Brandon,Timothy Sparey. Владелец: Individual. Дата публикации: 2007-04-12.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Номер патента: WO1995013073A1. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: Smithkline Beecham Plc. Дата публикации: 1995-05-18.

Use of a transition metal complex for the treatment of septic shock

Номер патента: CA2162154A1. Автор: Wieslaw Mieczyslaw Kazmierski,Luis Molina. Владелец: Molichem Medicines, Inc.. Дата публикации: 1994-11-24.

The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders

Номер патента: CA2965895C. Автор: Azmi NASSER,Christian Heidbreder,Celine M. Laffont. Владелец: Indivior UK Ltd. Дата публикации: 2019-08-06.

Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome

Номер патента: CA2675442A1. Автор: Thomas Klabunde,Andreas Herling,Hubert Heuer,Siegfried Stengelin,Dieter Kadereit,Matthias Urmann,Harm Brummerhop,Susanne Kilp. Владелец: Susanne Kilp. Дата публикации: 2008-07-24.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: EP4232032A1. Автор: Luc G. Berthiaume,Erwan BEAUCHAMP. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2023-08-30.

Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis

Номер патента: WO2008087461A3. Автор: MIHALY Boros,Istvan Szatmari,Ferenc Fueloep,Laszlo Vecsei,Jozsef Kaszaki,Jozsef Toldi. Владелец: Jozsef Toldi. Дата публикации: 2008-09-18.

Use of 13-cis retinoic acid for the treatment of emphysema

Номер патента: EP1307187A2. Автор: Paula Nanette Belloni. Владелец: F Hoffmann La Roche AG. Дата публикации: 2003-05-07.

Use of 13-cis retinoic acid for the treatment of emphysema

Номер патента: WO2002009679A2. Автор: Paula Nanette Belloni. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2002-02-07.

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin

Номер патента: EP1755604A2. Автор: Helmut Schmidhammer. Владелец: AlcaSynn Pharmaceuticals GmbH. Дата публикации: 2007-02-28.

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin

Номер патента: CA2566398A1. Автор: Helmut Schmidhammer. Владелец: Individual. Дата публикации: 2005-11-17.

Use of histamine h2 mimicking substances for the treatment of multiple sclerosis

Номер патента: WO2000000184A8. Автор: Elaine A Delack. Владелец: Elaine A Delack. Дата публикации: 2001-06-07.

Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system

Номер патента: US20030087917A1. Автор: Liliane Unger,Gerhard Gross,Hans-Jurgen Teschendorf,Hans-Jorg Treiber,Dorothea Strack. Владелец: Individual. Дата публикации: 2003-05-08.

Use of a derivative of imidazole for the treatment of leukotriene related disorders

Номер патента: WO2007028524A2. Автор: Josep Prous Blancafort. Владелец: Prous Institute For Biomedical Research S.A.. Дата публикации: 2007-03-15.

Use of a derivative of imidazole for the treatment of leukotriene related disorders

Номер патента: WO2007028524A3. Автор: Blancafort Josep Prous. Владелец: Prous Inst For Biomedical Res. Дата публикации: 2007-05-31.

Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder

Номер патента: EP1126846B1. Автор: Arvid Carlsson,Maria Carlsson. Владелец: A Carlsson Research AB. Дата публикации: 2003-08-06.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097C. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2007-11-27.

Use of tri-substituted glycerol compounds for the treatment of radiation injuries

Номер патента: CA2668923C. Автор: Wolfgang Richter,Lutz Weber. Владелец: Radioprotect Alphaptose Ug (haftungsbeschraenkt) & Co KG. Дата публикации: 2015-01-13.

USE OF 4,9-ANHYDRO-TETRODOTOXIN FOR THE TREATMENT OF DISEASES RELATED TO THE VOLTAGE-GATED SODIUM CHANNEL α SUBUNIT NAV 1.6

Номер патента: WO2007110220A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Wolfgang Screibmayer. Владелец: Wex Pharmaceuticals Inc.. Дата публикации: 2007-10-04.

Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

Номер патента: CA2544332C. Автор: Linda Greensmith,Geoffrey Burnstock,Rudolf Urbanics. Владелец: Orphazyme AS. Дата публикации: 2014-09-23.

Use of a vitamin d3 analogue for the treatment of autoimmune diabetes

Номер патента: AU2002314056A1. Автор: Milan Radoje Uskokovic,Luciano Adorini,Silvia Gregori,Nadia Giarratana,Simona Smiroldo. Владелец: Bioxell SpA. Дата публикации: 2002-12-03.

Use of a vitamin d3 analogue for the treatment of autoimmune diabetes

Номер патента: EP1392323A2. Автор: Milan Radoje Uskokovic,Luciano Adorini,Silvia Gregori,Nadia Giarratana,Simona Smiroldo. Владелец: Bioxell SpA. Дата публикации: 2004-03-03.

Use of 5-ht7 receptor agonists for the treatment of pain

Номер патента: EP2049090A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Antonio Torrens-Jover,Luz Romero-Alonso. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2009-04-22.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prevention of cerebral degenerative disorders

Номер патента: US5827873A. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Novo Nordisk AS. Дата публикации: 1998-10-27.

Use of 5-ht7 receptor agonists for the treatment of pain

Номер патента: US20090326014A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Antonio Torrens-Jover,Luz Romero-Alonso. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2009-12-31.

Use of Inhibitors of Steroid Activity for the Treatment of Substance Related Disorders

Номер патента: US20080167282A1. Автор: Giuseppe La Pera. Владелец: Individual. Дата публикации: 2008-07-10.

Use of rapamycin and rapamycin derivatives for the treatment of bone loss

Номер патента: CA2531454C. Автор: Michaela Kneissel,Mira Susa Spring. Владелец: NOVARTIS AG. Дата публикации: 2011-10-25.

Use of an alkanoyl-L-carnitine for the treatment of glutamate mediated diseases

Номер патента: US6037372A. Автор: Sonia Moretti. Владелец: Mendes Srl. Дата публикации: 2000-03-14.

The use of halofuginone and related compounds for the treatment of urethral stricture by local administration

Номер патента: CA2384331C. Автор: Israel Vlodavsky,Arnon Nagler,Mark Pines. Владелец: Agricultural Research Organization of Israel Ministry of Agriculture . Дата публикации: 2008-10-14.

Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders

Номер патента: CA2188228C. Автор: Wilfried Schwab,Jorg Czech,Klaus Boslett. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2008-08-12.

Use of carbohydrates and compositions thereof for the treatment or prevention of diseases caused by imbalanced colon fermentation

Номер патента: CA2499665C. Автор: Juha Apajalahti,Nina Rautonen,Anu Kettunen,Osmo Siikanen. Владелец: Danisco AS. Дата публикации: 2012-02-28.

Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders

Номер патента: US6020372A. Автор: Wilfried Schwab,Jorg Czech,Klaus Boslett. Владелец: Hoechst AG. Дата публикации: 2000-02-01.

Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis

Номер патента: AU687432B2. Автор: Luca Gianni,Giampaolo Merlini. Владелец: POLICLINICO SAN MATTEO ISTITUT. Дата публикации: 1998-02-26.

Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas

Номер патента: NZ571119A. Автор: Bernhard Keppler. Владелец: Niiki Pharma Inc. Дата публикации: 2011-11-25.

Use of an NK-3 receptor antagonist in the treatment of conditions characterised by altered bowel function and/or visceral pain

Номер патента: NZ529462A. Автор: Douglas William Pierre Hay,Gareth John Sanger,Tadataka Yamada. Владелец: SmithKline Beecham Corp. Дата публикации: 2005-07-29.

Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions

Номер патента: WO2010127878A3. Автор: Armin Schneider,Rico Laage,Anja Moraru,Carola Krüger. Владелец: SYGNIS BIOSCIENCE GmbH & Co. KG. Дата публикации: 2011-02-03.

Use of senicapoc for treatment of stroke

Номер патента: EP3573609A1. Автор: Thomas Moller,Roland G. W. STAAL,Jonathan R. WEINSTEIN. Владелец: Staal Roland GW. Дата публикации: 2019-12-04.

Use of senicapoc for treatment of stroke

Номер патента: WO2018140965A1. Автор: Thomas Moller,Roland G. W. STAAL,Jonathan R. WEINSTEIN. Владелец: Paracelsus Neuroscience Llc. Дата публикации: 2018-08-02.

Use of senicapoc for treatment of stroke

Номер патента: US20200000749A1. Автор: Thomas Moller,Roland STAAL,Jonathan Weinstein. Владелец: Paracelsus Neuroscience Ii LLC. Дата публикации: 2020-01-02.

Use of nad information inhibitors for the treatment of ischemia-reperfusion injury

Номер патента: WO2009109610A1. Автор: Oberdan Leo,Thibaut De Smedt,Frederic Van Gool,Mara Galli,Véronique Flamand,Patrizia Loi. Владелец: Topotarget Switzerland S.A.. Дата публикации: 2009-09-11.

Anethole trithione administration regimen for the prevention or treatment of ischemia-reperfusion injuries

Номер патента: EP4259124A1. Автор: Bruno Le Grand. Владелец: Individual. Дата публикации: 2023-10-18.

Anethole trithione administration regimen for the prevention or treatment of ischemia-reperfusion injuries

Номер патента: US20240050402A1. Автор: Bruno Le Grand. Владелец: Individual. Дата публикации: 2024-02-15.

Use of thiamphenicol for the preparation of pharmaceutical compositions useful in the treatment of vancomycin-intermediates and multiresistant staphylococci

Номер патента: US20020183246A1. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon Group SpA. Дата публикации: 2002-12-05.

Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections

Номер патента: WO2001060344A2. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon Group S.P.A.. Дата публикации: 2001-08-23.

Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections

Номер патента: EP1207871A2. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon SpA. Дата публикации: 2002-05-29.

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ISCHEMIA REPERFUSION INJURY AND INFECTION

Номер патента: US20220401453A1. Автор: CASELLA Daniel. Владелец: . Дата публикации: 2022-12-22.

Use of pinanylsulfide with methyl mercaptoacetate fragment - methyl 2-({[(1s,2r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]methyl}thio) acetate, as an agent with inhibitory effect on platelet activation

Номер патента: RU2671567C2. Автор: Сергей Васильевич Киселёв,Лилия Евгеньевна Никитина,Валерия Андреевна Старцева,Рамиль Габдельхакович Тураев,Елена Евгеньевна Бельская,Адэля Анваровна Рахматуллина. Владелец: Рухматуллина Адэля Анваровна. Дата публикации: 2018-11-02.

Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors

Номер патента: NZ502201A. Автор: Paul Norman Jenner. Владелец: Smithkline Beecham P. Дата публикации: 2001-12-21.

Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma

Номер патента: CA2596618C. Автор: Hans-Rainer Hoffmann,Rudolf Matusch,Aria Baniahmad. Владелец: LTS Lohmann Therapie Systeme AG. Дата публикации: 2013-05-07.

Use of thiamphenicol for the treatment of chlamydia pneumoniae infections

Номер патента: WO2001076585A3. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Maria Rita Gismondo. Дата публикации: 2002-03-28.

Use of thiamphenicol for the treatment of chlamydia pneumoniae infections

Номер патента: WO2001076585A2. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon Group S.P.A.. Дата публикации: 2001-10-18.

Use of thiamphenicol for thetreatment of chlamydia pneumoniae infections

Номер патента: EP1212049A2. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon SpA. Дата публикации: 2002-06-12.

Use of thiamphenicol for thetreatment of chlamydia pneumoniae infections

Номер патента: EP1212049B1. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon SpA. Дата публикации: 2005-07-06.

Use of ifenprodil and diastereoisomers thereof for the preparation of medicines useful in the treatment of pheripheral neuropathies and central neurodegenerative diseases

Номер патента: CA2154906A1. Автор: Badia Ferzaz,Jesus Benavides,Pascal George,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-01-30.

USE OF IFENPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES AND CENTRAL NEURODEGENERATIVE DISEASES

Номер патента: FR2722989A1. Автор: Badia Ferzaz,Jesus Benavides,Pascal George,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-02-02.

USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR THE PRODUCTION OF MEDICAMENTS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME

Номер патента: MA29131B1. Автор: Hubert Heuer,Siegfried Stengelin,Dieter Kadereit,Harm Brummerhop. Владелец: Sanofi Aventis Deutschland. Дата публикации: 2008-01-02.

The use of AICA riboside and ribavirin for the preparation of a medicament for the treatment of allergies

Номер патента: EP0623348A1. Автор: Harry Edward Gruber. Владелец: GRUBER, Harry, Edward. Дата публикации: 1994-11-09.

A combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders

Номер патента: EP4319731A1. Автор: Alon Chen,Juan Pablo Lopez. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2024-02-14.

Combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders

Номер патента: US20240065988A1. Автор: Alon Chen,Juan Pablo Lopez. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2024-02-29.

Use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain

Номер патента: EP1809268A1. Автор: Luiz F. Pianowski,Joao B. Calixto,Dagoberto de C. BRANDÃO. Владелец: Ach Laborat Rios Farmac Uticos SA. Дата публикации: 2007-07-25.

USE OF GUANABENZ AND ITS DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF MUCOVISCIDOSIS AND DISEASES ASSOCIATED WITH A DEFECT OF ADDRESSING PROTEINS IN CELLS

Номер патента: FR2893844B1. Автор: Frederic Becq,Marc Blondel,Deborah Tribouillard. Владелец: Universite De Poitiers. Дата публикации: 2008-02-01.

Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Номер патента: HK1060855A1. Автор: Volker Brinkmann,Marc Bigaud,Tomasz Sablinski. Владелец: NOVARTIS AG. Дата публикации: 2004-08-27.

The use of carotenoids for producing drugs for the treatment of dermatoses

Номер патента: CA2210957A1. Автор: Karl Kolter,Wolfgang Schmutzler. Владелец: Individual. Дата публикации: 1996-08-08.

Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions

Номер патента: NO20021909L. Автор: Andreas Weichert,Udo Albus,Hans-Willi Jansen. Владелец: Aventis Pharma Gmbh. Дата публикации: 2002-04-23.

USE OF GUANABENZ OR DERIVATES THEREOF FOR THE TREATMENT OF TYPE I IFN-DEPENDENT PATHOLOGIES

Номер патента: US20210177814A1. Автор: Pierre Philippe,PEREGO Jessica,GATTI Evelina. Владелец: . Дата публикации: 2021-06-17.

USE OF TIANEPTINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF NEURODEGENERESCENCE CONDITIONS

Номер патента: FR2791891A1. Автор: Michael Spedding,Antoine Deslandes. Владелец: ADIR SARL. Дата публикации: 2000-10-13.

Use of 2-phenylene diamine derivatives for the treatment of infections

Номер патента: WO2001062709A3. Автор: Hassan Jomaa,Jochen Wiesner,Martin Schlitzer. Владелец: Martin Schlitzer. Дата публикации: 2002-04-18.

Use of 2-Methylamino-2-Phenylcyclohexanone for the Treatment of Bacterial, Fungal, Virus or Protozoan Infections as Well as for Immunomodulation

Номер патента: CA2138447A1. Автор: Ákos Tatár,Detlef Preiss. Владелец: Detlef Preiss. Дата публикации: 1995-09-16.

Pre-treatment of msc with pparb/delta agonist for treatment of ischemia-reperfusion injury

Номер патента: US20240091267A1. Автор: Christian Jorgensen,Farida DJOUAD SAMRI,Stéphanie BARRERE-LEMAIRE. Владелец: Centre Hospitalier Universitaire de Montpellier CHUM. Дата публикации: 2024-03-21.

Pre-treatment of msc with pparbeta/delta agonist for treatment of ischemia-reperfusion injury

Номер патента: EP4263806A1. Автор: Christian Jorgensen,Farida DJOUAD SAMRI,Stéphanie BARRERE-LEMAIRE. Владелец: Centre Hospitalier Universitaire de Montpellier CHUM. Дата публикации: 2023-10-25.

Pre-treatment of msc with pparb/.delta. agonist for treatment of ischemia-reperfusion injury

Номер патента: CA3201966A1. Автор: Christian Jorgensen,Farida DJOUAD SAMRI,Stéphanie BARRERE-LEMAIRE. Владелец: Centre Hospitalier Universitaire de Montpellier CHUM. Дата публикации: 2022-06-23.

Compounds for the treatment of ischemia-reperfusion-related diseases

Номер патента: US9932352B2. Автор: Antonio Guarna,Federico Cozzolino. Владелец: Minerva Patent SA. Дата публикации: 2018-04-03.

Use of an estrogen agonist/antagonist for treating female sexual dysfunction

Номер патента: EP1149579A3. Автор: Andrew George Pfizer Global Lee,David Duane Pfizer Global Thompson,Wesley Warren Pfizer Global Day. Владелец: Pfizer Products Inc. Дата публикации: 2003-06-04.

Use of Medications with Neuroprotective Properties to Prevent or Reduce the Risk of Ischemia-Reperfusion Injury in a Subject

Номер патента: US20170100410A1. Автор: Vrabec Tamara. Владелец: . Дата публикации: 2017-04-13.

Use of Medications with Neuroprotective Properties to Prevent or Reduce the Risk of Ischemia-Reperfusion Injury in a Subject

Номер патента: US20190038636A1. Автор: Vrabec Tamara. Владелец: . Дата публикации: 2019-02-07.

Use of hif-1α stabilizing agents for the treatment of type i interferonopathies

Номер патента: WO2024165507A1. Автор: Mickaël MENAGER,Maxime BATIGNES. Владелец: Université Paris Cite. Дата публикации: 2024-08-15.

Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases

Номер патента: WO1996011005A3. Автор: Leon T Atlas. Владелец: Leon T Atlas. Дата публикации: 1996-05-30.

Use of selective progesterone receptor modulators for the treatment of androgen deficiency

Номер патента: EP1569655A1. Автор: Kristof Chwalisz. Владелец: Tap Pharmaceuticals Inc. Дата публикации: 2005-09-07.

Use of selective progesterone receptor modulators for the treatment of androgen deficiency

Номер патента: WO2004045620A1. Автор: Kristof Chwalisz. Владелец: Tap Pharmaceutical Products Inc.. Дата публикации: 2004-06-03.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: US20230000865A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2023-01-05.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: EP4065081A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2022-10-05.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: CA3158468A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: TORFS Koen. Дата публикации: 2021-06-03.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in Fontan-palliated patients

Номер патента: AU2020393489A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2022-07-14.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: WO2021105164A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2021-06-03.

Vitamin K2 compositions for the treatment of drug induced neuropathy

Номер патента: AU2018389092B2. Автор: Anselm De Souza,Dilip Mehta,Ashok Vaidya,Rama Vaidya,Yogesh Dound. Владелец: Synergia Life Sciences Pvt Ltd. Дата публикации: 2023-08-24.

USE OF JUMONJI C DEMETHYLASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF CHEMOTHERAPY RESISTANCE AND RADIORESISTANCE IN CANCER

Номер патента: US20190151296A1. Автор: Das Amit,DALVI Maithili P,MARTINEZ Elisabeth D,MINNA John D,BAYO-FINA Juan. Владелец: . Дата публикации: 2019-05-23.

Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders

Номер патента: CA2872216C. Автор: José Ignacio Andrés-Gil,Frederik Jan Rita Rombouts,Andrés Avelino Trabanco-Suárez,Greta Constantia Peter Vanhoof,Antonius Adrianus Hendrikus Petrus Megens,Xavier Jean Michel Langlois,Peter Jacobus Johannes Antonius Buijnsters,Meri De Angelis. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2021-07-20.

Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy

Номер патента: EP2753331A1. Автор: Donald Johns,Klaus KUCHER,George IMBERT. Владелец: NOVARTIS AG. Дата публикации: 2014-07-16.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: EP4310082A3. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-04-10.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: EP4310082A2. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-01-24.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: AU2022203515B2. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-02-22.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: AU2024203366A1. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-06-06.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: ZA202210004B. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-05-30.

Methods for the treatment of pancreatitis and prevention of pancreatic cancer

Номер патента: EP4153174A4. Автор: I-Lin Ho,Andrea Viale,Alessandro CARUGO,Poggetto Edoardo Del. Владелец: University of Texas System. Дата публикации: 2024-10-09.

Pharmaceutical composition containing a derivative of N-phenylpyrazole and permethrin, and use for the production of a topical veterinary medicament

Номер патента: AU2013368970A1. Автор: Bertrand Havrileck,Nathalie Delhom. Владелец: VIRBAC SA. Дата публикации: 2015-07-16.

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome

Номер патента: US11883385B2. Автор: George GARIBALDI. Владелец: Noema Pharma Ag. Дата публикации: 2024-01-30.

Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension

Номер патента: US5889052A. Автор: Verney L. Sallee,Paul W. Zinke,John E. Bishop,Peter G. Klimko. Владелец: Alcon Laboratories Inc. Дата публикации: 1999-03-30.

Use of selective progesterone receptor modulators for the treatment of androgen deficiency

Номер патента: CA2504250A1. Автор: Kristof Chwalisz. Владелец: Individual. Дата публикации: 2004-06-03.

Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2

Номер патента: HK1061209A1. Автор: Alberto Mantovani,Marco Presta,Marco Rusnati,Barbara Bottazzi. Владелец: Sigma Tau Ind Farmaceutche Riu. Дата публикации: 2004-09-10.

Use of a histamine H4 antagonist for the treatment of post-operative adhesions

Номер патента: US20130202685A1. Автор: Thurmond Robin L.,Wadsworrth Scott A.. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2013-08-08.

USE OF INHIBITORS OF PHOSPHOLIPASE A2 FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTION

Номер патента: US20130209403A1. Автор: BARTENSCHLAGER Ralf,PIETSCHMANN Thomas,Menzel Nicolas,Fischl Wolfgang. Владелец: . Дата публикации: 2013-08-15.

USE OF ARGININE VASOPRESSIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PROSTATE CANCER

Номер патента: US20160022635A1. Автор: Burnstein Kerry L.. Владелец: . Дата публикации: 2016-01-28.

USE OF TETRAHYDROINDAZOLYLBENZAMIDE AND TETRAHYDROINDOLYLBENZAMIDE DERIVATIVES FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)

Номер патента: US20160143884A1. Автор: Haynes Barton F.,Ferrari Guido,Haystead Timothy,Orlemans Everardus O.M.,Kwiek Jesse John. Владелец: . Дата публикации: 2016-05-26.

USE OF POLY-N-ACETYLGLUCOSAMINE NANOFIBERS FOR THE TREATMENT OF GINGIVAL RECESSION

Номер патента: US20210169922A1. Автор: Finkielsztein Sergio,Finkielsztein Marco. Владелец: Marine Polymer Technologies, Inc.. Дата публикации: 2021-06-10.

Use of a trpm8-activating substance for the treatment of tumours

Номер патента: WO2004054497A2. Автор: Thomas Plath,Matthias Reule,Simone Kaiser,Rosemarie Lichtner,Esmeralda Heiden Constanios-Velez. Владелец: Metagen Pharmaceuticals Gmbh. Дата публикации: 2004-07-01.

Use of arginine vasopressin receptor antagonists for the treatment of prostate cancer

Номер патента: US10231952B2. Автор: Kerry L. Burnstein. Владелец: UNIVERSITY OF MIAMI. Дата публикации: 2019-03-19.

Use of pegylated type iii interferons for the treatment of hepatitis c

Номер патента: CA2727026A1. Автор: Diana F. Hausman,Michael G. Dodds. Владелец: Zymogenetics LLC. Дата публикации: 2009-12-10.

USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR THE TREATMENT OF SEBORRHEA

Номер патента: FR2954124A1. Автор: Daniel Redoules,Corinne Dechelette. Владелец: Pierre Fabre Dermo Cosmetique SA. Дата публикации: 2011-06-24.

Use of 2,3-dihydroxypropyl dedkanot for the treatment of seborrheic dermatitis

Номер патента: MA33842B1. Автор: Daniel Redoules,Corinne Dechelette. Владелец: Fabre Pierre Dermo Cosmetique. Дата публикации: 2012-12-03.

Use of poly-n-acetylglucosamine nanofibers for the treatment of gingival recession

Номер патента: WO2019217796A1. Автор: Sergio Finkielsztein,Marco Finkielsztein. Владелец: Marine Polymer Technologies, Inc.. Дата публикации: 2019-11-14.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: WO2011101881A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-08-25.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: EP2536424A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore di Sanita ISS. Дата публикации: 2012-12-26.

Use of rho gtpase activating toxins for the treatment and/or prevention symptomatology associated with rett syndrome

Номер патента: WO2011101881A3. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-10-27.

Use of quercetin-3-o-glucoside for the treatment of flavivirus infections

Номер патента: WO2019185579A1. Автор: Philippe Despres,Chaker EL KALAMOUNI. Владелец: Universite de la Reunion Saint Denis. Дата публикации: 2019-10-03.

Use of human prostate cell lines for the treatment of prostate cancer

Номер патента: EP1137422B1. Автор: Angus George Onyvax Limited DALGLEISH,Peter Michael Onyvax Limited SMITH,Andrew Derek Onyvax Limited SUTTON,Anthony Ian Onyvax Limited WALKER. Владелец: Onyvax Ltd. Дата публикации: 2005-09-14.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: US20240301074A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: Boehringer Ingelheim Pharmaceuticals Inc. Дата публикации: 2024-09-12.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: WO2024187058A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-09-12.

Use of rhamnolipids in a composition for the treatment of signs of aging

Номер патента: CA2321926C. Автор: Goran Piljac,Tatjana Piljac. Владелец: Paradigm Biomedical Inc. Дата публикации: 2010-04-27.

Use of attenuated strains of parasites for the prevention or treatment of pathologies associated with an apicomplexan

Номер патента: US20150165008A1. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: VITAMFERO. Дата публикации: 2015-06-18.

Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan

Номер патента: US09585949B2. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: VITAMFERO. Дата публикации: 2017-03-07.

Use of umbilical vein endothelial cells for the treatment of lung injury

Номер патента: WO2024155791A1. Автор: John K. Fraser,Paul William FINNEGAN. Владелец: Angiocrine Bioscience, Inc.. Дата публикации: 2024-07-25.

Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin

Номер патента: US20080260667A1. Автор: Marcel Schnyder,Werner Baschong. Владелец: Individual. Дата публикации: 2008-10-23.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20110269801A1. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Individual. Дата публикации: 2011-11-03.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20100076031A1. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Individual. Дата публикации: 2010-03-25.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20110112150A2. Автор: Manfred Bohn,Karl Kraemer,Astrid Markus. Владелец: Individual. Дата публикации: 2011-05-12.

Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders

Номер патента: CA2595564C. Автор: In Geun Jo,Taehwan Kwak,Sang-Ku Yoo,Myunggyu Park. Владелец: KT&G Co Ltd. Дата публикации: 2015-03-31.

Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions

Номер патента: WO2009083768A3. Автор: Bruno Silvestrini,Michele Bonanomi. Владелец: Michele Bonanomi. Дата публикации: 2010-03-04.

Use of epidermal growth factor depleting agents in the treatment of the chronic obstructive pulmonary disease

Номер патента: ZA202302273B. Автор: Ramos Tania Crombet,MONZÓN KALET LEÓN,Mary Reid,Abraham Amparo Emilia Macias,Kelvin Lee,Hernandez Danay Saavedra,Morales Orestes Santos,Vinageras Elia Neninger,Alfonso Pedro Pablo Pino,Reyes Jenysbel De La Caridad Hernandez. Владелец: Ct Inmunologia Molecular. Дата публикации: 2024-05-30.

Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Номер патента: US09872876B2. Автор: Chris Vervaet,Enrico Bastianelli,Pierre Attali. Владелец: Bone Therapeutics SA. Дата публикации: 2018-01-23.

Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Номер патента: US09446065B2. Автор: Chris Vervaet,Enrico Bastianelli,Pierre Attali. Владелец: Bone Therapeutics SA. Дата публикации: 2016-09-20.

Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome

Номер патента: CA2339628C. Автор: Wolfgang Mueller,Lothar Farber,Thomas Stratz. Владелец: NOVARTIS AG. Дата публикации: 2008-06-03.

Use of a bis-peroxovanadium compound for the treatment of immunosuppressed patients

Номер патента: CA2389348A1. Автор: Michel J. Tremblay,Jean-Francois Fortin,Benoit Barbeau. Владелец: Individual. Дата публикации: 2001-05-03.

Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction

Номер патента: AU2003255646A1. Автор: Frederic Becq,Jean Michel Vierfond,Renaud Robert,Yvette Mettey,Michel Joffre,Cecile Marivingt-Mounir,Laurence Pignoux,Christian Rogier. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2003-12-22.

Use of cns penetrating anticancer compounds for the treatment of protozan diseases

Номер патента: CA2635825A1. Автор: Matthias Dormeyer. Владелец: Individual. Дата публикации: 2007-07-19.

Use of cns penetrating anticancer compounds for the treatment of protozan diseases

Номер патента: EP1971335A2. Автор: Matthias Dormeyer. Владелец: Individual. Дата публикации: 2008-09-24.

Use of bartonella quintana derived lipopolysaccharide for the treatment of autoimmune, autoinflammatory or infectious diseases

Номер патента: WO2008095679A1. Автор: Leonardus Antonius Bernardus Joosten,Mihai Gheorghe Netea,Johannes Willem Maarten van der Meer,Wilhelmus Bernard Van Den Berg,Bart-Julian Kullberg. Владелец: Stichting Katholieke Universiteit. Дата публикации: 2008-08-14.

Use of attenuated strains of toxoplasma for the prevention or treatment of cryptosporidiosis

Номер патента: NZ705406A. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: Univ Francois Rabelais De Tours. Дата публикации: 2017-11-24.

Use of lupinus albus conglutin gamma for the treatment of type ii diabetes

Номер патента: CA2515607C. Автор: Paolo Morazzoni,Marcello Duranti. Владелец: Indena SpA. Дата публикации: 2013-10-15.

Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c

Номер патента: WO1999013894A2. Автор: Friederike Zahm. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 1999-03-25.

The use of an ester of inositoltrisphosphate for the preparing of medicaments

Номер патента: WO1997023229A1. Автор: Matti Siren. Владелец: PERSTORP AB. Дата публикации: 1997-07-03.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: CA2533423C. Автор: Thomas Helleday. Владелец: University of Sheffield. Дата публикации: 2014-07-22.

Use of selective cox-2 inhibitors for the treatment of urinary incontinence

Номер патента: CA2443031A1. Автор: Amedeo Leonardi,Rodolfo Testa,Luciano Guarneri. Владелец: Individual. Дата публикации: 2002-10-17.

Use of erythropoietin and iron preparations for the production of pharmaceutical combination preparations for the treatment of rheumatic diseases

Номер патента: CA2297959A1. Автор: Paul Lehmann,Joachim Peter Kaltwasser. Владелец: Individual. Дата публикации: 1999-02-18.

Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis

Номер патента: WO2000032193A1. Автор: Anker Jon Hansen,Uffe Bang Olsen,Tine Krogh Jorgensen. Владелец: Novo Nordisk A/S. Дата публикации: 2000-06-08.

Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan

Номер патента: US20160166662A1. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: VITAMFERO. Дата публикации: 2016-06-16.

Use of a phytosterol containing composition for the treatment of luts.

Номер патента: EP2091546A1. Автор: Lars Karnerud,Clas Tufvesson,Arata Paul Yamasaki. Владелец: Natumin Pharma AB. Дата публикации: 2009-08-26.

Use of a phytosterol containing composition for the treatment of luts.

Номер патента: WO2008073040A1. Автор: Lars Karnerud,Clas Tufvesson,Arata Paul Yamasaki. Владелец: Natumin Pharma AB. Дата публикации: 2008-06-19.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: CA2733636A1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2010-02-18.

Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis

Номер патента: CA2267165C. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2003-12-16.

Use of 1,2-diaryl benzimidazoles for the preparation of pharmaceutical compositions for treating illnesses associated with a microglia activation and some such novel compounds

Номер патента: IL150150A. Автор: . Владелец: Bayer Ip Gmbh. Дата публикации: 2014-03-31.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: US20240082218A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO,Andrea Helga Emmi VAUPEL. Владелец: NOVARTIS AG. Дата публикации: 2024-03-14.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: US20230406924A1. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2023-12-21.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: EP4267134A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2023-11-01.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: AU2020475443A9. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2024-02-08.

Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Номер патента: CA2114250C. Автор: David G. Ward,Michael Cronin,G. Roger Thomas,Phyllis L. Osheroff. Владелец: Genentech Inc. Дата публикации: 2007-10-16.

Use of angiotensin ii receptor antagonists for the preparation of medicaments for treating acute myocardial infarction

Номер патента: IL144216A. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2007-07-04.

Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Номер патента: CA2114250A1. Автор: David G. Ward,Michael Cronin,G. Roger Thomas,Phyllis L. Osheroff. Владелец: Phyllis L. Osheroff. Дата публикации: 1993-03-04.

Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin

Номер патента: WO2005013931B1. Автор: Marcel Schnyder,Werner Baschong. Владелец: Werner Baschong. Дата публикации: 2005-04-07.

Use of thiostrepton or its derivatives for the treatment of genetic diseases linked to a protein conformational disorder

Номер патента: WO2020151988A1. Автор: Isabelle Richard,Lucile Hoch,Xavier Nissan,Sara HENRIQUES. Владелец: Centre D'etude Des Cellules Souches (Cecs). Дата публикации: 2020-07-30.

Use of a tyrosine kinase inhibitor for the treatment of hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension

Номер патента: WO2024112656A1. Автор: Edda SPIEKERKOETTER,Md Khadem ALI,Adam M. ANDRUSKA. Владелец: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. Дата публикации: 2024-05-30.

Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction

Номер патента: US7897610B2. Автор: Frederic Becq,Jean Michel Vierfond,Renaud Robert,Yvette Mettey,Michel Joffre,Cecile Marivingt-Mounir,Laurence Pignoux,Christian Rogier. Владелец: Universite De Poitiers. Дата публикации: 2011-03-01.

Use of epidermal growth factor depleting agents in the treatment of the chronic obstructive pulmonary disease

Номер патента: CA3189461A1. Автор: Mary Reid,Kalet Leon Monzon,Tania Crombet Ramos,Kelvin Lee,Amparo Emilia Macias Abraham,Danay SAAVEDRA HERNÁNDEZ,Orestes SANTOS MORALES,Elia NENINGER VINAGERAS,Pedro Pablo PINO ALFONSO,Jenysbel de la Caridad HERNANDEZ REYES. Владелец: Centro de Immunologia Molecular. Дата публикации: 2022-02-03.

Use of epidermal growth factor depleting agents in the treatment of the chronic obstructive pulmonary disease

Номер патента: AU2021317553A1. Автор: Mary Reid,Kalet Leon Monzon,Tania Crombet Ramos,Kelvin Lee,Amparo Emilia Macias Abraham,Danay SAAVEDRA HERNÁNDEZ,Orestes SANTOS MORALES,Elia NENINGER VINAGERAS,Pedro Pablo PINO ALFONSO,Jenysbel de la Caridad HERNANDEZ REYES. Владелец: Centro de Immunologia Molecular. Дата публикации: 2023-03-16.

Use of epidermal growth factor depleting agents in the treatment of the chronic obstructive pulmonary disease

Номер патента: EP4190348A1. Автор: Mary Reid,Kalet Leon Monzon,Tania Crombet Ramos,Kelvin Lee,Amparo Emilia Macias Abraham,Danay SAAVEDRA HERNÁNDEZ,Orestes SANTOS MORALES,Elia NENINGER VINAGERAS,Pedro Pablo PINO ALFONSO,Jenysbel de la Caridad HERNANDEZ REYES. Владелец: Centro de Immunologia Molecular. Дата публикации: 2023-06-07.

Use of epidermal growth factor depleting agents in the treatment of chronic obstructive pulmonary disease

Номер патента: US20230256069A1. Автор: Mary Reid,Kalet Leon Monzon,Tania Crombet Ramos,Kelvin Lee,Amparo Emilia Macias Abraham,Danay SAAVEDRA HERNÁNDEZ,Orestes SANTOS MORALES,Elia NENINGER VINAGERAS,Pedro Pablo PINO ALFONSO,Jenysbel de la Caridad HERNANDEZ REYES. Владелец: Centro de Immunologia Molecular. Дата публикации: 2023-08-17.

Compounds for their use as drugs for the treatment and/or the prevention of infection(s) caused by biofilm-forming bacteria

Номер патента: EP3186253A1. Автор: Olivier Martin,Piotr B. Heczko,Magdalena Strus,Grazyna Stochel,Estelle GALLIENNE-BOIVINEAU,Cyril NICOLAS,Agnieszka KYZIOL,Diana MIKOLAJCZYK,Agnieszka MACHUL. Владелец: Universite dOrleans. Дата публикации: 2017-07-05.

Compounds for their use as drugs for the treatment and/or the prevention of infection(s) caused by biofilm-forming bacteria

Номер патента: WO2016030434A1. Автор: Olivier Martin,Piotr B. Heczko,Magdalena Strus,Grazyna Stochel,Estelle GALLIENNE-BOIVINEAU,Cyril NICOLAS,Agnieszka KYZIOL,Diana MIKOLAJCZYK,Agnieszka MACHUL. Владелец: Jagiellonian University. Дата публикации: 2016-03-03.

Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions

Номер патента: EP2222316A2. Автор: Bruno Silvestrini,Michele Bonanomi. Владелец: Individual. Дата публикации: 2010-09-01.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: WO2007104646A3. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Silvia Bozza. Дата публикации: 2007-11-15.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: WO2002036151A2. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.. Дата публикации: 2002-05-10.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: CA2646419A1. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Individual. Дата публикации: 2007-09-20.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: EP1993585A2. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Tecnogen SpA. Дата публикации: 2008-11-26.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: WO2007104646A2. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Tecnogen S.P.A. Дата публикации: 2007-09-20.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: EP1370279A2. Автор: Alberto c/o Ist. di Ricerche Farma. MANTOVANI,Barbara c/o Ist. di Ricerche Farma. BOTTAZI,Giuseppe c/o Ist. di Ricerche Farma. PERI,Angelo c/o Ist. di Ricerche Farma. MANFREDI. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2003-12-17.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: WO2002036151A3. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: Barbara Bottazi. Дата публикации: 2003-10-16.

Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: AU2002215189B2. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2006-08-03.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: EP1370279B1. Автор: Alberto c/o Ist. di Ricerche Farma. MANTOVANI,Barbara c/o Ist. di Ricerche Farma. BOTTAZI,Giuseppe c/o Ist. di Ricerche Farma. PERI,Angelo c/o Ist. di Ricerche Farma. MANFREDI. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2005-09-07.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: US20040029803A1. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazzi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2004-02-12.

Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Номер патента: CA2703866C. Автор: Chris Vervaet,Enrico Bastianelli,Pierre Attali. Владелец: Bone Therapeutics SA. Дата публикации: 2016-11-29.

Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Номер патента: AU2009214028B2. Автор: Chris Vervaet,Enrico Bastianelli,Pierre Attali. Владелец: Glob Co Srl. Дата публикации: 2014-06-12.

The use of apolipoprotein A-I Milano, for the manufacture ofa composition for treating preventing or reducing ischemic reperfusion injury in a tissue or organ

Номер патента: NZ537006A. Автор: Charles L Bisgaier. Владелец: Esperion Therapeutics Inc. Дата публикации: 2008-01-31.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: WO2002058623A2. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech, Inc.. Дата публикации: 2002-08-01.

Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the head or brain

Номер патента: EP2552461B1. Автор: John Francis Martin,Mervyn Singer,Alex Peter Dyson. Владелец: Magnus TTM IC. Дата публикации: 2014-12-17.

Methods and compositions for the prevention and/or treatment of ischemia and of ischemia/reperfusion injury

Номер патента: WO2020115095A3. Автор: Lina Badimon Maestro,Gemma VILAHUR GARCIA,Judit CUBEDO RÀFOLS. Владелец: Glycardial Diagnostics, S.L.. Дата публикации: 2020-07-23.

Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the heart

Номер патента: EP2556834B1. Автор: John Francis Martin,Mervyn Singer,Alex Peter Dyson. Владелец: Magnus TTM IC. Дата публикации: 2014-11-26.

Tetrathiomolybdate for use in the therapy of ischemia-reperfusion injury of the kidney

Номер патента: EP2842562B1. Автор: John Francis Martin,Mervyn Singer,Alex Peter Dyson. Владелец: Magnus Oxygen Ltd. Дата публикации: 2016-04-27.

TREATMENT OF ISCHEMIA REPERFUSION INJURY USING ALPHA-2 MACROGLOBULIN

Номер патента: US20190142899A1. Автор: Abbate Antonio,TOLDO Stefano. Владелец: . Дата публикации: 2019-05-16.

Novel aminothiol reduction of ischemia-reperfusion-induced cell death

Номер патента: US20210299066A1. Автор: William E. Fahl,Ningfeng LI. Владелец: Obvia Pharmaceuticals Ltd. Дата публикации: 2021-09-30.

Novel aminothiol reduction of ischemia-reperfusion-induced cell death

Номер патента: CA3092596A1. Автор: William E. Fahl,Ningfeng LI. Владелец: Suzhou Ng Biomedicine Co Ltd. Дата публикации: 2019-09-06.

Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia

Номер патента: AU7409900A. Автор: Reinhard Kirsch,Eugen Falk,Hans-Ludwig Schaefer,Norbert Krass. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2001-03-26.

Compounds for use in the treatment of dystrophinopathies

Номер патента: WO2023156645A1. Автор: Raúl INSA BORONAT,Núria REIG BOLAÑO,Oscar HUERTAS GAMBÍN,Yoko Asakura,Gal.La Pericot Mohr,Atsushi Asakura,Marisol Montolio Del Olmo. Владелец: Som Innovation Biotech, S.A.. Дата публикации: 2023-08-24.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US6696454B2. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2004-02-24.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: WO2002058623A3. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Dganit Bar. Дата публикации: 2003-08-21.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US20040229886A1. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2004-11-18.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US20020160978A1. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2002-10-31.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: PL349335A1. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Christoph Gleiter. Дата публикации: 2002-07-15.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: EP1140139A2. Автор: Hannelore Ehrenreich,Christophe Gleiter. Владелец: Christophe Gleiter. Дата публикации: 2001-10-10.

N-palmitoylethanolamide and melatonin for use in the treatment of autism spectrum disorder and other neurobehavioral disorders similarly accompanied by restlessness, irritability, sleep disorders, and potentially stereotypies

Номер патента: EP4265244A1. Автор: Maria Federica Della Valle,Gabriele Marcolongo,Salvatore Cuzzocrea,Antonio Calignano,Chiara Gomiero,Claudia Cristiano,Raffaella DELLA VALLE. Владелец: Epitech Group SpA. Дата публикации: 2023-10-25.

N-palmitoylethanolamide and melatonin for use in the treatment of autism spectrum disorder and other neurobehavioral disorders similarly accompanied by restlessness, irritability, sleep disorders, and potentially stereotypies

Номер патента: US20230381121A1. Автор: Maria Federica Della Valle,Gabriele Marcolongo,Salvatore Cuzzocrea,Antonio Calignano,Chiara Gomiero,Claudia Cristiano,Raffaella DELLA VALLE. Владелец: Epitech Group SpA. Дата публикации: 2023-11-30.

N-palmitoylethanolamide and melatonin for use in the treatment of autism spectrum disorder and other neurobehavioral disorders similarly accompanied by restlessness, irritability, sleep disorders, and potentially stereotypies

Номер патента: AU2023202443A1. Автор: Maria Federica Della Valle,Gabriele Marcolongo,Salvatore Cuzzocrea,Antonio Calignano,Chiara Gomiero,Claudia Cristiano,Raffaella DELLA VALLE. Владелец: Epitech Group SpA. Дата публикации: 2023-11-09.

N-palmitoylethanolamide and melatonin for use in the treatment of autism spectrum disorder and other neurobehavioral disorders similarly accompanied by restlessness, irritability, sleep disorders, and potentially stereotypies

Номер патента: CA3197298A1. Автор: Maria Federica Della Valle,Gabriele Marcolongo,Salvatore Cuzzocrea,Antonio Calignano,Chiara Gomiero,Raffaella DELLA VALLE,Claudio Cristiano. Владелец: Epitech Group SpA. Дата публикации: 2023-10-22.

Use of a composition comprising vitamin K1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Номер патента: US7939568B2. Автор: Alfred Marchal. Владелец: Auriga International SA. Дата публикации: 2011-05-10.

Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Номер патента: CA2513324A1. Автор: Alfred Marchal. Владелец: Individual. Дата публикации: 2004-08-05.

Use of a composition comprising vitamin K1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Номер патента: CN1738594A. Автор: A·马沙尔. Владелец: Auriga International SA. Дата публикации: 2006-02-22.

Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Номер патента: SI1594456T1. Автор: Alfred Marchal. Владелец: Auriga Internat S A. Дата публикации: 2009-02-28.

The use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive, bipolar disorders

Номер патента: NO317641B1. Автор: Richard P Shank. Владелец: Ortho Mcneil Pharm Inc. Дата публикации: 2004-11-29.

The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders

Номер патента: CA2251197A1. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 1999-04-24.

The use of MMP-13 selective inhibitors for the treatment of osteoarthristis and other MMP-mediated disorders

Номер патента: AU758147B2. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 2003-03-13.

The use of estrogen receptor alpha modulators for the treatment of multiple sclerosis

Номер патента: CA2512021A1. Автор: Steven J. Adelman,Robert Mitchell,M. Merle Elloso,Douglas C. Harnish. Владелец: Douglas C. Harnish. Дата публикации: 2004-07-29.

Use of the hdac inhibitor panobinostat for the treatment of myeloma

Номер патента: EP1912640B1. Автор: Peter W. Atadja. Владелец: NOVARTIS AG. Дата публикации: 2015-06-17.

USE OF ANTI-INTERLEUKIN-9 ANTIBODY FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ASTHMA

Номер патента: DE69635305D1. Автор: Clifford Levitt,W Lee Maloy,U Kari,Nicolas Nicolaides. Владелец: Genaera Corp. Дата публикации: 2006-03-02.

Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders

Номер патента: EP0932398A1. Автор: Richard P. Shank. Владелец: Ortho Pharmaceutical Corp. Дата публикации: 1999-08-04.

Use of an ampa receptor potentiator for the treatment of obesity

Номер патента: WO2001089510A2. Автор: Phil Skolnick. Владелец: ELI LILLY AND COMPANY. Дата публикации: 2001-11-29.

Use of a spermidine comprising extract for the enhancement of mitochondrial respiration

Номер патента: EP3538081C0. Автор: Frank Madeo,Tobias Eisenberg,Slaven STEKOVIC. Владелец: Tll Longevity Labs GmbH. Дата публикации: 2023-08-02.

Use of AMPK Inducers and Metformin for the Treatment of Fibromyalgia

Номер патента: US20150272911A1. Автор: Cordero Morales Mario David,Bullon Fernandez Pedro,Alcocer Gomez Elisabet. Владелец: Universidad de Sevilla. Дата публикации: 2015-10-01.

Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: KR101451414B1. Автор: 마띠외 귀통,쟝-뤼끄 푸엘,레미 퓌졸. Владелец: 앵스티띠 나셔날 드 라 쌍뜨 에 드 라 르셰르슈 메디깔. Дата публикации: 2014-10-22.

Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: KR101189261B1. Автор: 마띠외 귀통,쟝-뤼끄 푸엘,레미 퓌졸. Владелец: 앵스티띠 나셔날 드 라 쌍뜨 에 드 라 르셰르슈 메디깔. Дата публикации: 2012-10-09.

Use of nitric oxide/nucleophile complexes for the treatment of cancer

Номер патента: WO1993020806A1. Автор: Larry K. Keefer,Chris M. Maragos,Ji Ming Wang,Joost J. Oppenheim. Владелец: The United States Of America, Represented By The Secretary, Department Of Health And Human Services. Дата публикации: 1993-10-28.

Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: WO2005094799A2. Автор: Jean-Luc Puel,Rémy PUJOL,Matthieu Guitton. Владелец: AURIS MEDICAL AG. Дата публикации: 2005-10-13.

Use of an NMDA receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: AU2005229543B2. Автор: Jean-Luc Puel,Rémy PUJOL,Matthieu Guitton. Владелец: AURIS MEDICAL AG. Дата публикации: 2009-12-03.

Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: WO2005094799A3. Автор: Jean-Luc Puel,Rémy PUJOL,Matthieu Guitton. Владелец: Matthieu Guitton. Дата публикации: 2006-03-02.

Use of an NMDA receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: EP2077108A1. Автор: Jean-Luc Puel,Rémy PUJOL,Matthieu Guitton. Владелец: AURIS MEDICAL AG. Дата публикации: 2009-07-08.

Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Номер патента: EP1729753B1. Автор: Jean-Luc Puel,Rémy PUJOL,Matthieu Guitton. Владелец: AURIS MEDICAL AG. Дата публикации: 2009-07-22.

Use of Kv7 potassium channel openers for the treatment of pain

Номер патента: JP2023504166A. Автор: ジェイアール ジェームズ フィリップ ジョンソン,グレゴリー エヌ． ビーチ. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2023-02-01.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: EP1721157A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2006-11-15.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: IL177285A0. Автор: . Владелец: Axaron Bioscience AG. Дата публикации: 2006-12-10.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: CA2558770A1. Автор: Armin Schneider,Gerhard Vogt,Moritz Rossner,Markus Schwaninger. Владелец: Individual. Дата публикации: 2005-09-01.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: AU2005214843A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2005-09-01.

Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders

Номер патента: AU2017278329B2. Автор: Wei Chen,Paul A. Moore,Ezio Bonvini,Jon Marc Wigginton,Naimish Bharat Pandya. Владелец: Macrogenics Inc. Дата публикации: 2024-08-08.

Use of Phospholipase A2 from Elapidae snakes in the treatment of diabetic nephropathy

Номер патента: US20240245757A1. Автор: Zhankai QI. Владелец: Individual. Дата публикации: 2024-07-25.

Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases

Номер патента: US20110212060A1. Автор: Rosa Maria Hernandez Martin,Jose Luis Pedraz Muñoz,Gorka Orive Arroyo,Carlos Spuch Calvar,Felix Bermejo-Pareja,Desiree Antequera Tienda,Eva Carro Diaz. Владелец: Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre. Дата публикации: 2011-09-01.

Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response

Номер патента: WO2004062559A2. Автор: James Edward Eyles,Gareth David Healey,Ethel Diane Williamson,Angie Westwood. Владелец: The Secretary of State For Defence. Дата публикации: 2004-07-29.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: EP3423111A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2019-01-09.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: US20190248835A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2019-08-15.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: WO2017150997A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2017-09-08.

Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response

Номер патента: WO2004062559A3. Автор: James Edward Eyles,Gareth David Healey,Ethel Diane Williamson,Angie Westwood. Владелец: Angie Westwood. Дата публикации: 2004-09-02.

Use of pegylated igf-i variants for the treatment of neuromuscular disorders

Номер патента: CA2720408C. Автор: Michael Sendtner,Friedrich Metzger,Bettina Holtmann. Владелец: F Hoffmann La Roche AG. Дата публикации: 2016-09-06.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: US10556925B2. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2020-02-11.

Use of histamine h4 receptor modulators for the treatment of allergy and asthma

Номер патента: EP1545596A2. Автор: Lars Karlsson,Ping Ling,Wai-Ping Leung,Robin L. Thurmond,Paul J. Dunford,Pragnya J. Desai,Claudia L. Hofstra. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2005-06-29.

Use of histamine h4 receptor modulators for the treatment of allergy and asthma

Номер патента: WO2004021999A3. Автор: Lars Karlsson,Ping Ling,Robin L Thurmond,Wai-Ping Leung,Pragnya J Desai,Paul J Dunford,Claudia L Hofstra. Владелец: Claudia L Hofstra. Дата публикации: 2004-10-07.

Use of a fragment of rasgap peptide in the treatment or prevention of metastasis

Номер патента: EP2391378A1. Автор: Christian Widmann. Владелец: UNIVERSITÉ DE LAUSANNE. Дата публикации: 2011-12-07.

Use of modified pore-forming proteins for the preparation of a medicament for treating or preventing benign prostatic hyperplasia

Номер патента: IL188143A. Автор: . Владелец: Protox Therapeutics Inc. Дата публикации: 2012-10-31.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: EP2268362A2. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: Albaad Massuot Yitzhak Ltd. Дата публикации: 2011-01-05.

Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity

Номер патента: EP2318545A1. Автор: Steven Lewitzky,Joanne Meyer,Charles Paulding,Jonathan Benjamin Singer. Владелец: NOVARTIS AG. Дата публикации: 2011-05-11.

Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure

Номер патента: EP1595547A3. Автор: Terrence E. Martin,Margaret M. Walsh-Reitz,Gary F. Toback. Владелец: University of Chicago. Дата публикации: 2006-07-12.

Use of macrophage inflammatory protein-1 (mip-1 ) inhibitor to protect pancreas and prevent blood sugar from rising

Номер патента: EP3210616A1. Автор: Ting-Ting Chang,Jaw-Wen Chen. Владелец: Farmar Licensing Co Ltd. Дата публикации: 2017-08-30.

Hepatic Stem-Like Cells for the Treatment and/or the Prevention of Liver Disorders

Номер патента: US20230407264A1. Автор: Tuan Huy NGUYEN,Angélique Fourrier,Raphaël RISPAL,Frédéric DELBOS. Владелец: Goliver Therapeutics. Дата публикации: 2023-12-21.

Use of a particular metal oxide for the photoconversion of organic compounds on keratin materials

Номер патента: WO2022112053A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: L'oreal. Дата публикации: 2022-06-02.

Use of a particular metal oxide for the photoconversoin of organic compounds on keratin materials

Номер патента: US20230414464A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: LOreal SA. Дата публикации: 2023-12-28.

Use of a particular metal oxide for the photoconversion of organic compounds on keratin materials

Номер патента: EP4251120A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: LOreal SA. Дата публикации: 2023-10-04.

Use of mirnas for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities

Номер патента: EP2622075A1. Автор: Devrim Gozuacik,Gozde Korkmaz. Владелец: Sabanci Universitesi. Дата публикации: 2013-08-07.

Use of epitopes inducing specific tolerance for the prevention of tissue rejection

Номер патента: EP2736526A1. Автор: Johann Bauer,Monika ETTINGER,Iris GRATZ,Doris PECKL-SCHMID. Владелец: Individual. Дата публикации: 2014-06-04.

Use of an extract of sichuan pepper for a skin treatment and a composition suitable for this use.

Номер патента: WO2024052756A1. Автор: Amandine FISCHER DESNOS. Владелец: CRODAROM. Дата публикации: 2024-03-14.

Use of peptides as transporters intended for the internalization of molecules of interest into target cells

Номер патента: US20130116201A1. Автор: Jean-Luc Lenormand,Romy Rothe Walther. Владелец: Universite Joseph Fourier Grenoble 1. Дата публикации: 2013-05-09.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A2. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: ALBAAD MASSUOT YITZHAK LTD.. Дата публикации: 2009-10-15.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A9. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: ALBAAD MASSUOT YITZHAK LTD.. Дата публикации: 2010-12-23.

Use of common .gamma. chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes

Номер патента: CA2618580A1. Автор: Attilio Bondanza,Maria Chiara Bonini. Владелец: Maria Chiara Bonini. Дата публикации: 2007-02-15.

Use Of C1 Inhibitor For The Prevention Of Ischemia-Reperfusion Injury

Номер патента: US20130244941A1. Автор: Pieper Frank,Mannesse Maurice,Nuijens Johannes Henricus,De Simoni Maria Grazia,Ziere Gijsbertus Johannes. Владелец: PHARMING INTELLECTUAL PROPERTY B.V.. Дата публикации: 2013-09-19.

NEW USES OF ANTI-SIRPg ANTIBODIES

Номер патента: US20190382483A1. Автор: Nicolas Poirier,Vanessa GAUTTIER,Caroline Mary,Bernard Vanhove,Virginie Thepenier,Sabrina PENGAM. Владелец: OSE Immunotherapeutics SA. Дата публикации: 2019-12-19.

New uses of anti-SIRPg antibodies

Номер патента: AU2018221774B2. Автор: Nicolas Poirier,Vanessa GAUTTIER,Caroline Mary,Bernard Vanhove,Virginie Thepenier,Sabrina PENGAM. Владелец: OSE Immunotherapeutics SA. Дата публикации: 2024-08-22.

COMBINATION THERAPY FOR THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY

Номер патента: US20160175379A1. Автор: Wilson D. Travis. Владелец: . Дата публикации: 2016-06-23.

USES OF ANTI-SIRPg ANTIBODIES

Номер патента: US20220242951A1. Автор: Nicolas Poirier,Vanessa GAUTTIER,Caroline Mary,Bernard Vanhove,Virginie Thepenier,Sabrina PENGAM. Владелец: OSE Immunotherapeutics SA. Дата публикации: 2022-08-04.

USE OF TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

Номер патента: US20130266591A1. Автор: Weber Lutz,Richter Wolfgang,Zander Axel Rolf,Ayuketang Francis Ayuk. Владелец: . Дата публикации: 2013-10-10.

USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG DISEASES AND DISORDERS

Номер патента: US20210030811A1. Автор: KIM Carla F.,LOUIE Sharon M.,ARARAT Erhan,RAISER David. Владелец: The Children's Medical Center Corporation. Дата публикации: 2021-02-04.

USE OF A COMPOSITION COMPRISING DEOXYNUCLEOSIDES FOR THE TREATMENT OF MITOCHONDIAL DNA DEPLETION SYNDROME (MDDS) IN A HUMAN SUBJECT

Номер патента: BR122020021913B1. Автор: Michio Hirano,Caterina Garone,Ramon MARTI. Владелец: Fundacio Hospital Universitari Vall D'hebron-Institut De Recerca. Дата публикации: 2021-07-06.

Remedy for the treatment of endometritis in cows

Номер патента: RU2744919C1. Автор: Елена Николаевна Новикова,Игорь Сергеевич Коба,Омар Одех Абдль-Мути Аль-Равашдех. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина". Дата публикации: 2021-03-17.

Combined use of imiquimod and a casein hydrolysate for the treatment of condyloma

Номер патента: EP4401733A1. Автор: Guillermo LÓPEZ ZARCO. Владелец: Ntd Labs SLU. Дата публикации: 2024-07-24.

Gap junction modulators and their use for the treatment of age-related macular degeneration

Номер патента: CA3240515A1. Автор: Ulrik Mouritzen,Bradford YOUNG. Владелец: Breye Therapeutics ApS. Дата публикации: 2023-06-29.

Compounds for the treatment of diseases caused by oxalate accumulation

Номер патента: US20200197418A1. Автор: Jose Antonio Gomez Vidal,Miguel Xavier Fernandes,Mónica Díaz Gavilán,María Dolores Moya Garzón,Eduardo Salido Ruiz,Cristina Martín Higueras. Владелец: Universidad de Granada. Дата публикации: 2020-06-25.

USE OF 17-$g(a)-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY

Номер патента: EP1006996A1. Автор: James A. Mezick,Gerard J. Gendimenico. Владелец: Johnson and Johnson Consumer Companies LLC. Дата публикации: 2000-06-14.

Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer

Номер патента: US20110105425A1. Автор: Victoria-Eugenia Chagoya-Hazas,Rolando-Efraín Hernandez Muñoz,Saúl Villa-Treviño. Владелец: Universidad Nacional Autonoma De México. Дата публикации: 2011-05-05.

Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer

Номер патента: US8507459B2. Автор: Victoria-Eugenia Chagoya-Hazas,Rolando-Efraín Hernandez Muñoz,Saúl Villa-Treviño. Владелец: Universidad Nacional Autonnoma de Mexico. Дата публикации: 2013-08-13.

Use of gymnodimine, analogues and derviatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid

Номер патента: EP2484362A4. Автор: Lopez Luis Miguel Botana,Lopez Eva Alonso,Gonzalez Carmen Vale. Владелец: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA. Дата публикации: 2013-04-10.

Use of morphine derivatives as medicaments for the treatment of neuropathic problems

Номер патента: US20020165247A1. Автор: Helmut Buschmann,Wolfgang Strassburger,Thomas Krueger,Stephan Wnendt,Elke Reiss-Mueller. Владелец: GRUENENTHAL GmbH. Дата публикации: 2002-11-07.

Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 6 infections

Номер патента: ZA948907B. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: Smithkline Beecham Plc. Дата публикации: 1995-08-17.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: AU2003299065A1. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2004-04-19.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: EP1545534A1. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2005-06-29.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: AU2003299065B2. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2006-10-26.

Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases

Номер патента: WO2005020881A3. Автор: Ren Jin,Bang Qiang Gong,Han Xin Chun. Владелец: Shanghai Comman Pharmaceutical. Дата публикации: 2005-07-28.

Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract

Номер патента: AU6991300A. Автор: Wolfgang Müller,Lothar Farber,Christian Stratz. Владелец: Novartis Erfindungen Verwaltungs GmbH. Дата публикации: 2001-03-05.

Use of N-alkylamino-heterocylic compounds for the treatment of migraine

Номер патента: US20020169322A1. Автор: TAO Xin,Methvin Isaac,Abdelmalik Slassi,Louise Edwards,Ashok Tehim,Jalaj Arora,Anne O'brien. Владелец: NPS Allelix Corp Canada. Дата публикации: 2002-11-14.

The use of acetyl CoA carboxylase inhibitors for the treatment of acne vulgaris

Номер патента: RU2016106829A. Автор: Уильям Пол ЭСЛЕР,Габриэль Элизабет СОННЕНБЕРГ. Владелец: Пфайзер Инк.. Дата публикации: 2017-10-17.

Use of mnk inhibitors for the treatment of alzheimer's disease

Номер патента: US20100247517A1. Автор: Martin Schneider,Matthias Austen,Marcus Geese. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2010-09-30.

Use of mannuronic diacid composition in treatment of vascular dementia

Номер патента: AU2019296854A1. Автор: Jian Ding,Meiyu Geng,Zhenqing ZHANG,Xianliang Xin,Xiaoguang Du. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-01-28.

USE OF 1,2-DIAZADIBENZOES, HAZAZULES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Номер патента: DE602004019133D1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic. Владелец: GlaxoSmithKline Istrazivacki Centar Zagreb doo. Дата публикации: 2009-03-05.

USE OF BRADIQUININE ANTAGONISTS NOT PREPARED FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT AND PREVENTION OF CHRONIC DISEASES OF FIBROGENETIC SYMPTOMS OF ACUTE FIGURE DISEASES AND RELATED COMPLICATIONS

Номер патента: PT808628E. Автор: Holger Heitsch,Adalbert Wagner,Martin Bickel,Klaus Wirth,Max Hropot. Владелец: Hoechst AG. Дата публикации: 2000-05-31.

Use of dehydroeburicoic acid from antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia

Номер патента: US20170216384A1. Автор: Yueh-Hsiung Kuo,Chun-Ching Shih,Cheng-Hsiu Lin. Владелец: Individual. Дата публикации: 2017-08-03.

Use of rotigotine for the treatment or prevention of dopaminergic neuron loss

Номер патента: CA2547645C. Автор: Dieter Scheller,Frank Dressen. Владелец: UCB PHARMA GMBH. Дата публикации: 2013-07-16.

Use of fluoroquinolone antibiotics for the treatment of Q fever

Номер патента: GB2400033A. Автор: Graham Lloyd,Mark Stephen Lever,Kevin R Bewley,Barry Dowsett. Владелец: UK Secretary of State for Defence. Дата публикации: 2004-10-06.

Use of non-peptide bradykinin antagonists for the treatment and prevention of chronic fibrosing liver disease, acute liver disease and related complications

Номер патента: JP4034849B2. Автор: マルティン・ビッケル,クラウス・ヴイルト,マクス・フロポト,ホルガー・ハイチユ,アーダルベルト・ヴアーグナー. Владелец: ヘキスト・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング. Дата публикации: 2008-01-16.

Combined use of imiquimod and a casein hydrolysate for the treatment of condyloma

Номер патента: AU2022388863A1. Автор: Guillermo LÓPEZ ZARCO. Владелец: Ntd Labs S L U. Дата публикации: 2024-06-20.

The use of polyols in combating yeast infection and polyol preparations for said use

Номер патента: EP1035844A1. Автор: Tammy Pepper,David Saunders,Julita Pearson,Markku Tapio Virkki,Sergio Luis Infectious Disease Div. VARGAS MUNITA. Владелец: Xyrofin Oy. Дата публикации: 2000-09-20.

Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia

Номер патента: EP0556947A1. Автор: Pierre Mallorga. Владелец: Merck and Co Inc. Дата публикации: 1993-08-25.

New use of ethoxylated phytosterols and phytostanols

Номер патента: EP1448167A1. Автор: Erik Soderlind. Владелец: AstraZeneca AB. Дата публикации: 2004-08-25.

The use of anti-histaminics for acute reduction of elevated intracranial pressure

Номер патента: CA2690483C. Автор: Joseph Elisabeth Leenaerts,Frans Eduard Janssens,Manuel Jesus Alcazar-Vaca,José Manuel Bartolomé-Nebreda,Francisco Javier FERNÁNDEZ-GADEA,Antonio Gomez-Sanchez,Frank Tegtmeier,Koenraad Arthur Van Rossem,Pedro Martinez-Jimenez,Jozef Leo Henri Van Reempts. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2012-07-24.

Use of donerezil for the treatment of functional and/or organic pain syndromes

Номер патента: US6608088B1. Автор: Maria Nicolodi,Federigo Sicuteri. Владелец: Eisai Co Ltd. Дата публикации: 2003-08-19.

Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease

Номер патента: WO2007042811A1. Автор: Geoffrey Guy,Philip Robson. Владелец: GW Pharma Limited. Дата публикации: 2007-04-19.

Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections

Номер патента: WO1998038986A2. Автор: Akira Matsumori. Владелец: Roche Diagnostics GmbH. Дата публикации: 1998-09-11.

Use of 3,11 b-cis - dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis

Номер патента: IL204990A0. Автор: . Владелец: Biovail Lab Int Srl. Дата публикации: 2010-11-30.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: EP4232032A4. Автор: Erwan BEAUCHAMP,Luc G Berthiaume. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-10-02.

1,3-oxathiolanes useful in the treatment of hepatitis

Номер патента: CA2068943C. Автор: Nghe Nguyen-Ba,Bernard Belleau (Deceased). Владелец: Biochem Pharma Inc. Дата публикации: 2000-11-28.

Triple monoamine reuptake inhibitors for the treatment of chronic pain

Номер патента: CA2484482C. Автор: Gordon John Blackburn-Munro,Joergen Scheel-Krueger. Владелец: Neurosearch AS. Дата публикации: 2011-07-26.

Use of 3,1IB-Cis-Dihydrotetrabenazine for the Treatment of Symptoms of Huntingtons Disease

Номер патента: US20080319000A1. Автор: Robert Tridgett,Thierry Filloux. Владелец: Cambridge Laboratories Ireland Ltd. Дата публикации: 2008-12-25.

Cannabinoid combinations and their use in the treatment of cancer

Номер патента: EP4203925A1. Автор: Carminita Lara FROST,Natasha BEUKES,Recardia Laken Simoney SCHOEMAN,Ruby-Ann LEVENDAL. Владелец: Nelson Mandela University. Дата публикации: 2023-07-05.

Use of N-(indolecarbonyl)piperazine derivatives for treating obesity

Номер патента: NZ533667A. Автор: Amsterdam Christoph Van,Gerd Bartoszyk,Ewen Sedman,Jürgen Hellmann,Landenberg Friedrich Von. Владелец: Merck Patent GmBH. Дата публикации: 2006-11-30.

Use of NK-1 receptor antagonists for the manufacture of a medicament for intravenous formulation for the treatment and / or prevention of brain, spinal cord or nerve damage

Номер патента: NO20040057L. Автор: Robert Vink,Alan John Nimmo,Torsten Hoffmann,Andrew Sleight,Pierre Vankan. Владелец: Hoffmann La Roche. Дата публикации: 2004-01-07.

Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.

Номер патента: FR2717080B1. Автор: Serge Braun,Badia Ferzaz,Philippe Poindron. Владелец: Synthelabo SA. Дата публикации: 1996-12-13.

Mixed orl1/mu-agonists for the treatment of pain

Номер патента: CA2664702C. Автор: Thomas Christoph,Elmar Friderichs,Klaus Linz,Jean De Vry,Babette-Yvonne Koegel,Wolfgang Schroeder. Владелец: GRUENENTHAL GmbH. Дата публикации: 2016-08-09.

Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.

Номер патента: FR2717080A1. Автор: Ferzaz Badia,Poindron Philippe,Braun Serge. Владелец: Synthelabo SA. Дата публикации: 1995-09-15.

Use of rapamycin to prepare medicaments for the treatment of adult t-cell leukemia/lymphoma

Номер патента: NZ243175A. Автор: Glenn Alvin Miller,Mark Barry Rabin,William Joseph Harrington. Владелец: American Home Prod. Дата публикации: 1997-06-24.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097A1. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 1998-02-19.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: EP0959888A1. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 1999-12-01.

USE OF THE CLIOQUINOL CHELATING AGENT FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE.

Номер патента: ES2162319T3. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2001-12-16.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: WO2004028542A1. Автор: Margaret Han Dugan,Alan List. Владелец: Novartis Pharma Gmbh. Дата публикации: 2004-04-08.

Use of paclitaxel and its derivatives for the manufacture of a medicament for the treatment of restenosis

Номер патента: DE69434598T3. Автор: James L. Kinsella,Steven J. Sollot. Владелец: US Department of Health and Human Services. Дата публикации: 2010-07-29.

Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease.

Номер патента: FR2706303A1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1994-12-23.

Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease.

Номер патента: FR2706303B1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-09-08.

Use of efaroxan and its derivatives for the manufacture of medicaments intended for the treatment of neurodegenerative diseases and their progression.

Номер патента: FR2707166B1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-09-29.

Use of idazoxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease and its evolution.

Номер патента: FR2698789B1. Автор: Thierry Imbert,Francis Colpaert,Mike Briley. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-03-03.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: PL3456333T3. Автор: Stephen Kelsey,Monic J. Stuart. Владелец: Geron Corporation. Дата публикации: 2020-09-21.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma

Номер патента: CA2241559A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Dyhr Christensen,Niels Korsgaard. Владелец: Individual. Дата публикации: 1997-07-17.

Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema

Номер патента: CA2488861A1. Автор: Cornelia Norden,Nicolas Aigner. Владелец: Individual. Дата публикации: 2003-12-18.

Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Номер патента: IL124882A0. Автор: . Владелец: Novo Nordisk AS. Дата публикации: 1999-01-26.

Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin

Номер патента: CN1761467B. Автор: F·科尔帕特,B·瓦谢. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2011-09-21.

Use of the telomerase inhibitor imetelstat for the treatment of myelofibrosis

Номер патента: ES2744790T3. Автор: Stephen Kelsey,Monic Stuart. Владелец: Geron Corp. Дата публикации: 2020-02-26.

Use of adenosine and analogues thereof for the manufacture of a medicament for the treatment of insulin resistance syndrome and diabetes mellitus

Номер патента: EE200300551A. Автор: HERLING Andreas,P. Maguire Martin,P. Spada Alfred,R. Myers Michael,Mi Choi-Sledeski Yong,W. Pauls Heinz,R. Ewing William,J�hne Gerhard. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2004-02-16.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: ES2789176T3. Автор: Stephen Kelsey,Monic Stuart. Владелец: Geron Corp. Дата публикации: 2020-10-26.

Use of idazoxan and its derivatives for the preparation of a medicament for the treatment of Parkinson's disease and its evolution.

Номер патента: FR2698789A1. Автор: Imbert Thierry,Colpaert Francis,Briley Mike. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1994-06-10.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy

Номер патента: CA2241519A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Dyhr Christensen,Niels Korsgaard. Владелец: Individual. Дата публикации: 1997-07-17.

The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Номер патента: AU2002213830A1. Автор: Jes Olesen,Lars Bendtsen,Rigmor Jensen. Владелец: Head Explorer ApS. Дата публикации: 2002-05-15.

Use of the telomerase inhibitor imetelstat for the treatment of myelofibrosis

Номер патента: RS59363B1. Автор: Stephen Kelsey,Monic J Stuart. Владелец: Geron Corp. Дата публикации: 2019-11-29.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: HRP20200993T1. Автор: Stephen Kelsey,Monic J. Stuart. Владелец: Geron Corporation. Дата публикации: 2020-11-27.

USE OF 2-AMINO PURINE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIA OF INFECTION BY HERPES 7 HUMAN VIRUS

Номер патента: PT728002E. Автор: Richard Anthony Vere Hodge. Владелец: Novartis Int Pharm Ltd. Дата публикации: 2002-05-31.

Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow edema

Номер патента: ZA200500097B. Автор: Cornelia Norden,Nicolas Aigner. Владелец: Schering AG. Дата публикации: 2006-06-28.

USE OF BIOACTIVE METABOLITES OF GEPIRONA FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF PSYCHOLOGICAL DISORDERS

Номер патента: PT1242061E. Автор: Joseph P Yevich,Stephen J Kramer,Louis F Fabre. Владелец: Fabre Kramer Pharmaceuticals I. Дата публикации: 2005-09-30.

USE OF EFAROXAN AND ITS DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Номер патента: PT707477E. Автор: Thierry Imbert,Francis Colpaert,Michael Briley. Владелец: Pf Medicament. Дата публикации: 2000-04-28.

Use of compositions containing isoindolinone derivatives for the preparation of a medicament for the treatment of phosphodiesterase mediated diseases

Номер патента: CN111514135A. Автор: 向飞,周小刚. Владелец: Individual. Дата публикации: 2020-08-11.

Use of 1,3-oxathiolannucleoside analogues for the preparation of a preparation for the treatment of hepatitis B

Номер патента: DK0565549T3. Автор: Nghe Nguyen-Ba,Bernard Belleau. Владелец: Iaf Biochem Int. Дата публикации: 1995-07-03.

USE OF EFAROXAN AND ITS DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PARKINSON'S DISEASE

Номер патента: ATE192650T1. Автор: Thierry Imbert,Francis Colpaert,Michael Briley. Владелец: Pf Medicament. Дата публикации: 2000-05-15.

Use of the telomerase inhibitor imetelstat for the treatment of myelofibrosis

Номер патента: HRP20191784T1. Автор: Stephen Kelsey,Monic J. Stuart. Владелец: Geron Corporation. Дата публикации: 2019-12-27.

The use of halofuginone and related compounds for the treatment of urethral stricture by local administration

Номер патента: CA2384331A1. Автор: Israel Vlodavsky,Arnon Nagler,Mark Pines. Владелец: Individual. Дата публикации: 2001-03-15.

Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin

Номер патента: US20060241141A1. Автор: Francis Colpaert,Bernard Vacher. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2006-10-26.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis

Номер патента: HUP9800521A3. Автор: . Владелец: Novo Nordisk AS. Дата публикации: 1999-12-28.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: HRP20050281A2. Автор: LIST Alan,Han Dugan Margaret. Владелец: The Arizona Board of Regents on Behalf of the University of Arizona. Дата публикации: 2006-07-31.

Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression

Номер патента: ZA9469B. Автор: Thierry Imbert,Francis Colpaert. Владелец: Pf Medicament. Дата публикации: 1996-02-01.

Use of n-(indolcarbonyl)- piperazine derivatives for the preparation of medicaments for the treatment of obesity

Номер патента: IL162125A. Автор: . Владелец: Merck Patent GmBH. Дата публикации: 2010-12-30.

Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss

Номер патента: US20120232011A1. Автор: Michaela Kneissel,Mira Susa Spring. Владелец: Individual. Дата публикации: 2012-09-13.

Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections

Номер патента: US20120322766A1. Автор: Christine Schmitt,Hans Locher,Christian Hubschwerlen,Jean-Luc Specklin,Daniel Baeschlin. Владелец: Morphochem AG fuer Kombinatorische Chemie. Дата публикации: 2012-12-20.

USE OF AN H4 AGONIST MOLECULE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Номер патента: US20190076422A1. Автор: Terrasse Gaetan,BUR Catherine. Владелец: H4 ORPHAN PHARMA. Дата публикации: 2019-03-14.

Use of cold menthol receptor modulators for the treatment of respiratory disorders

Номер патента: WO2006040103A1. Автор: Cristina Alonso-Alija,Beatrix Stelte-Ludwig,Peter Sandner. Владелец: Bayer Healthcare AG. Дата публикации: 2006-04-20.

Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome

Номер патента: DE10066158B4. Автор: Reinhardt Dr. Horowski,Adalbert Dr. Engfer,Günther Dr. Clemens,Fred Windt,Johannes Dr. Tack. Владелец: NeuroBiotec GmbH. Дата публикации: 2007-08-09.

Use of cyclopentadienyl metal-acido complexes for the treatment of cancer and pharmaceutical compositions containing said complexes

Номер патента: US4608387A. Автор: Hartmut Kopf,Petra Kopf-Maier. Владелец: Koepf Hartmut. Дата публикации: 1986-08-26.

Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders

Номер патента: US20110071163A1. Автор: Richard M. Woodward. Владелец: Adolor Corp. Дата публикации: 2011-03-24.

Use of nk-3 receptor antagonists for the treatment of nausea and vomiting

Номер патента: EP1868606A2. Автор: Michael Rigby,Frederick David Tattersall. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2007-12-26.

Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury

Номер патента: CN1523988A. Автор: ,��Ī������,T,T·霍夫曼,A·J·尼莫,A·斯雷特,P·万肯,R·漫克. Владелец: F Hoffmann La Roche AG. Дата публикации: 2004-08-25.

Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder

Номер патента: WO2004075902A1. Автор: Graham Andrew Showell. Владелец: Amedis Pharmaceuticals Ltd.. Дата публикации: 2004-09-10.

Use of rapamycin and rapamycin derivatives for the treatment of bone loss

Номер патента: PL1646634T3. Автор: Michaela Kneissel,Spring Mira Susa. Владелец: NOVARTIS AG. Дата публикации: 2009-04-30.

USE OF AN AGONIST H4 MOLECULE FOR THE TREATMENT OF MUCOVISCIDOSIS

Номер патента: FR2990859B1. Автор: Gaetan Terrasse. Владелец: Gaetan Terrasse. Дата публикации: 2014-05-23.

Use of pyrazole derivative as cannabinoid CB1 receptor antagonist, for treatment and prevention of metabolic syndrome, particularly cardiovascular risks and dyslipidemia associated with obesity

Номер патента: FR2861301A1. Автор: Philip Janiak,Jean Marc Herbert,Michele Arnone,Hassan Massoud Hesmati. Владелец: Sanofi Synthelabo SA. Дата публикации: 2005-04-29.

Use of carbohydrates and compositions thereof for the treatment or prevention of diseases caused by imbalanced colon fermentation

Номер патента: CA2499665A1. Автор: Juha Apajalahti,Nina Rautonen,Anu Kettunen,Osmo Siikanen. Владелец: Individual. Дата публикации: 2004-04-01.

USE OF AN AGONIST H4 MOLECULE FOR THE TREATMENT OF MUCOVISCIDOSIS

Номер патента: FR2990859A1. Автор: Gaetan Terrasse. Владелец: Gaetan Terrasse. Дата публикации: 2013-11-29.

Use of tri-substituted glycerol compounds for the treatment of radiation injuries

Номер патента: CA2668923A1. Автор: Wolfgang Richter,Lutz Weber. Владелец: Individual. Дата публикации: 2008-05-15.

Use of glycine / NMDA receptor ligand for the treatment of drug dependence and withdrawal symptoms

Номер патента: JP2575569B2. Автор: エツチ．ハトスン ピーター. Владелец: メルク シヤープ エンド ドーム リミテツド. Дата публикации: 1997-01-29.

Use of ribavirin and interferon alpha for the treatment of hepatitis c

Номер патента: HU9802324A3. Автор: . Владелец: Schering Corp Kenilwort. Дата публикации: 2001-04-28.

Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury

Номер патента: PL211246B1. Автор: Robert Vink,Alan John Nimmo,Torsten Hoffmann,Andrew Sleight,Pierre Vankan. Владелец: Hoffmann La Roche. Дата публикации: 2012-04-30.

Use of ribavirin and interferon alpha for the treatment of h epatitis c

Номер патента: AU5919296A. Автор: Janice K. Albrecht,Paul C. Grint. Владелец: Schering Corp. Дата публикации: 1996-11-29.

Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections

Номер патента: CA2529347A1. Автор: Christine Schmitt,Hans Locher,Christian Hubschwerlen,Jean-Luc Specklin,Daniel K. Baeschlin. Владелец: Daniel K. Baeschlin. Дата публикации: 2004-11-11.

USE OF A GAMMA SECRETASE INHIBITOR FOR THE TREATMENT OF CANCER

Номер патента: MA33076B1. Автор: John Frederick Boylan,Kathryn E Packman,Leopoldo Ladores Luistro Iii. Владелец: Hoffmann La Roche. Дата публикации: 2012-03-01.

Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease

Номер патента: US20100286098A1. Автор: Geoffrey Guy,Philip Robson,Roger Pertwee,Joanna Jamontt. Владелец: GW Pharma Ltd. Дата публикации: 2010-11-11.

Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis

Номер патента: CA2868558A1. Автор: Ernest LOUMAYE,Jean-Pierre Gotteland,Oliver Pohl. Владелец: PregLem SA. Дата публикации: 2013-10-10.

Use of benzofused heterocyclic sulfamide derivatives for the treatment of mania and bipolar disorder

Номер патента: NO20083032L. Автор: Allen B Reitz,Virginia L Smith-Swintosky. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2008-09-16.

Combined use of bendamustine, doxorubicin and bortezomib for the treatment of multiple myeloma

Номер патента: EP2350665A4. Автор: Sherif S Farag. Владелец: Indiana University Research And Technology Corp. Дата публикации: 2012-06-06.

Use of sucralfate or sucrose octasulfate for the treatment of cervical erosion

Номер патента: KR100765683B1. Автор: 기안프란코 고리,아디테오 구이디,알베르토토 페드리기,피에트로 비안치니,엔리코 볼드리니. Владелец: 파르미게아 에스.피.에이. Дата публикации: 2007-10-11.

Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome

Номер патента: PT2120923E. Автор: Thomas Klabunde,Andreas Herling,Hubert Heuer,Siegfried Stengelin,Dieter Kadereit,Matthias Urmann,Harm Brummerhop,Susanne Kilp. Владелец: SANOFI SA. Дата публикации: 2012-08-31.

Use of treosulfan and derivatives thereof for the treatment of multiple sclerosis

Номер патента: DE10237146A1. Автор: Gretel Sass. Владелец: MEDAC GESELLSCHAFT FUER KLINISCHE SPEZIALPRAEPARATE MBH. Дата публикации: 2004-03-04.

Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptoms of Huntington's didease

Номер патента: EP2027861A1. Автор: Robert Tridgett,Thierry Filloux. Владелец: Cambridge Laboratories Ireland Ltd. Дата публикации: 2009-02-25.

Use of 5-ht2 receptor antagonists for the treatment of sleep disorders

Номер патента: US20060040951A1. Автор: Gerd Bartoszyk,Christoph Van Amsterdam. Владелец: Merck Patent GmBH. Дата публикации: 2006-02-23.

Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury

Номер патента: KR100589106B1. Автор: 빙크로버트,님모알란존,호프만토르스텐,슬레이트앤드류,반칸삐에르. Владелец: 에프. 호프만-라 로슈 아게. Дата публикации: 2006-06-14.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: WO2003057919A3. Автор: Lars Karlsson,Siquan Sun,Robin Thurmond. Владелец: Ortho Mcneil Pharm Inc. Дата публикации: 2003-10-30.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: EP1458885A2. Автор: Lars Karlsson,Siquan Sun,Robin Thurmond. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2004-09-22.

Use of a modulator of gene expression in the treatment of cancer

Номер патента: WO2005107782A2. Автор: Helen Louise ROGERS,Anne Willis,Martin Bushell. Владелец: THE UNIVERSITY OF NOTTINGHAM. Дата публикации: 2005-11-17.

Use of a modulator of gene expression in the treatment of cancer

Номер патента: WO2005107782A3. Автор: Helen Louise ROGERS,Anne Willis,Martin Bushell. Владелец: Martin Bushell. Дата публикации: 2006-02-02.

Liquid dosage form for treatment and prevention of flu and arvi

Номер патента: RU2770521C2. Автор: Наталья Александровна Голубева,Антон Петрович Переверзев. Владелец: Общество С Ограниченной Ответственностью "Валента-Интеллект". Дата публикации: 2022-04-18.

Phospholipase inhibitors for the treatment of cancer

Номер патента: EP1135141A1. Автор: Albert Peng Sheng Tseng,Kevin William Broady. Владелец: Analytica Ltd. Дата публикации: 2001-09-26.

Conjugate compounds and their use in cancer treatment and diagnosis

Номер патента: WO2024133780A1. Автор: Ali Azhdarinia,Wolfgang Weber,Susanne KOSSATZ,Sukhen C. Ghosh,Beatrice Stefanie LUDWIG,Lena KOLLER. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2024-06-27.

Conjugate compounds and their use in cancer treatment and diagnosis

Номер патента: EP4389150A1. Автор: designation of the inventor has not yet been filed The. Владелец: University of Texas System. Дата публикации: 2024-06-26.

Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases

Номер патента: US20230233554A1. Автор: Allan Zijian Zhao,Fanghong LI,Zhenggang Zhao,Yunping MU,Huidan ZHU. Владелец: Shenzhen Hanhui Pharmaceutical Technology Co Ltd. Дата публикации: 2023-07-27.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: US20090285907A1. Автор: József Haller,Tamas Freund. Владелец: Individual. Дата публикации: 2009-11-19.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: EP2043668A2. Автор: József Haller,Tamas Freund. Владелец: Individual. Дата публикации: 2009-04-08.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: WO2007144676A2. Автор: József Haller,Tamas Freund. Владелец: Haller Jozsef. Дата публикации: 2007-12-21.

Use of p38 inhibitors for the treatment of inflammation-enhanced cough

Номер патента: EP1337255A2. Автор: David C. Underwood,Don E. Griswold. Владелец: SmithKline Beecham Corp. Дата публикации: 2003-08-27.

Methods for the treatment and prevention of age-related retinal dysfunction

Номер патента: NZ600498A. Автор: Krzysztof Palczewski,Tadao Maeda,David Saperstein. Владелец: Univ Washington. Дата публикации: 2014-01-31.

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

Номер патента: WO2005102374A3. Автор: John Robertson,Robert Harris,Anders Essen-Moller. Владелец: Diamyd Medical Ab. Дата публикации: 2006-03-16.

Use of low dose il-2 for treating autoimmune - related or inflammatory disorders

Номер патента: US20190351023A1. Автор: Claude Bernard,David Klatzmann,Eliane Piaggio,Gilbert BENSIMON,David SAADOUN,Patrice CACOUB,Michèle ROSENZWAJG. Владелец: Assistance Publique Hopitaux de Paris APHP. Дата публикации: 2019-11-21.

Use of mannan from saccharomyces cerevisiae for the treatment of asthma

Номер патента: US20050085442A1. Автор: D. Lew. Владелец: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION. Дата публикации: 2005-04-21.

Use of mannan from saccharomyces cerevisiae for the treatment of asthma

Номер патента: WO2005037064A3. Автор: D Betty Lew. Владелец: Univ Tennessee Res Foundation. Дата публикации: 2005-06-16.

Compositions and methods for blocking neuropilin receptor 1 for the treatment of pain and prevention of viral entry

Номер патента: US20240002361A1. Автор: Rajesh Khanna,Aubin Moutal,Samantha Perez-Miller. Владелец: University of Arizona. Дата публикации: 2024-01-04.

Compositions and methods for blocking neuropilin receptor 1 for the treatment of pain and prevention of viral entry

Номер патента: WO2022108995A1. Автор: Rajesh Khanna,Aubin Moutal,Samantha Perez-Miller. Владелец: Arizona Board of Regents on Behalf of the University of Arizona. Дата публикации: 2022-05-27.

Compositions for the prevention or treatment of dry eyes

Номер патента: RU2763423C1. Автор: Нина ХА,Йоунг Ил ЧОЙ,Таек Хван ШИН. Владелец: Чонг Кун Данг Фармасьютикал Корп.. Дата публикации: 2021-12-29.

A pharmaceutical composition comprising an extract from trichilia sp. and its use for treating and preventing ventricular fibrillation

Номер патента: CA2534869C. Автор: Carlos Eduardo De Carvalho,Ney Osvaldo Silva Filho,Luc Edmond Leon Andre Raes,Irineu Tadeu Velasco,Vera Pontieri,Augusto Scalabrini Neto,Celia Ivete Fernandes. Владелец: Laboratorio Catarinense SA. Дата публикации: 2013-10-15.

The use of gonadoliberin and gonadoliberin agonists for the treatment of metabolic disorders which are attributable to the level of parathyroid hormone being too low

Номер патента: ZA847047B. Автор: Wolfgang Koenig,Horst Neubauer. Владелец: Hoechst AG. Дата публикации: 1985-04-24.

Use of rho gtpase activating toxins for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: EP2536424B1. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore di Sanita ISS. Дата публикации: 2014-06-04.

Treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction

Номер патента: CA2254528A1. Автор: Naranjan S. Dhalla,Rajat Sethi,Krishnamurti Dakshinamurti. Владелец: University of Manitoba . Дата публикации: 2000-01-09.

Pharmaceutical composition and its use for treatment and/or prevention of diseases of the respiratory tract

Номер патента: WO2010091489A1. Автор: Emanuel Sávio Cavalcanti SARINHO. Владелец: Hebron Farmacêutica Pesquisa, Desenvolvimento E Inovação Tecnológica Ltda.. Дата публикации: 2010-08-19.

Use of mannuronic diacid composition in treatment of pain

Номер патента: AU2019296850A1. Автор: Jian Ding,Meiyu Geng,Zhenqing ZHANG,Xianliang Xin. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-01-28.

Pharmaceutical product for the treament of obesity and associated metabolic syndrome diseases, uses and methods of treatment

Номер патента: WO2023164752A1. Автор: Joao Batista Calixto,Melina Heller,Rodrigo Marcon,Jarbas Mota SIQUEIRA JUNIOR,Cristina Setim FREITAS,Edinéia LEMOS DE ANDRADE,Adara ÁUREA DOS SANTOS,Sérgio José MACEDO JÚNIOR. Владелец: Centro De Inovação E Ensaios Pré-Clínicos. Дата публикации: 2023-09-07.

Use of the gdf-5 mutant for the treatment of pain and cartilage destruction

Номер патента: IL293988A. Автор: Anne GIGOUT,Daniela WERKMANN,Kerstin Kleinschmidt-Doerr. Владелец: Kleinschmidt Doerr Kerstin. Дата публикации: 2022-08-01.

Use of derivatives of polyunsaturated fatty acids as medicaments

Номер патента: US09907772B2. Автор: Pablo Vicente Escribá Ruiz,María Laura MARTÍN,Xavier Busquets Xaubet,Victoria LLADÓ CAÑELLAS,Rafael ÁLVAREZ MARTÍNEZ. Владелец: Lipopharma Therapeutics SL. Дата публикации: 2018-03-06.

Use of derivatives of polyunsaturated fatty acids as medicaments

Номер патента: US09763907B2. Автор: Pablo Vicente Escribá Ruiz,María Laura MARTÍN,Xavier Busquets Xaubet,Victoria LLADÓ CAÑELLAS,Rafael ÁLVAREZ MARTÍNEZ. Владелец: Lipopharma Therapeutics SL. Дата публикации: 2017-09-19.

Use of derivatives of polyunsaturated fatty acids as medicaments

Номер патента: US09763906B2. Автор: Pablo Vicente Escribá Ruiz,María Laura MARTÍN,Xavier Busquets Xaubet,Victoria LLADÓ CAÑELLAS,Rafael ÁLVAREZ MARTÍNEZ. Владелец: Lipopharma Therapeutics SL. Дата публикации: 2017-09-19.

Use of antisecretory factors for treating intraocular hypertension

Номер патента: CA2771087C. Автор: Stefan Lange,Hans-Arne Hansson,Eva Jennische. Владелец: LANTMANNEN AS-FAKTOR AB. Дата публикации: 2016-03-15.

Use of antisecretory protein to treat intraocular hypertension

Номер патента: CA2650344C. Автор: Stefan Lange,Hans-Arne Hansson,Eva Jennische. Владелец: LANTMANNEN AS-FAKTOR AB. Дата публикации: 2017-10-31.

Use of polypeptides of human origin for the treatment of microbial infectious diseases

Номер патента: AU2003219059A1. Автор: Hans Henning Von Horsten,Christiane Kirchhoff,Petra Derr. Владелец: LAGOW GmbH. Дата публикации: 2003-09-29.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: EP2326667A1. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2011-06-01.

Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas

Номер патента: WO2007033959A3. Автор: Geert Raes,Baetselier Patrick De,Ghassabeh Gholamre Hassanzadeh. Владелец: Ghassabeh Gholamre Hassanzadeh. Дата публикации: 2007-11-22.

Use of the protein uk114 or of fragments thereof for treatment and prevention of the endotoxic shock

Номер патента: IL158333A0. Автор: . Владелец: Zetesis SpA. Дата публикации: 2004-05-12.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: WO2010025530A9. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal Do Rio De Janeiro - Ufrj. Дата публикации: 2010-07-29.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: WO2010025530A1. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal Do Rio De Janeiro - Ufrj. Дата публикации: 2010-03-11.

Pharmaceutical combinations of statins and fibrates for the treatment and prevention of hyperlipidemias and cardiovascular disease

Номер патента: US20230355578A1. Автор: Jorge Alejandro GONZÁLEZ CANUDAS,Sixto Serafin Espinoza Leon,Paola Yazmin Ollervides Rubio,Claudia Delfina FARFÁN SALAZAR. Владелец: Laboratorios Silanes SA de CV. Дата публикации: 2023-11-09.

Use of an anti-microtubule agent for the treatment of uveitis

Номер патента: AU2002350362A1. Автор: Pierre E. Signore. Владелец: Angiotech Pharmaceuticals Inc. Дата публикации: 2003-07-30.

Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux

Номер патента: AU2003249541A8. Автор: Bernard Perbal. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2004-02-02.

Use of kynurenic acid amide derivatives for the treatment of huntington disease

Номер патента: HUP1000343A2. Автор: Istvan Dr Szatmari,Ferenc Dr Fueloep,Andras Szoenyi,Laszlo Dr Vecsei,Denes Dr Zadori,Peter Dr Klivenyi,Jozsef Dr Toldi,Tamas Dr Freund,Gabor Dr Nyiri. Владелец: Univ Szegedi. Дата публикации: 2012-02-28.

Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux

Номер патента: AU2003249541A1. Автор: Bernard Perbal. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2004-02-02.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: EP4267134A4. Автор: Porta Diana Graus,BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2024-11-06.

USE OF HEMOLYMPH OR HEMOLYMPH COMPONENTS FOR THE TREATMENT AND PREVENTION OF INFLAMMATION AND DRY SKIN

Номер патента: US20210177913A1. Автор: Bayer Robert,Breeding William Patrick. Владелец: . Дата публикации: 2021-06-17.

Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis

Номер патента: WO2002067974A1. Автор: Kerstin Uvnas-Moberg,Thomas Lundeberg. Владелец: Uvnaes-Moberg Kerstin. Дата публикации: 2002-09-06.

Dosing regimens for the treatment of fabry disease

Номер патента: CA2829947C. Автор: Douglas Stuart Greene,Kenneth Joseph Valenzano. Владелец: Amicus Therapeutics Inc. Дата публикации: 2019-01-15.

Use of angiotensin in the treatment of cancer metastasis

Номер патента: EP1104305B1. Автор: Gavin Paul Division of Biom. Sciences VINSON,John Richard Division of Biom. Science PUDDEFOOT,Miles Gordon Division of Biom. Sciences BERRY. Владелец: QUEEN MARY AND WESTFILED COLLEGE UNIVERSITY OF LONDON. Дата публикации: 2005-03-23.

Combination comprising pterostilbene for the treatment of cancer

Номер патента: US20180214390A1. Автор: José María ESTRELA ARIGÜEL,Maria Benlloch Garcia,María Elena PLÁ OBRADOR,Lilian Soraya VALLÉS MARTÍN,María Lucía RODRÍGUEZ ROMERO,Joan Antoni SIREROL TALENS,Javier Luis ALCÁCER GARCÍA,José Alfredo PELLICER ARTÉS,Rosario SALVADOR PALMER,Guillermo María SÁEZ TORMO,Concepción CERDÁ MICÓ. Владелец: Fundacio Investigacio Hospital General Universitari De Valencia Per A La Investigacio. Дата публикации: 2018-08-02.

Use of low volume plasma exchange for treating the early and middle stages of alzheimer's disease

Номер патента: US20240115665A1. Автор: Victor Grifols Roura,Antonio Manuel Paez Regadera,Laura Nunez Domenech. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2024-04-11.

The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure

Номер патента: WO2003070274A1. Автор: William T. Barchuk,Martin Kaul,Lothar Daum,Jürgen EISELSTEIN,Heidrun Dorothea Abdelghany,Lori L. Van Meter. Владелец: Abbott GmbH & Co. KG. Дата публикации: 2003-08-28.

USE OF N-CARBOXIMETABLE BENZOLACTAMES REPLACED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE INHIBITION OF THE METALOPROTEINAS OF THE MATRIX, PARATRATATION OF A STATE OF NEOPLASIC DISEASE, FOR THE TREATMENT OF ATEROSCLEROSIS, FOR THE TREATMENT OF A INFRINGEMENT

Номер патента: AR023366A1. Автор: . Владелец: Hoechst Marion Roussel Inc. Дата публикации: 2002-09-04.

Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases

Номер патента: WO1994022441A3. Автор: James Ferguson,Michael Goodman. Владелец: Bioglan Ireland R & D Ltd. Дата публикации: 1994-11-24.

Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases

Номер патента: WO1994022441A2. Автор: James Ferguson,Michael Goodman. Владелец: Bioglan Ireland (R & D) Limited. Дата публикации: 1994-10-13.

Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid

Номер патента: US20020147137A1. Автор: Herwig Reichl,Konstantin Hiotakis. Владелец: Hamosan Erzeugung Pharmazeutischer Grundstoffe GmbH. Дата публикации: 2002-10-10.

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

Номер патента: EP1572709A2. Автор: Holger Beckmann,Richard G. Wilde,Neil G. Almstead,Ellen M. Welch. Владелец: PTC Therapeutics Inc. Дата публикации: 2005-09-14.

Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis

Номер патента: CA2568997C. Автор: Geoffrey Guy,Philip Robson. Владелец: GW Pharma Ltd. Дата публикации: 2012-12-04.

Vascular endothelial growth factor inhibitors for the treatment of joint disorders

Номер патента: WO2024020641A1. Автор: Sumit Raniga. Владелец: Macquarie University. Дата публикации: 2024-02-01.

Use of a metal ion chelating agent for the treatment of animal and human parasites

Номер патента: EP1879576A1. Автор: Russell Taylor. Владелец: AQand PLC. Дата публикации: 2008-01-23.

Use of a metal ion chelating agent for the treatment of animal and human parasites

Номер патента: CA2606908A1. Автор: Russell Taylor. Владелец: Aq+Plc. Дата публикации: 2006-10-19.

Compositions and methods for the prevention and/or treatment of covid-19

Номер патента: CA3154578A1. Автор: Eric G. Marcusson. Владелец: Providence Therapeutics Holdings Inc. Дата публикации: 2023-10-08.

Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy

Номер патента: EP1562575A1. Автор: Sanjay R. Chemburkar,Youssef L. Bennani,Michael J. Dart,Sou-Jen Chang,Timothy A. Grieme,Dilinie P. Fernanado. Владелец: ABBOTT LABORATORIES. Дата публикации: 2005-08-17.

Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy

Номер патента: WO2004037241A1. Автор: Sanjay R. Chemburkar,Youssef L. Bennani,Michael J. Dart,Sou-Jen Chang,Timothy A. Grieme,Dilinie P. Fernanado. Владелец: ABBOTT LABORATORIES. Дата публикации: 2004-05-06.

Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders

Номер патента: AU6247996A. Автор: Ake Dahlgren,Attila Dahlgren. Владелец: ISM INST FOR SOCIO MEDICAL RES. Дата публикации: 1997-01-22.

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

Номер патента: AU2003261237A8. Автор: Holger Beckmann,Neil G Almstead,Richard G Wilde,Ellen M Welch. Владелец: PTC Therapeutics Inc. Дата публикации: 2004-02-09.

Combinations of tumor-associated antigens for the treatment of various types of cancers

Номер патента: AU2004249254B2. Автор: John J. L. Simard,David C. Diamond,Adrian Bot,Chih-Sheng Chiang. Владелец: MANNKIND CORP. Дата публикации: 2010-07-08.

Combinations of tumor-associated antigens for the treatment of various types of cancers

Номер патента: WO2004112825A3. Автор: Adrian Bot,David C Diamond,Chih-Sheng Chiang,John J L Simard. Владелец: John J L Simard. Дата публикации: 2005-05-06.

Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases

Номер патента: WO2003086408A8. Автор: Joel M Linden,Jayson M Rieger,Timothy L Macdonald,Gail W Sullivan,W Michael Scheld,Tom G Obrig. Владелец: Tom G Obrig. Дата публикации: 2005-01-13.

Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases

Номер патента: EP1496911A1. Автор: Joel M. Linden,Jayson M. Rieger,Gail W. Sullivan,Timothy L. MacDonald,Michael W. Scheld,Tom G. Obrig. Владелец: University of Virginia UVA. Дата публикации: 2005-01-19.

Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity

Номер патента: AU2003237933A8. Автор: Peter Eriksson,Jenny Nyberg. Владелец: CELLARTIS AB. Дата публикации: 2003-12-22.

Use of a liposome encapsulated vincristine for the preparation of a pharmaceutical composition for treating cancer

Номер патента: IL145720A. Автор: . Владелец: Hana Biosciences Inc. Дата публикации: 2011-05-31.

Use of an adsorbate comprising tadalafil for the preparation of a dosage form and use thereof for the treatment of erectile dysfunction, as well as processes for the preparation of said adsorbate and said dosage form

Номер патента: EA031818B1. Автор: Рок Грахек,Андрей Бастарда,Миха Томаз Яклиц,Клемен Коцевар,Само Пирц. Владелец: Лек Фармасьютиклз Д.Д.. Дата публикации: 2019-02-28.

Use of CBP/EP300 bromodomain inhibitors for cancer immunotherapy

Номер патента: AU2014331697A1. Автор: Jean-Christophe Harmange,Benjamin Fauber,Srimoyee GHOSH,James Edmund Audia,Brian K. Albrecht,Alexandre Cote,F. Anthony Romero,Terry CRAWFORD,Alexander M. Taylor,Steven Magnuson,Vickie Tsui,Steven Bellon,Jeong Kim,Andrea Cochran,Jose M. Lora,Georgia Hatzivassiliou,Hariharan JAYARAM,Ira Mellman. Владелец: Constellation Pharmaceuticals Inc. Дата публикации: 2016-05-05.

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF HYPERCHOLESTEREMIA CAUSED BY ANTIRETROVIRAL TREATMENT IN HIV-INFECTED PATIENTS

Номер патента: RU2007123368A. Автор: Жан ГАРДЕТТ,Жан ГАРДЕТТ (FR). Владелец: Пьер Фабр Медикаман (Fr). Дата публикации: 2009-01-10.

compounds, process for their preparation, pharmaceutical composition comprising them, use of these compounds and method for the treatment and prophylaxis of diabetes, obesity, eating disorders, dyslipidemia and hypertension

Номер патента: BRPI0615039A2. Автор: Bernd Kuhn,Daniel Hunziker,Werner Neidhart,Kurt Amrein,Alexander V Mayweg. Владелец: Hoffmann La Roche. Дата публикации: 2011-04-26.

Process for the preparation of a compound derived from etorphine; etorphine derivative compound; pharmaceutical composition comprising it; use of the compound as an analgesic in the treatment of pain.

Номер патента: CL2011001363A1. Автор: Steve Whitelock,Deborah Phyllis Harding,Carl David Turner. Владелец: Euro Celtique SA. Дата публикации: 2011-09-23.

Use of anti-ngf antibody for improving stiffness in osteoarthritis

Номер патента: CA2604443C. Автор: Arnon Rosenthal,David L. Shelton,Patricia Ann Walicke. Владелец: Rinat Neuroscience Corp. Дата публикации: 2018-04-03.

USE OF BETA-CAROTIN AND LYCOPINE FOR THE TREATMENT OF SKIN AGING BY INHIBITING THE IMPACT OF THE METAL OPROTEINASE OF TYPE 1 OF THE EXTRACELLULAR MATRIX

Номер патента: DE60135364D1. Автор: Lionel Breton,Markus Baur. Владелец: LOreal SA. Дата публикации: 2008-09-25.

Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations

Номер патента: PH12016501553A1. Автор: Shankar Bodapunti Prabha,Gulik Frederick Van,Yamsani Madhusudan Rao. Владелец: Eurodrug Laboratories B V. Дата публикации: 2017-09-11.

Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations

Номер патента: PH12015500353A1. Автор: Gulik Van Frederick,Rao Yamsani Madhusudan,Prabha Shankar Bodapunti. Владелец: Eurodrug Lab B V. Дата публикации: 2015-04-20.

Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases

Номер патента: US09415036B2. Автор: Enrico Bastianelli. Владелец: Bone Therapeutics SA. Дата публикации: 2016-08-16.

Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer

Номер патента: US20180000822A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2018-01-04.

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

Номер патента: US20220062286A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2022-03-03.

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

Номер патента: US20200237762A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2020-07-30.

GPR120 RECEIVER AGONISTS AND USES OF THE SAME IN MEDICINES FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME.

Номер патента: AR074760A1. Автор: Xin Chen,Jiangao Song,Jingyuan Ma,Aaron Novack,Dong Fang Shi,Phuongly Pham,Christopher J Rabbat,Imad Fayek Nashashibi. Владелец: Metabolex Inc. Дата публикации: 2011-02-09.

Method of local treatment of typical form of lichen planus of oral mucosa with use of adhesive plates containing lamifaren biogel

Номер патента: RU2675860C1. Автор: Миляуша Фаузиевна Кабирова,Лариса Павловна Герасимова,Расима Рашитовна Хайбуллина,Ирина Николаевна Усманова,Марсель Маратович Туйгунов,Ирина Александровна Галимова,Ирек Рамимович Усманов,Рауза Фазыловна Хуснаризанова. Владелец: федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации. Дата публикации: 2018-12-25.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: KR101136702B1. Автор: 토마스 헬레데이. Владелец: 더 유니버시티 오브 셰필드. Дата публикации: 2012-04-20.

The use of Wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: AU2009282525A1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2010-02-18.

Nitrocarboxylic acid is used for the treatment of, diagnose and prevent the purposes of aggressive healing pattern

Номер патента: CN102970972B. Автор: 安雷戚·迪兹. Владелец: Individual. Дата публикации: 2015-12-16.

Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma

Номер патента: AU7726796A. Автор: Verney L. Sallee,Thomas R. Dean,Mark Hellberg. Владелец: Alcon Laboratories Inc. Дата публикации: 1997-07-17.

THE USE OF BRADYKININ-B2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OSTEOARTHROSIS

Номер патента: DE502004001159D1. Автор: Martin Michaelis,Karl Rudolphi. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2006-09-21.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: CA2533423A1. Автор: Thomas Helleday. Владелец: Thomas Helleday. Дата публикации: 2005-02-10.

Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Номер патента: EP0676199A1. Автор: Arthur E. Girard,Thomas D. Gootz. Владелец: PFIZER INC. Дата публикации: 1995-10-11.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: PL1649017T5. Автор: Thomas Helleday. Владелец: Univ Sheffield. Дата публикации: 2015-02-27.

Use of a phosphoric acid diester for the manufacture of a medicament for the treatment of acne

Номер патента: EP0821962B1. Автор: Kazumi Ogata,Takahiro Sakaue,Sachiko Matsuura,Masahito Iemura. Владелец: Senju Pharmaceutical Co Ltd. Дата публикации: 2001-10-17.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: EP2328604A4. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2012-03-14.

Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis.

Номер патента: DE68912195D1. Автор: Ian Richard Scott. Владелец: Unilever NV. Дата публикации: 1994-02-24.

Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections

Номер патента: EP0286825A3. Автор: Fritz Prof. Dr. Eckstein,Gerhard Prof. Dr. Hunsmann,Heinz Dr. Hartmann. Владелец: Deutsches Primatenzentrum GmbH. Дата публикации: 1989-04-12.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Номер патента: HU9800133A2. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Novo Nordisk A/S. Дата публикации: 1998-12-28.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: EP2328604B1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2014-10-08.

Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

Номер патента: AU2021297152A1. Автор: Maurice Zauderer,Elizabeth E. Evans,Wendy Gold,Matthew Yilin MAO. Владелец: Sydney Childrens Hospitals Network. Дата публикации: 2023-02-02.

Compound, pharmaceutical composition, use of a compound, and, processes for the treatment of a retrovirus infection in a human being and for the preparation of a compound.

Номер патента: BR9912156A. Автор: Hardev Singh,Ian Gordon Armitage,Andre David Searle. Владелец: Glaxo Group Ltd. Дата публикации: 2001-04-10.

USES OF GROWTH HORMONE IN COMPOSITIONS FOR THE TREATMENT OF INSULIN RESISTANCE IN THE HEART

Номер патента: PT1007085E. Автор: Harriet Ronnholm,Stephen James,Thomas Olin,Christina Reuterdahl,Axel STÅHLBOM,Antek Wielburski. Владелец: Pharmacia AB. Дата публикации: 2002-05-31.

THE USE OF INHALED HENLE HANDLE DIURETICS FOR THE TREATMENT OF ALLERGEN-INDUCED NASAL REACTIONS.

Номер патента: ES2052998T3. Автор: Sebastiano Bianco. Владелец: Hoechst AG. Дата публикации: 1994-07-16.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia

Номер патента: CA2208868A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Individual. Дата публикации: 1996-07-18.

Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies

Номер патента: EP1039916B8. Автор: Patrick Durand,Jacqueline Jozefonvicz,Corinne Sinquin,Karim Senni,Didier Letourneur,Bruno Gogly,Sylvia Colliec-Jouault,Bernard Pellat,Catherine Blondin. Владелец: Institut Francais de Recherche pour lExploitation de la Mer (IFREMER). Дата публикации: 2004-04-21.

USE OF A SERENOA REPENS EXTRACT FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PROSTATE CANCER

Номер патента: FR2791573B1. Автор: Henri Cousse,Pierre Fabre,Jean Pierre Raynaud. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2003-04-11.

USE OF A CHRYSANTHELLUM INDICUM EXTRACT FOR THE TREATMENT OF THE ACNE ROSACEA

Номер патента: DE60312988D1. Автор: Nicolas Fouchere. Владелец: SICOBEL LAB. Дата публикации: 2007-05-16.

Use of myristoylated n-terminal peptide for the manufacture of a medicament for the treatment of inflammatory conditions

Номер патента: IL193846A. Автор: . Владелец: Biomarck Pharmaceuticals Ltd. Дата публикации: 2015-05-31.

Use of npy y5 receptor antagonist for the treatment of circadian rhythm disorders

Номер патента: CA2540190A1. Автор: Jeffrey Scott Sprouse,Francisca Fatima Matos. Владелец: Francisca Fatima Matos. Дата публикации: 2005-04-07.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Номер патента: HUP9800133A3. Автор: . Владелец: Novo Nordisk AS. Дата публикации: 1999-12-28.

Mirna composition comprising 11 specific mirnas and its use in the treatment of cancer

Номер патента: EP4263830A1. Автор: Sebastien Jauliac. Владелец: Université Paris Cite. Дата публикации: 2023-10-25.

Mirna composition comprising 11 specific mirnas and its use in the treatment of cancer

Номер патента: US20240084300A1. Автор: Sebastien Jauliac. Владелец: Université de Paris. Дата публикации: 2024-03-14.

Use of polypeptides and nucleic acids for the preparation of medicaments for the treatment of cancer and/or arthritis

Номер патента: IL186754A0. Автор: . Владелец: Yorke Smith Melanie. Дата публикации: 2008-02-09.

Use of an il-21 polypeptide for the preparation of pharmaceutical composition for decreasing cd4+ t-cell autoimmune response in a mammal

Номер патента: IL174175A. Автор: . Владелец: Zymogenetics Inc. Дата публикации: 2011-06-30.

Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome

Номер патента: US20150045312A1. Автор: Neary Michael,Beyer Chad. Владелец: . Дата публикации: 2015-02-12.

USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF A CHRONIC INFLAMMATORY INTESTINAL DISEASE

Номер патента: US20220062247A1. Автор: Le Grand Bruno,SABLAYROLLES Sylvie. Владелец: . Дата публикации: 2022-03-03.

USE OF CAPRYLIC AND CAPRIC TRIGLYCERIDES FOR THE TREATMENT OF A DISEASE OR CONDITION MEDIATED BY FILAGGRIN OR COLLAGEN DEFICIENCY

Номер патента: US20220175712A1. Автор: GRANGER Corinne Jeanne Rose,TRULLAS CABANAS Carlos Ramon. Владелец: . Дата публикации: 2022-06-09.

USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS

Номер патента: US20200207848A1. Автор: Mpofu Shephard. Владелец: . Дата публикации: 2020-07-02.

USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS

Номер патента: US20210309736A1. Автор: Mpofu Shephard. Владелец: . Дата публикации: 2021-10-07.

USE OF A POSTBIOTIC-BASED COMPOSITION FOR THE TREATMENT OF SKIN DISEASES

Номер патента: US20200353021A1. Автор: RESCIGNO Maria,PENNA Giuseppe,ALGIERI Francesca. Владелец: POSTBIOTiCA S.R.L.. Дата публикации: 2020-11-12.

USE OF IBOGAINE AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN

Номер патента: US20170368073A1. Автор: Friedhoff Lawrence. Владелец: DEMERX, INC.. Дата публикации: 2017-12-28.

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

Номер патента: US20040224997A1. Автор: Gan Wang,Stephen O'Connor,LEI Zhu,Roger Smith,Ning Su,Ann-Marie Campbell,Philip Coish,Miao Dai,Susan Jenkins,Derek Lowe,Mingbao Zhang. Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2004-11-11.

USE OF ANTAGONIST ANTI-CD40 ANTIBODIES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Номер патента: DE602004028270D1. Автор: Li Long,Mohammad Luqman,Asha Yabannavar,Isabel Zaror,Sharon Lea Aukerman. Владелец: Novartis Vaccines and Diagnostics Inc. Дата публикации: 2010-09-02.

Use of semaphorin-4d binding molecules for the treatment of rett syndrome

Номер патента: US20210403559A1. Автор: Maurice Zauderer,Elizabeth E. Evans,Yilin MAO,Wendy Gold. Владелец: SYDNEY CHILDREN'S HOSPITAL NETWORK. Дата публикации: 2021-12-30.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: WO2022089767A1. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2022-05-05.

Use of locally delivered metal ions for the treatment of periodontal disease

Номер патента: JP2001515042A. Автор: エフ． ドナルド ロバーツ,フィリップ エム． フライデン,ピーター スパシアポリ,エリック ネルソン. Владелец: ピリオドンティックス インク．. Дата публикации: 2001-09-18.

Use of pyrazole derivative as cannabinoid CB1 receptor antagonist, for treatment and prevention of metabolic syndrome, particularly cardiovascular risks, dyslipidemia and liver disease associated with obesity

Номер патента: FR2861303A1. Автор: Philip Janiak,Jean Marc Herbert,Michele Arnone,Hassan Massoud Hesmati. Владелец: Sanofi Synthelabo SA. Дата публикации: 2005-04-29.

USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF CHRONIC INTESTINAL INFLAMMATORY DISEASE

Номер патента: FR3090317A1. Автор: Sylvie Sablayrolles,Bruno Le Grand. Владелец: Cvasthera. Дата публикации: 2020-06-26.

USE OF A TNF-ALPHA ANTAGONIST FOR THE TREATMENT OF CUTANEOUS REDNESS OF NEUROGENIC ORIGIN

Номер патента: FR2741262B1. Автор: Lionel Breton,Lacharriere Olivier De. Владелец: LOreal SA. Дата публикации: 1999-03-05.

Use of substituted 2,5-diamidoindoles for the treatment of urological diseases

Номер патента: CA2510811A1. Автор: Hiroko Takagi,Stefan Weigand,Joerg Keldenich,Michael Brands,Hanno Wild,Masaomi Tajimi,Christian Schroeder,Stephan Siegel,Thomas Krahn,Jens Erguden,Johannes Peter Stasch,Dirk Heimbach. Владелец: Individual. Дата публикации: 2004-07-08.

use of isolated mastic gum fractions for the treatment of optic neuropathy

Номер патента: BR112017019154A2. Автор: Hazan Zadik,ADAMSKY Konstantin,C B Lucassen Andre. Владелец: Regenera Pharma Ltd. Дата публикации: 2018-05-02.

Use of polyphenol-containing plant extracts for the treatment of obesity and type 2 diabetes mellitus

Номер патента: DE102009005201A1. Автор: Ludwig Prof. Dr. Jonas,Peeter Dr. Toomik,Tönu Dr. Püssa. Владелец: UNIVERSITAET ROSTOCK. Дата публикации: 2010-07-22.

Use of anti-PD-L1 antibodies for the treatment of head and neck cancer

Номер патента: CN113365659A. Автор: 陈杰,赵伟,张喜全,陈飞洋,陈德培,周雅倩,王训强,魏娇,朱漫杰. Владелец: Nanjing Shunxin Pharmaceutical Co Ltd. Дата публикации: 2021-09-07.

Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Номер патента: EP1882473A1. Автор: Paolo Morazzoni,Ezio Bombardelli. Владелец: Indena SpA. Дата публикации: 2008-01-30.

Use of asafetida extract as medicine for the treatment of withdrawal symptoms due to abstinence from drugs

Номер патента: GB2419092B. Автор: Zemin Wang. Владелец: Individual. Дата публикации: 2006-09-06.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: CA3197465A1. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2022-05-05.

USE OF EXENDINS AND THEIR AGONISTS FOR THE TREATMENT OF PREGNANCY DIABETES

Номер патента: DE60035584T2. Автор: Richard San Diego HILES,Kathryn S. San Diego PRICKETT. Владелец: Amylin Pharmaceuticals LLC. Дата публикации: 2008-04-10.

USE OF A TNF-ALPHA ANTAGONIST FOR THE TREATMENT OF CUTANEOUS REDNESS OF NEUROGENIC ORIGIN

Номер патента: FR2741262A1. Автор: Lionel Breton,Lacharriere Olivier De. Владелец: LOreal SA. Дата публикации: 1997-05-23.

Use of substituted 2,5-diamidoindoles for the treatment of urological diseases

Номер патента: AU2003303217A8. Автор: Hiroko Takagi,Jörg Keldenich,Stefan Weigand,Michael Brands,Christian Schröder,Hanno Wild,Masaomi Tajimi,Stephan Siegel,Thomas Krahn,Jens Erguden,Johannes Peter Stasch,Dirk Heimbach. Владелец: Bayer Healthcare AG. Дата публикации: 2004-07-14.

Use of certain isoquinoline sulfonyl compounds for the treatment of glaucoma and ocular ischemia

Номер патента: JP3719609B2. Автор: エイ． カピン，マイケル,エム．，ジュニア デサンティス，ルイス. Владелец: Asahi Kasei Pharma Corp. Дата публикации: 2005-11-24.

Use of semaphorin-4d binding molecules for the treatment of rett syndrome

Номер патента: CA3181833A1. Автор: Maurice Zauderer,Elizabeth E. Evans,Wendy Gold,Matthew Yilin MAO. Владелец: SYDNEY CHILDREN'S HOSPITAL NETWORK. Дата публикации: 2021-12-30.

Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists

Номер патента: EP1267867B1. Автор: Gordon Smith Baxter,Robert Alexander Coleman,Nicholas Tilford. Владелец: Asterand UK Ltd. Дата публикации: 2008-05-14.

Use of angiotensin II receptor antagonists for the treatment of acute myocardial infarction

Номер патента: DK1146872T3. Автор: Eric Michel Neuhart,Pascale Oddou,Jessica M Mann. Владелец: NOVARTIS AG. Дата публикации: 2006-10-16.

Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis

Номер патента: CA2267165A1. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Karl Theodor Kraemer. Дата публикации: 1998-04-02.

Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancer

Номер патента: WO2024072241A4. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-06-06.

Compound-diagnostic marker for uterine body cancer, method for detecting enzymatic activity, method for diagnosis of uterine body cancer, kit comprising the compound, uses of the compound and method for the treatment of uterine body cancer

Номер патента: WO2024005658A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-01-04.

Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancer

Номер патента: WO2024072241A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-04-04.

Compound - diagnostic marker for kidney cancer, method lor detecting enzymaticactivity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancer

Номер патента: WO2023204721A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2023-10-26.

Method for the determination and use of a standard operational value for the delay time of a radiographic system

Номер патента: US20150085987A1. Автор: Walter Exelmans,Patrick Pandelaers,Patrick Lambrechts. Владелец: AGFA HEALTHCARE NV. Дата публикации: 2015-03-26.

Method for the determination and use of a standard operational value for the delay time of a radiographic system

Номер патента: US9474499B2. Автор: Walter Exelmans,Patrick Pandelaers,Patrick Lambrechts. Владелец: AGFA HEALTHCARE NV. Дата публикации: 2016-10-25.

Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection

Номер патента: EP2063908A2. Автор: Andreas J. Kungl,Hermann-Josef Gröne,Jens Bedke. Владелец: PROTAFFIN BIOTECHNOLOGIE AG. Дата публикации: 2009-06-03.

Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection

Номер патента: US20110229433A1. Автор: Andreas J. Kungl,Hermann-Josef Gröne,Jens Bedke. Владелец: PROTAFFIN BIOTECHNOLOGIE AG. Дата публикации: 2011-09-22.

Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection

Номер патента: WO2008025507A2. Автор: Andreas J. Kungl,Hermann-Josef Gröne,Jens Bedke. Владелец: PROTAFFIN BIOTECHNOLOGIE AG. Дата публикации: 2008-03-06.

Carbohydrate composition extracted from panax ginseng and its use in the treatment of ischemic conditions

Номер патента: US20180125906A1. Автор: LIANG Liu,Hua Zhou,Quanbing Han,Yihan Zuo,Ruiqi Yue. Владелец: Macau Univ of Science and Technology. Дата публикации: 2018-05-10.

Treatment of ischemia reperfusion injury using alpha-2 macroglobulin

Номер патента: US20190142899A1. Автор: Antonio Abbate,Stefano TOLDO. Владелец: Virginia Commonwealth University. Дата публикации: 2019-05-16.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: WO2016097213A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health, S.L. Дата публикации: 2016-06-23.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: US20180011095A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health SL. Дата публикации: 2018-01-11.

Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection

Номер патента: WO2008025507A3. Автор: Andreas J Kungl,Jens Bedke,Hermann-Josef Groene. Владелец: Hermann-Josef Groene. Дата публикации: 2008-04-17.

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Номер патента: US20160296569A1. Автор: Andrea BIFFI,Simone Domenico Guglielmetti,Walter FIORE,Ruggero ROSSI. Владелец: SOFAR SPA. Дата публикации: 2016-10-13.

Use of vegf antagonist for treating retinopathy of prematurity

Номер патента: RU2676303C2. Автор: Сергей АКСЕНОВ,Габриэла БУРЬЯН. Владелец: НОВАРТИС АГ. Дата публикации: 2018-12-27.

Anti-toll-like receptor 2 antibodies for use in the treatment of cardiac inflammatory conditions

Номер патента: CA2693237C. Автор: Mark Heffernan,Christopher Locher,Luke O'neill,Peter Mcguirk,Brian Keogh,Dominique De Kleijn,Fatih Arslan,Gerard Pasterkamp. Владелец: OPSONA Therapeutics Ltd. Дата публикации: 2016-11-01.

Anti-S100A7 antibodies for the treatment and diagnosis of cancer

Номер патента: US09914768B2. Автор: Jaume Adan Plana,Laura Barbera Ferrando,Carme Calvis Calpe,Antonio Coll Manzano,Sheila Dakhel Plaza,Jose Luis Hernandez Miguez,Rosa Ma Hervas Villegas,Josep Maria Martinez Escola,Marc Masa Alvarez,Ramon Messeguer Peypoch,Francesc Mitjans Prat,Laura Padilla Garcia,Manuel Rivas Canas,Lourdes Tatiana Roque Navarro. Владелец: LYKERA BIOMED SA. Дата публикации: 2018-03-13.

Combination for the treatment of endothelial damage

Номер патента: US20030099687A1. Автор: Carl-Henrik Heldin,Arne Östman,Kari Alitalo,Seppo Yla-Herttuala,Olli LEPPÄNEN. Владелец: LICENTIA OY. Дата публикации: 2003-05-29.

Method for the treatment of keratin fibres employing alkali metal/alkaline earth metal ions, phosphate ions and an organic alkaline agent

Номер патента: WO2020260180A1. Автор: Christian Blaise. Владелец: L'oreal. Дата публикации: 2020-12-30.

Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages

Номер патента: US20060110396A1. Автор: Gerhard Gaedicke,Holger Lode,Veit Krenn,Raphaela Guenther. Владелец: Charite Universitaetsmedizin Berlin. Дата публикации: 2006-05-25.

Method of use of Xenon-133 for the treatment of AIDS, other viral and non-viral infections

Номер патента: US20050042301A1. Автор: Donald VanDeripe. Владелец: Individual. Дата публикации: 2005-02-24.

Use of akkermansia in the treatment of oral diseases

Номер патента: US20240293475A1. Автор: Salomon Amar,Willem M. deVOS. Владелец: Individual. Дата публикации: 2024-09-05.

Use of measles virus nucleoprotein for treating atherosclerosis

Номер патента: EP2083855A1. Автор: Branka Horvat,Alain Tedgui,Ziad Mallat. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2009-08-05.

Use of measles virus nucleoprotein for treating atherosclerosis

Номер патента: WO2008049888A1. Автор: Ziad Mallat. Владелец: Inserm (Institut National de la Sante et de la Recherche Medicale). Дата публикации: 2008-05-02.

Use of b cell depleting agents for the treatment of rheumatic heart disease

Номер патента: US20240270862A1. Автор: Xavier JOUVEN,Alexandre LOUPY. Владелец: Université Paris Cite. Дата публикации: 2024-08-15.

Composition for treatment and / or prevention of diseases of oral cavity, method for its preparation and use

Номер патента: RU2747983C1. Автор: Светлана Константиновна Матело,Александр Владимирович Гроссер,Татьяна Владимировна Купец. Владелец: Светлана Константиновна Матело. Дата публикации: 2021-05-18.

Structural carotenoid analogs for the inhibition and amelioration of disease

Номер патента: CA2495167C. Автор: Sean O'Malley,Henry Jackson,Geoff Nadolski,Samuel Fournier Lockwood,David G. Watumull,Laura M. Hix. Владелец: Cardax Pharma Inc. Дата публикации: 2018-08-21.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: EP3793567A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2021-03-24.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: US20190382761A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2019-12-19.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: WO2019241624A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc.. Дата публикации: 2019-12-19.

Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis

Номер патента: US20040053846A1. Автор: Walter Schubert. Владелец: Meltec Multi-Epitope-Ligand-Technologies GmbH. Дата публикации: 2004-03-18.

Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis

Номер патента: US20010055592A1. Автор: Walter Schubert. Владелец: Individual. Дата публикации: 2001-12-27.

Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors

Номер патента: US09458212B2. Автор: Sylviane Muller,Louis Danicher,Yves Frere,Anne Wawrezinieck. Владелец: Universite De Strasbourg. Дата публикации: 2016-10-04.

Method for the prevention or treatment of ischemia reperfusion injury.

Номер патента: EP2103310A1. Автор: Gerardus Anna Franciscus Nicolaes,Jan Rosing,Ten Hugo Cate,Björn Ulfson Dahlbäck. Владелец: UNIVERSITEIT MAASTRICHT. Дата публикации: 2009-09-23.

Methods for the production of committed cardiac progenitor cells

Номер патента: EP4402249A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2024-07-24.

Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders

Номер патента: US09585932B2. Автор: Wei Lu,Rui Rong Yuan,Peter C. Dowling. Владелец: Individual. Дата публикации: 2017-03-07.

Use of alveolar or airway organoids for the treatment of lung diseases and disorders

Номер патента: US12109242B2. Автор: Carla F. KIM,David RAISER,Sharon M. LOUIE,Erhan ARARAT. Владелец: Childrens Medical Center Corp. Дата публикации: 2024-10-08.

Prevention and Treatment of Ischemia-Reperfusion Injury and Related Conditions

Номер патента: US20130171236A1. Автор: Kulik Liudmila,Tsokos George C.,Holers Vernon Michael,Tomlinson Stephen. Владелец: . Дата публикации: 2013-07-04.

ALLEVIATION AND TREATMENT OF ISCHEMIA REPERFUSION-INDUCED LUNG INJURY USING PLURIPOTENT STEM CELLS

Номер патента: US20190201456A1. Автор: Okada Yoshinori,Dezawa Mari,YABUKI Hiroshi. Владелец: Life Science Institute, Inc.. Дата публикации: 2019-07-04.

Glycolipid for treatment of ischemia reperfusion injury

Номер патента: CA2807191A1. Автор: Monica Molteni. Владелец: Bluegreen Biotech SRL. Дата публикации: 2012-02-09.

Use of salt-bromine-iodine waters for the nasal treatment of the inflammation of the three areas of the upper airways and medical devices adapted to such a treatment

Номер патента: EP4175616A1. Автор: Antonio De Laurentiis. Владелец: Adl Farmaceutici Srl. Дата публикации: 2023-05-10.

Uses of hydroquinone substituted polyunsaturated fatty acids as antioxidants

Номер патента: US20040162347A1. Автор: Edward Leonard. Владелец: Individual. Дата публикации: 2004-08-19.

Use of salt-bromine-iodine waters for the nasal treatment of the inflammation of the three areas of the upper airways and medical devices adapted to such a treatment

Номер патента: WO2022003618A1. Автор: Antonio De Laurentiis. Владелец: Adl Farmaceutici S.R.L.. Дата публикации: 2022-01-06.

Use of hydrophilic-rich alkylmethylsiloxane-dimethylsiloxane-polyoxyalkylene copolymers as emulsifiers for the preparation of cosmetic o/w emulsions of improved aesthetic properties and mildness

Номер патента: US09566457B2. Автор: Michael E. Silver. Владелец: Individual. Дата публикации: 2017-02-14.

Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species

Номер патента: US8389482B2. Автор: Evgeny A. Nudler,Ruslan R. Rafikov. Владелец: New York University NYU. Дата публикации: 2013-03-05.

Polymeric fatty acid salt compounds for the treatment of fibrous amino acid-based substrates, especially hair

Номер патента: EP4355726A1. Автор: Roland Wagner,Christian Wenske,Katharina Streicher,Laura Rohmann,Shrutisagar Dattatraya HAVELI. Владелец: MOMENTIVE PERFORMANCE MATERIALS GMBH. Дата публикации: 2024-04-24.

Prevention, treatment and diagnosis of P. gingivalis infection

Номер патента: US09518109B2. Автор: Eric Charles Reynolds,Neil Martin O'brien Simpson,Nada Slakeski,Keith J Cross. Владелец: ORAL HEALTH AUSTRALIA PTY LTD. Дата публикации: 2016-12-13.

Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases

Номер патента: CA2269034A1. Автор: Jurg Tschopp,Michael Hahne,Michael SCHRÖTER,Fatima Da Conceicao-Silva. Владелец: Apotech Sa. Дата публикации: 1998-04-30.

Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state

Номер патента: CA2699624C. Автор: Christoph Gleiter,Lusine Danielyan,Rolf Gebhardt,Gayane Buniatian,Barbara Proksch. Владелец: UNIVERSITAET LEIPZIG. Дата публикации: 2017-11-21.

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Номер патента: US11839634B2. Автор: Andrea BIFFI,Simone Domenico Guglielmetti,Walter FIORE,Ruggero ROSSI. Владелец: Alfasigma Spa. Дата публикации: 2023-12-12.

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Номер патента: US20240050497A1. Автор: Andrea BIFFI,Simone Domenico Guglielmetti,Walter FIORE,Ruggero ROSSI. Владелец: Alfasigma Spa. Дата публикации: 2024-02-15.

C-cbl and antagonists thereof for the treatment and diagnosis of cancer

Номер патента: EP2396407A1. Автор: Daniel Regnier,Serge Manie,Sadok Yakoub,Eric Tabone. Владелец: Universite Claude Bernard Lyon 1 UCBL. Дата публикации: 2011-12-21.

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Номер патента: EP3041489A1. Автор: Andrea BIFFI,Simone Domenico Guglielmetti,Walter FIORE,Ruggero ROSSI. Владелец: SOFAR SPA. Дата публикации: 2016-07-13.

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Номер патента: CA2923392C. Автор: Andrea BIFFI,Simone Domenico Guglielmetti,Walter FIORE,Ruggero ROSSI. Владелец: SOFAR SPA. Дата публикации: 2023-01-03.

Use of an anti-microbial composition

Номер патента: WO1999009835A1. Автор: Johan de Faire. Владелец: Micro Active Protein In Sweden Ab. Дата публикации: 1999-03-04.

Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression

Номер патента: AU9162298A. Автор: Fritz Maurer,Bernard Schmidt,Franz-Josef Van Der Staay,Stephan Lensky. Владелец: Bayer AG. Дата публикации: 1999-03-16.

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Номер патента: US09914937B2. Автор: Frédéric Tangy,Clarisse Lorin,Lucile Mollet,Frederic Delebecque. Владелец: Institut Pasteur de Lille. Дата публикации: 2018-03-13.

Bacterium and extracts of said bacterium and the use of same in therapy

Номер патента: US09486486B2. Автор: Thien Nguyen,Christine Libon,Nathalie Castex-Rizzi,Bertrand Chol. Владелец: Pierre Fabre Dermo Cosmetique SA. Дата публикации: 2016-11-08.

Method for the in vitro production of a hepatocyte organoid

Номер патента: NL2033783B1. Автор: Schneeberger Kerstin,Kelsey Marsee Ary,Spee Bart. Владелец: Univ Utrecht Holding Bv. Дата публикации: 2024-06-27.

Method for the in vitro production of a hepatocyte organoid

Номер патента: WO2024133751A1. Автор: Kerstin SCHNEEBERGER,Bart SPEE,Ary Kelsey MARSEE. Владелец: Universiteit Utrecht Holding B.V.. Дата публикации: 2024-06-27.

Inhibitors of MRP4 for the Treatment of Vascular Disorders

Номер патента: US20100278809A1. Автор: Jean-Sébastien HULOT,Philippe Lechat,Anne-Marie Lompre,Yassine Sassi. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2010-11-04.

Use of amino acids as stabilizing compounds in pharmaceutical compositions containing high concentrations of protein-based therapeutic agents

Номер патента: EP3443346A1. Автор: Sajal Manubhai Patel,Sureshkumar Bhanaram CHOUDHARY. Владелец: MEDIMMUNE LLC. Дата публикации: 2019-02-20.

Use of amino acids as stabilizing compounds in pharmaceutical compositions containing high concentrations of protein-based therapeutic agents

Номер патента: US20240269273A1. Автор: Sajal Manubhai Patel,Sureshkumar Bhanaram CHOUDHARY. Владелец: MEDIMMUNE LLC. Дата публикации: 2024-08-15.

POLYMIXIN DERIVATIVE OF THE GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; METHOD FOR THE TREATMENT, RELIEF OR IMPROVEMENT OF AN INFECTION, IN A PATIENT, CAUSED BY A GRAM-NEGATIVE BACTERIA; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA TO AN ANTIBACTERIAL AGENT; METHOD FOR THE DEVELOPMENT OF UNPUBLISHED ANTIBIOTICS; METHODS FOR REDUCING THE TOXICITY OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING THE APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD TO IMPROVE PHARMACOKINETIC PROPERTIES, OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR THE AWARENESS OF CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA TO A DEFENSE MECHANISM COMPLEMENT IN THE SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A POLYMIXIN DERIVATIVE OF FORMULA (I)

Номер патента: BRPI0715095A2. Автор: Timo Vaara,Martti Vaara. Владелец: Northern Antibiotics Oy. Дата публикации: 2013-10-15.

Oregano for the treatment of internal parasites and protozoa

Номер патента: EP1089745A4. Автор: Daryl L Deluca,William S Sparks,Denis R Deluca,Robert A Ronzio. Владелец: Biotics Research Corp. Дата публикации: 2002-03-20.

Oregano for the treatment of internal parasites and protozoa

Номер патента: AU4442099A. Автор: Denis R. DeLuca,Robert A. Ronzio,Daryl L Deluca,William S Sparks. Владелец: Biotics Research Corp. Дата публикации: 2000-01-05.

Oregano for the treatment of internal parasites and protozoa

Номер патента: AU741087B2. Автор: Denis R. DeLuca,Robert A. Ronzio,Daryl L Deluca,William S Sparks. Владелец: Biotics Research Corp. Дата публикации: 2001-11-22.

Oregano for the treatment of internal parasites and protozoa

Номер патента: WO1999065505A1. Автор: Daryl L. DeLuca,William S. Sparks,Denis R. DeLuca,Robert A. Ronzio. Владелец: Biotics Research Corporation. Дата публикации: 1999-12-23.

Oregano for the treatment of internal parasites and protozoa

Номер патента: EP1089745A1. Автор: Daryl L. DeLuca,William S. Sparks,Denis R. DeLuca,Robert A. Ronzio. Владелец: Biotics Research Corp. Дата публикации: 2001-04-11.

Removal and prevention of tooth staining

Номер патента: RU2717682C2. Автор: Аарти РЕГЕ,Ричард САЛЛИВАН,Дэвид СУРИАНО. Владелец: КОЛГЕЙТ-ПАЛМОЛИВ КОМПАНИ. Дата публикации: 2020-03-25.

Use of b cell depleting agents for the treatment of rheumatic heart disease

Номер патента: EP4347647A1. Автор: Xavier JOUVEN,Alexandre LOUPY. Владелец: Université Paris Cite. Дата публикации: 2024-04-10.

Compositions and methods for the prevention and/or treatment of covid-19

Номер патента: WO2024073848A1. Автор: Richard Tran,Aleksandra Pastrak,Lawrence Reiter,Natalia Martin Orozco,Anne-Claude Gingras,Reuben SAMSON. Владелец: Providence Therapeutics Holdings Inc.. Дата публикации: 2024-04-11.

Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases

Номер патента: EP2322147A4. Автор: Munoz José Luis Pedraz,Calvar Carlos Spuch,Martin Rosa Maria Hernandez,Arroyo Gorka Orive,Tienda Desiree Antequera,Felix Bermejo-Pareja,Diaz Eva Carro. Владелец: Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre. Дата публикации: 2011-12-14.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: IL279391A. Автор: . Владелец: Ovid Therapeutics Inc. Дата публикации: 2021-01-31.

Agents for the prevention and/or treatment of central nervous system damage

Номер патента: US09889150B2. Автор: Jeremy Ewan Turnbull,Scott Ernest Guimond,Sophie Marie Thompson,Susan Carol Barnett,Jennifer Rosemary Higginson. Владелец: University of Glasgow. Дата публикации: 2018-02-13.

Therapeutic uses of factors which inhibit or neutralize MIF activity

Номер патента: US6774227B1. Автор: Jason Chesney,Richard J. Bucala. Владелец: Cytokine Pharmasciences Inc. Дата публикации: 2004-08-10.

Application of il-18 inhibitor for healing and/or prevention of atherosclerosis

Номер патента: YU82602A. Автор: Yolande Chvatchko,Alain Tedgui,Ziad Mallat. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2006-01-16.

POLYMIXIN DERIVATIVE OF GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; Method for Sensitizing Gram-Negative Bacteria to an Antibacterial Agent; METHOD FOR DEVELOPING ANTIBIOTICS; METHOD FOR REDUCING THE TOXICITY OF POLYMIXINES, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD FOR IMPROVING PHARMACOKINETIC PROPERTIES OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA CLINICALLY IMPORTANT TO A DEFENSE MECHANISM COMPLEMENT IN SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A FORMULA POLYMIXIN DERIVATIVE (I).

Номер патента: BRPI0715095B1. Автор: Vaara Martti,Vaara Timo. Владелец: Northern Antibiotics Oy. Дата публикации: 2018-08-07.

Neuropeptide y overexpression for use in the treatment of premature aging

Номер патента: WO2014174467A1. Автор: Clévio David RODRIGUES NÓBREGA,Luís Fernando MORGADO PEREIRA DE ALMEIDA,Cláudia Margarida GONÇALVES CAVADAS,Célia Alexandra FERREIRA DE OLIVEIRA AVELEIRA,Mariana BOTELHO DA ROCHA,Sara MATIAS CARMO SILVA. Владелец: UNIVERSIDADE DE COIMBRA. Дата публикации: 2014-10-30.

COSMETIC USES OF A JASMONIC ACID DERIVATIVE FOR THE NATURAL ANTIOXIDANT PROTECTION OF THE SKIN, FOR THE TREATMENT OF HAIR AND SCALP

Номер патента: FR2947449A1. Автор: Maria Dalko,Christophe Boulle. Владелец: LOreal SA. Дата публикации: 2011-01-07.

COSMETIC USES OF A JASMONIC ACID DERIVATIVE FOR THE NATURAL ANTIOXIDANT PROTECTION OF THE SKIN, FOR THE TREATMENT OF HAIR AND SCALP

Номер патента: FR2947449B1. Автор: Maria Dalko,Christophe Boulle. Владелец: LOreal SA. Дата публикации: 2011-10-21.

The purposes of penthorum chinense pursh and its extract in the oral cavity medicine thing for the treatment of or/and prevention of gingivitis is prepared

Номер патента: CN107362184A. Автор: 陈志敏,李文斌,吴珊珊,胡昌江,胡麟. Владелец: Chengdu University of Traditional Chinese Medicine. Дата публикации: 2017-11-21.

Pyropheophorbide conjugate and use thereof in the treatment of cancer and as a fluorescent marker

Номер патента: US11975072B2. Автор: Serge Mordon,Olivier Morales,Regis Vanderesse,Henri Azais,Pierre Collinet,Nadira Delhem-Fellahi,Celine Frochot,Aurelie Stallivieri. Владелец: Centre Hospitalier Regional Universitaire de Lille CHRU. Дата публикации: 2024-05-07.

Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders

Номер патента: US20190322741A1. Автор: Wei Chen,Paul A. Moore,Ezio Bonvini,Jon Marc Wigginton,Naimish Bharat Pandya. Владелец: Macrogenics Inc. Дата публикации: 2019-10-24.

Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction

Номер патента: WO1997004797A1. Автор: Thomas Gary Heffner,Michael Francis Rafferty,James Nicholson Wiley. Владелец: Warner-Lambert Company. Дата публикации: 1997-02-13.

USE OF AN ILEX AQUIFOLIUM EXTRACT FOR THE TREATMENT OF PIGMENTATION DISORDERS AND FOR BLEACHING OF THE SKIN

Номер патента: FR3078891B1. Автор: Jose Luis,Didier Gigmes,Kamel Mabrouk,Laila Mkimer,Abd Haq Bengeloune,Marion Verdoni. Владелец: Laboratoire Inoya. Дата публикации: 2020-12-25.

Use of a natural polysaccharide gel for the preparation of an injectable formulation for the treatment of joint degeneration

Номер патента: CA2691600C. Автор: Samuel Gavard Molliard,Olivier Benoit. Владелец: APTISSEN SA. Дата публикации: 2017-01-10.

Use of a protein-bound polysaccharide For the manufacture of a medicament for the treatment of AIDS.

Номер патента: DE3855525D1. Автор: Kenichi Matsunaga,Masaaki Takahashi,Koichi Niimura,Chikao Yoshikumi,Yoshiharu Oguchi,Kunitaka Hirose,Takao Furusho,Shigeaki Muto,Minoru Oohara,Junji Kakuchi,Norifumi Sugita. Владелец: Kureha Corp. Дата публикации: 1996-10-17.

Use of the FGFR1 ECD proteins for the treatment of cancer diseases characterized by ligand dependent activating mutations in FGFR2

Номер патента: DK2498799T3. Автор: Thomas Harding,Michael W Kavanaugh. Владелец: Five Prime Therapeutics Inc. Дата публикации: 2016-12-05.

USE OF A DNA OR RNA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF TUMOR CELLS.

Номер патента: ES2301602T3. Автор: Gary J. Nabel,Elizabeth G. Nabel. Владелец: University of Michigan. Дата публикации: 2008-07-01.

Methods for the use of cd32b x cd79b-binding molecules in the treatment of inflammatory diseases and disorders.

Номер патента: MX2018015265A. Автор: Chen Wei,Bonvini Ezio,A Moore Paul,Marc Wigginton Jon,Bharat Pandya Naimish. Владелец: Macrogenics Inc. Дата публикации: 2019-09-06.

Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals

Номер патента: AU2003264257A1. Автор: Günter Müller,Eckhard Boles,Silke Dlugai,Dörthe VOSS. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2004-04-08.

Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals

Номер патента: IL197621A0. Автор: . Владелец: Sanofi Aventis Deutschland. Дата публикации: 2011-08-01.

Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals

Номер патента: HK1084401A1. Автор: Guenter Mueller,Eckhard Boles,Silke Dlugai,Doerthe Voss. Владелец: Sanofi Aventis Deutschland. Дата публикации: 2006-07-28.

Use of Saccharomyces cerevisiae ERG4 mutants for the expression of glucose transporters from mammals

Номер патента: AU2003264257B2. Автор: Günter Müller,Eckhard Boles,Silke Dlugai,Dörthe VOSS. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2010-05-20.

Use of a particular metal oxide for the photoconversion of organic compounds on keratin materials

Номер патента: EP4251120B1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: LOreal SA. Дата публикации: 2024-10-09.

USE OF PEGYLATED IGF-1 VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

Номер патента: US20170014488A1. Автор: Metzger Friedrich,Holtmann Bettina,Sendtner Michael. Владелец: . Дата публикации: 2017-01-19.

USE OF ANTAGONISTS OF TH17 CYTOKINES FOR THE TREATMENT OF BRONCHIAL REMODELING IN PATIENTS SUFFERING FROM ALLERGIC ASTHMA

Номер патента: US20220033486A1. Автор: TSICOPOULOS Anne,AIT YAHIA SENDED Saliha,NANOU Julie,BOUTE Mélodie,VORNG Han,CHENIVESSE Cécile. Владелец: . Дата публикации: 2022-02-03.

USE OF EPO-DERIVED PEPTIDE FRAGMENTS FOR THE TREATMENT OF INFLAMMATORY DISEASES

Номер патента: US20170137483A1. Автор: Lu Wei,Yuan Rui Rong,Dowling Peter C.. Владелец: . Дата публикации: 2017-05-18.

USE OF EPO-DERIVED PEPTIDE FRAGMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Номер патента: US20140256629A1. Автор: Lu Wei,Dowling Peter C.,Rong Rui. Владелец: . Дата публикации: 2014-09-11.

Use of PEGylated IGF-I Variants For The Treatment Of Neuromuscular Disorders

Номер патента: US20150273023A1. Автор: Metzger Friedrich,Holtmann Bettina,Sendtner Michael. Владелец: . Дата публикации: 2015-10-01.

USE OF EPO-DERIVED PEPTIDE FRAGMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Номер патента: US20160271206A9. Автор: Lu Wei,Yuan Rong,Dowling Peter C.. Владелец: . Дата публикации: 2016-09-22.

Composition and use of humoral immune suppressor antagonists for the treatment of humoral immuno-suppressed diseases

Номер патента: WO2021026376A1. Автор: Luigi Grasso,Nicholas C. Nicolaides,James Bradford Kline. Владелец: Navrogen. Inc.. Дата публикации: 2021-02-11.

USE OF ANTI-TNF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF BACTERIAL MENINGITIS.

Номер патента: ES2121907T3. Автор: Richard F Hector,Michael S Collins. Владелец: Bayer Corp. Дата публикации: 1998-12-16.

Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases

Номер патента: US7255854B1. Автор: Fabienne MacKay,Paul D. Rennert,Jeffrey L. Browning,Paula S. Hochman. Владелец: Biogen Inc. Дата публикации: 2007-08-14.

USE OF PLAZENTA GROWTH FACTOR INHIBITORS FOR THE TREATMENT OF A PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND / OR VASCULARITY OF LIQUIDITY (ÖDEM)

Номер патента: DE60118186T2. Автор: Ruvo Menotti,Peter Carmeliet,Desire Collen,Sandro De Falco. Владелец: Desire Collen Research Foundation vzw. Дата публикации: 2006-12-28.

USE OF PLACENTARY GROWTH FACTOR INHIBITORS FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, FORMATION OF TUMORS AND / OR VASCULAR FIGURES

Номер патента: PT1297016E. Автор: MENOTTI Ruvo,Carmeliet Peter,De Falco Sandro,Desire Jose Collen. Владелец: Collen Res Foundation Vzw Onde. Дата публикации: 2006-07-31.

USE OF PLAZENTA GROWTH FACTOR INHIBITORS FOR THE TREATMENT OF A PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND / OR VASCULARITY OF LIQUIDITY (ÖDEM)

Номер патента: DE60118186D1. Автор: Ruvo Menotti,Peter Carmeliet,Desire Collen,Falco Sandro De. Владелец: Desire Collen Research Foundation vzw. Дата публикации: 2006-05-11.

Composition and Use of Humoral Immune Suppressor Antagonists for the Treatment of Humoral Immune Suppressed Diseases

Номер патента: US20210040174A1. Автор: Luigi Grasso,Nicholas C. Nicolaides,James Bradford Kline. Владелец: Navrogen Inc. Дата публикации: 2021-02-11.

Use of engineered macrophages in combination for the treatment of fibrotic diseases

Номер патента: CN115590880A. Автор: 刘玉,刘军花,尹秀山,鞠悦,房晓彬. Владелец: Kunshi Biotechnology Shenzhen Co ltd. Дата публикации: 2023-01-13.

Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis

Номер патента: CA2286791A1. Автор: Dick Heinegard,Lars Klareskog,Johnny C. Lorentzen. Владелец: Individual. Дата публикации: 1998-10-22.

Cosmetic and dermatological use of probiotic lactobacillus paracasei microorganisms for the treatment of greasy scalp disorders

Номер патента: PT2149368T. Автор: Gueniche Audrey,Castiel Isabelle. Владелец: Oreal. Дата публикации: 2018-10-08.

Use of antibodies against flt-1 for the treatment of osteoporosis

Номер патента: EP1517704A1. Автор: Peter Carmeliet,Desire Collen,Roger Bouillon,Gertrudis Carmeliet. Владелец: KU Leuven Research and Development. Дата публикации: 2005-03-30.

Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases

Номер патента: US20080026980A1. Автор: Nalan Utku,Steven Richard Blumberg. Владелец: Individual. Дата публикации: 2008-01-31.

USE OF DERIVATIVES OF SALICYLIC ACIDS FOR THE TREATMENT OF STRETCH MARKS

Номер патента: FR2739290B1. Автор: Chantal Fanchon. Владелец: LOreal SA. Дата публикации: 1997-11-14.

Use of agents derived from CEACAM1 for the treatment of inflammatory diseases

Номер патента: US20110189181A1. Автор: Nalan Utku,Steven Richard Blumberg. Владелец: Individual. Дата публикации: 2011-08-04.

Use of an ilex aquifolium extract for the treatment of pigmentation disorders and for skin bleaching

Номер патента: EP3765161B1. Автор: Jose Luis,Didier Gigmes,Kamel Mabrouk,Laila Mkimer,Abd Haq Bengeloune,Marion Verdoni. Владелец: Laboratoire In'oya Sas. Дата публикации: 2022-10-12.

Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases

Номер патента: EP1448224A2. Автор: Steffen Goletz,Renate Stahn,Udo Jeschke,Iduna Fichtner,Reinhard Zeisig. Владелец: NEMOD Immuntherapie AG. Дата публикации: 2004-08-25.

Use of a fermented cereal composition for the treatment of IBD and IBS

Номер патента: EP1769801A1. Автор: Hans Israelsen. Владелец: Hans Israelsen. Дата публикации: 2007-04-04.

USE OF DERIVATIVES OF SALICYLIC ACIDS FOR THE TREATMENT OF STRETCH MARKS

Номер патента: FR2739290A1. Автор: Chantal Fanchon. Владелец: LOreal SA. Дата публикации: 1997-04-04.

Use of Vasoactive Intestinal Peptide (VIP) for the treatment of drug-induced pneumonia

Номер патента: CN114144195A. Автор: J·米勒-克尔恩黑姆,B·C·弗里. Владелец: Adevita Life Sciences Co ltd. Дата публикации: 2022-03-04.

Use of inhibitors of pi3k-c2a for the treatment of apoptos i s-related disorders

Номер патента: WO2007055773A3. Автор: Leon Murphy,Peter Finan,Keigan Jeff Mac,Ellen Triantafellow. Владелец: Ellen Triantafellow. Дата публикации: 2007-12-06.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: AU2002348265A1. Автор: Siquan Sun,Robin Thurmond,Lars Karlson. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2003-07-24.

Substituted benzimidazole compounds and their use for the treatment of cancer

Номер патента: US20050014811A1. Автор: François CLERC,François HAMY,Isabelle Depaty,Odile Angouillant-Boniface,Stéphanie Deprets,Chantal Carrez,Manfred Roesner. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-01-20.

Compound, pharmaceutical formulation, use of a compound, and, processes for the preparation of a compound, to inhibit the secretion of gastric acid, for the treatment of inflammatory gastrointestinal diseases, and for the treatment or prophylaxis of conditions involving helicobacter pylori infection of the human gastric mucosa

Номер патента: BR9814755A. Автор: Kosrat Amin,Peter Nordberg,Ingemar Starke,Dahlstr M Mikael. Владелец: AstraZeneca AB. Дата публикации: 2000-10-03.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders

Номер патента: EP3621963A1. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2020-03-18.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders

Номер патента: US11939324B2. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2024-03-26.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders

Номер патента: CA3060481C. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2024-04-30.

Use of imidazole-2-thione compounds, for the preparation of a composition for the treatment and/or prevention of hyperpigmentary disorders, melasma, chloasma, lentigines, senile lentigo and vitiligo

Номер патента: FR2903694A1. Автор: Isabelle Pelisson,Irene Erdelmeier,Jean Claude Yadan,Itaru Suzuki. Владелец: Galderma Research and Development SNC. Дата публикации: 2008-01-18.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: EP2792681B1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2016-10-19.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: CA2833976A1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2008-05-29.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders

Номер патента: AU2007322423B2. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2013-01-10.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: SI2097437T1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: Umecrine Cognition AB. Дата публикации: 2015-10-30.

The use of pregnan and androstane steroids for the preparation of a pharmaceutical composition for the treatment of central nervous system disorders

Номер патента: ES2662500T3. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: ASARINA PHARMA AB. Дата публикации: 2018-04-06.

Inhibitors and antagonists of calcium channels in the treatment of asthma

Номер патента: WO2011064395A3. Автор: Lucette Pelletier,Jean-Charles Guery. Владелец: INSERM. Дата публикации: 2011-08-04.

Compounds, process for their preparation, medication, use of said compounds and process for the treatment or prevention of central nervous disorders

Номер патента: BR9404203A. Автор: Michael Boes. Владелец: Hoffmann La Roche. Дата публикации: 1995-07-04.

USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR THE TREATMENT OF EYE DISEASES.

Номер патента: ES2174447T3. Автор: Carsten Enggaard Stidsen,Michael Ankersen,Michael Albert Crider. Владелец: Novo Nordisk AS. Дата публикации: 2002-11-01.

Electronic equipment for the treatment and care of living beings

Номер патента: WO2016170354A2. Автор: Nigel John Walker,Alan Chamberlain,Timothy James Barry,Alison MARSHALL,Stephen Aubrey CLARK. Владелец: Tintro Limited. Дата публикации: 2016-10-27.

Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

Номер патента: US20100056758A1. Автор: Sophie Lotersztajn,Ariane Mallat,Vanessa Deveaux,Fatima Teixeira Clerc,Jeanne Tran-Van-Nhieu,Syivie Manin. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2010-03-04.

Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

Номер патента: EP2129374A1. Автор: Sophie Lotersztajn,Ariane Mallat,Fatima Teixeira Clerc,Sylvie Manin,Jeanne Tran-Van-Nhieu. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2009-12-09.

Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

Номер патента: EP2129374B1. Автор: Sophie Lotersztajn,Ariane Mallat,Vanessa Deveaux,Fatima Teixeira Clerc,Sylvie Manin,Jeanne Tran-Van-Nhieu. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2011-10-26.

Treatment of ischemia-reperfusion injury by controlling patient temperature

Номер патента: US10413444B2. Автор: Erik Kulstad,Hugh Patrick Caherty. Владелец: Advanced Cooling Therapy LLC. Дата публикации: 2019-09-17.

Biomarkers For The Prediction Of Treatment Outcomes In ADHD

Номер патента: US20170000400A1. Автор: Evian Gordon. Владелец: BRC OPERATIONS Pty Ltd. Дата публикации: 2017-01-05.

TREATMENT OF ISCHEMIA-REPERFUSION INJURY BY CONTROLLING PATIENT TEMPERATURE

Номер патента: US20170100281A1. Автор: Kulstad Erik,Caherty Hugh Patrick. Владелец: . Дата публикации: 2017-04-13.

Electronic equipment for the treatment and care of living beings

Номер патента: EP3285646A2. Автор: Nigel John Walker,Alan Chamberlain,Timothy James Barry,Alison MARSHALL,Stephen Aubrey CLARK. Владелец: TINTRO Ltd. Дата публикации: 2018-02-28.

Methods for the treatment, diagnosis, and prognosis of cancer

Номер патента: US20060160762A1. Автор: Bruce Zetter,Sonia Kim,Ursula Mangold. Владелец: Childrens Medical Center Corp. Дата публикации: 2006-07-20.

Method for the alignment of a multiaxial manipulator with an input device

Номер патента: US09731415B2. Автор: Sebastian LOHMEIER,Cyrill von Tiesenhausen. Владелец: KUKA ROBOTER GMBH. Дата публикации: 2017-08-15.

Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders

Номер патента: US5830490A. Автор: Robert E. Weinstein,Alan M. Weinstein. Владелец: Weinstein; Alan M.. Дата публикации: 1998-11-03.

Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour

Номер патента: GB2414394A. Автор: Keith Edgett,Rosemary F Knuth. Владелец: PLAYTEX PRODUCTS LLC. Дата публикации: 2005-11-30.

Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity

Номер патента: CA2163211C. Автор: Jürgen Bernhagen,Anthony Cerami,Richard J. Bucala,Robert A. Mitchell,Thierry F. Calandra. Владелец: Baxter International Inc. Дата публикации: 2012-05-08.

Flashtube for light irradiation treatment and prevention and light irradiation treatment and prevention device

Номер патента: US20150352370A1. Автор: Youji Yamashita. Владелец: Panasonic Intellectual Property Management Co Ltd. Дата публикации: 2015-12-10.

Use of a fluid drug formulation for the treatment of an ocular disorder

Номер патента: CA2797258C. Автор: Mark R. Prausnitz,Henry F. Edelhauser,Samirkumar Rajnikant Patel. Владелец: Georgia Tech Research Corp. Дата публикации: 2018-03-20.

System and method for supply and shared use of breathing gas

Номер патента: RU2506961C2. Автор: Брэдли П. ФУРМАН,Марк С. ДАУИ. Владелец: Дзе Рисерч Фаундейшн Оф Стейт Юниверсити Оф Нью Йорк. Дата публикации: 2014-02-20.

Compound, pharmaceutical formulation, use of a compound, and, processes for the treatment of disorders in the central nervous system and / or urinary incontinence, vasospasm and tumor growth control and for the preparation of the compound

Номер патента: BR9811042A. Автор: Stefan Berg,Seth Olov Thorberg,Bengt Ulff,Svante Ross,Mats Linderberg. Владелец: Astra AB. Дата публикации: 2000-08-15.

Compound, use of it, pharmaceutical composition, process for the treatment of a human or non-human animal suffering or subject to conditions that can be improved by the administration of an a4b1-mediated cell adhesion inhibitor, and resin

Номер патента: BR9813331A. Автор: Barry Porter,Paul Joseph Cox,Andrew David Morley,Neil Victor Harris,David Edward Clark,Alan John Collis,Paul Joseph Eastwood,Justine Yen Quai Lai. Владелец: Aventis Pharma Ltd. Дата публикации: 2000-08-22.

Preparation and use of biphenyl amino acid derivatives for the treatment of obesity

Номер патента: CA2617055A1. Автор: Roger Smith,Philip Coish,Derek Lowe,Stephen J. O'connor,Tatiana Shelekhin,Georgiy Bondar. Владелец: Georgiy Bondar. Дата публикации: 2007-02-08.

Identification and use of effectors and allosteric molecules for the alteration of gene expression

Номер патента: US20050239061A1. Автор: Anastasia Khvorova,William Marshall,Sumedha Jayasena. Владелец: AMGEN INC. Дата публикации: 2005-10-27.

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

Номер патента: CN101198333A. Автор: R·史密斯,G·王,M·帕特尔,D·罗维,P·夸什,A·-M·坎贝尔,G·邦达. Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2008-06-11.

Use of a fluid drug formulation for the treatment of an ocular disorder

Номер патента: CA2797258A1. Автор: Mark R. Prausnitz,Henry F. Edelhauser,Samirkumar Rajnikant Patel. Владелец: Georgia Tech Research Corp. Дата публикации: 2011-11-10.

Method for the treatment, control, minimization, and prevention of bovine mastitis

Номер патента: US09737047B2. Автор: Carey J. Boote. Владелец: CCD HOLDINGS LLC. Дата публикации: 2017-08-22.

Biological culture of a strain of the species pseudomonas graminis and use of said culture as antagonist for the biocontrol of pathogenic bacteria

Номер патента: WO2015091643A1. Автор: Immaculada Vinas Almenar,Maria Isabel Abadias Sero,Josep Usall Rodie,Neus Teixido Espasa,Rosario TORRES SANCHIS. Владелец: Institut De Recerca I Tecnologia Agroalimentàries. Дата публикации: 2015-06-25.

Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof

Номер патента: EP1811833A2. Автор: Bradford C. Berk,Jun-ichi Abe. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2007-08-01.

Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof

Номер патента: CA2586542A1. Автор: Bradford C. Berk,Jun-ichi Abe. Владелец: Individual. Дата публикации: 2006-05-11.

1-monoglyceride of c12 fatty acid for the treatment or prevention of infectious plant diseases

Номер патента: WO2024165554A1. Автор: Maria BLASCO BIGATÁ. Владелец: Mbp 4 Life, S.L.. Дата публикации: 2024-08-15.

Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof

Номер патента: WO2006050532A3. Автор: Jun-ichi Abe,Bradford C Berk. Владелец: Bradford C Berk. Дата публикации: 2007-02-08.

Food supplement for the treatment of neuropathies

Номер патента: WO2010023065A1. Автор: Carlo Terruzzi. Владелец: Giellepi Chemicals S.P.A.. Дата публикации: 2010-03-04.

Transgenic Non-Human Animal Models of Ischemia-Reperfusion Injury and Uses Thereof

Номер патента: US20080104718A1. Автор: Bradford Berk,Jun-ichi Abe. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2008-05-01.

Organ preservation solution and methods of use thereof in the inhibition of ischemia-reperfusion injury

Номер патента: US20170265456A1. Автор: Ming Zhang,Tak Lee. Владелец: Research Foundation of State University of New York. Дата публикации: 2017-09-21.

Pectin, process for producing the same, acidic protein foods with the use of the same and process for the production thereof

Номер патента: EP1291363B1. Автор: Taro c/o Fuji Oil Company Limited TAKAHASHI,Hitoshi c/o Fuji Oil Company Limited FURUTA,Junko c/o Fuji Oil Company Limited TOBE. Владелец: Fuji Oil Co Ltd. Дата публикации: 2011-07-06.

Fish fodder and method for smoltification and preventing desmoltification of salmonids and preventing and treating haemorrhagic smalt syndrome (hsc) in salmonids

Номер патента: RU2708168C2. Автор: Джим Роджер НОРДЛИ,Артур ЛЮНГЁЙ,Клаудио Ретамаль МАНСИЛЬА. Владелец: Еврофарма Ас. Дата публикации: 2019-12-04.

Phytosanitary agent and its particular use in the treatment of plants infected by xylella fastidiosa

Номер патента: EP4057816A1. Автор: Costantino TOMASI. Владелец: Vextachem Srl. Дата публикации: 2022-09-21.

Phytosanitary agent and its particular use in the treatment of plants infected by xylella fastidiosa

Номер патента: US20230000077A1. Автор: Costantino TOMASI. Владелец: Tomasi Costantino. Дата публикации: 2023-01-05.

pesticide mixture, pyrazole compound, methods for the control or control of pests, for the protection of plant propagating material, use of a pesticide mixture, methods for the control of plant pathogenic fungi, for the protection of plants, for the protection of animals against infestation and for the treatment of infested animals.

Номер патента: BR112014032078A2. Автор: Haden Egon,LANGEWALD Jürgen,Defieber Christian,Gunjima Koshi,GOCKEL Birgit,SÄLINGER Daniel,SÖRGEL Sebastian,L Culberston Deborah. Владелец: BASF SE. Дата публикации: 2017-06-27.

Method for the Treatment, Control, Minimization, and Prevention of Bovine Mastitis

Номер патента: US20140373791A1. Автор: Boote Carey J.. Владелец: . Дата публикации: 2014-12-25.

Compound - diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosis of biliary tract cancer, kit comprising the compound, uses of the compound and method for the treatment of biliary tract cancer

Номер патента: WO2024151174A2. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-07-18.

Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancer

Номер патента: AU2023241522A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S A. Дата публикации: 2024-08-15.

Compound, diagnostic marker for stomach cancer, method for detecting enzymatic activity, method for the diagnosis of stomach cancer, kit comprising the compound, uses of the compound and method for the treatment of stomach cancer

Номер патента: WO2024177524A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-08-29.

Compound - diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosis of biliary tract cancer, kit comprising the compound, uses of the compound and method for the treatment of biliary tract cancer

Номер патента: WO2024151174A3. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-08-22.

Use of histamine metabolites as markers for the treatment of ibs with h1-r antagonists

Номер патента: WO2017102640A1. Автор: Guy BOECKXSTAENS,Mira WOUTERS. Владелец: Katholieke Universiteit Leuven. Дата публикации: 2017-06-22.

Module of use of leading heat conductor fluid for the power supplying of combined utilities

Номер патента: EP1949003A1. Автор: Dino D'angelosante,Fabrizio Mincone,Cesare Scenna. Владелец: Individual. Дата публикации: 2008-07-30.

Module of use of leading heat conductor fluid for the power supplying of combined utilities

Номер патента: WO2007054999A1. Автор: Dino D'angelosante,Fabrizio Mincone,Cesare Scenna. Владелец: D Angelosante Dino. Дата публикации: 2007-05-18.

Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancer

Номер патента: WO2023191647A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2023-10-05.

Use of an aqueous alkaline composition for the electroless deposition of a metal or metal alloy on a metal surface of a substrate

Номер патента: EP4444931A1. Автор: Heiko Brunner,Lars Kohlmann. Владелец: Atotech Deutschland GmbH and Co KG. Дата публикации: 2024-10-16.

Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv)

Номер патента: US20140342349A1. Автор: Emmanuel Drouet,Felix Agbalika,Mohammed Habib. Владелец: Universite Joseph Fourier Grenoble 1. Дата публикации: 2014-11-20.

Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the Epstein-Barr virus (EBV)

Номер патента: US09696308B2. Автор: Emmanuel Drouet,Felix Agbalika,Mohammed Habib. Владелец: Universite Joseph Fourier Grenoble 1. Дата публикации: 2017-07-04.

Use of radiofrequency wave absorbing markets for the authentication of security documents

Номер патента: US09581557B2. Автор: Javier Gamo Aranda,José Francisco FERNÁNDEZ LOZANO,Vicente García Juez,Miguel Ángel RODRÍGUEZ BARBERO,Juan José Romero Fanego. Владелец: Fabrica Nacional de Moneda y Timbre. Дата публикации: 2017-02-28.

Use of a tetraphenylborate (tpb) salt for the separation of biomolecules

Номер патента: US20170183375A1. Автор: Roland Callens,Laurent Jeannin. Владелец: Corden Pharma Brussels SA. Дата публикации: 2017-06-29.

Use of a tetraphenylborate (TPB) salt for the separation of biomolecules

Номер патента: US20110098446A1. Автор: Roland Callens,Laurent Jeannin. Владелец: SOLVAY SA. Дата публикации: 2011-04-28.

Organic electronic component with dopant, use of a dopant and method for the production of the dopant

Номер патента: US09799840B2. Автор: Guenter Schmid,Andreas Kanitz,Benedict Sandmann,Jan Hauke Wemken,Renate KELLERMANN. Владелец: OSRAM OLED GmbH. Дата публикации: 2017-10-24.

Use of a tetraphenylborate (TPB) salt for the separation of biomolecules

Номер патента: US09611291B2. Автор: Roland Callens,Laurent Jeannin. Владелец: Corden Pharma Brussels SA. Дата публикации: 2017-04-04.

Method, system and use of the method or system for the application of lacquer

Номер патента: CA2327473C. Автор: Uffe Norskov Laursen. Владелец: Ulmadan AS. Дата публикации: 2008-10-28.

Use of synthetic granulate or powder for the removal of liquid, gaseous and/or dissolved constituents from a process stream

Номер патента: US5750030A. Автор: Johannes Bos,Elwin Schomaker,Erik Leonard Middelhoek. Владелец: Individual. Дата публикации: 1998-05-12.

Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders

Номер патента: US5482940A. Автор: John P. Yardley,John A. Moyer,Wayne E. Childers, Jr.,Magid A.-M. Abou-Gharbia. Владелец: American Home Products Corp. Дата публикации: 1996-01-09.

Use of heterogeneous catalysts in methods for the production of polymides

Номер патента: MY121875A. Автор: Ralf Dr Mohrschladt,Volker Dr Hildebrandt. Владелец: Basf Ag. Дата публикации: 2006-02-28.

Use of aralkyl polyalkylene glycol ethers for the preparation of aqueous coal slurries

Номер патента: CA1226202A. Автор: Jan Mazanek,Gunther Boehmke,Gottfried Schneider,Hansjurgen Botsch. Владелец: Bayer AG. Дата публикации: 1987-09-01.

Charge detector semiconductor component, system comprising a charge detector semiconductor component and a reference semiconductor component, wafer, use of a wafer, and method for the qualitative and quantitative measurement of charging of a wafer

Номер патента: US6747303B2. Автор: Hans-Ulrich Schroeder. Владелец: KONINKLIJKE PHILIPS ELECTRONICS NV. Дата публикации: 2004-06-08.

Investment compound for moulding technics in dental technology, use of investment compound and method for the production thereof

Номер патента: AU4009297A. Автор: Helmut Hero. Владелец: Individual. Дата публикации: 1998-03-26.

The use of phosphonoalkanecarboxylic acid partial esters for the extraction of metals

Номер патента: AU1001388A. Автор: Helmut Blum,Werner Dr. Schwab. Владелец: Henkel AG and Co KGaA. Дата публикации: 1988-07-14.

The use of phosphonoalkanecarboxylic acid partial esters for the extraction of metals

Номер патента: AU596264B2. Автор: Helmut Blum,Werner Dr. Schwab. Владелец: Henkel AG and Co KGaA. Дата публикации: 1990-04-26.

Use of aralkyl polyalkylene glycol ethers for the preparation of aqueous coal slurries

Номер патента: US4547199A. Автор: Jan Mazanek,Gunther Boehmke,Gottfried Schneider,Hans-Jurgen Botsch. Владелец: Bayer AG. Дата публикации: 1985-10-15.

Use of a silicone rubber composition for the manufacture of an insulator for high voltage direct current applications

Номер патента: US11908595B2. Автор: Harry Zumaque,Lada Bemert,Oliver Safarowsky,Beatrice Grau. Владелец: MOMENTIVE PERFORMANCE MATERIALS GMBH. Дата публикации: 2024-02-20.

Use of radiofrequency wave absorbing markers for the authentication of security documents

Номер патента: PH12013502034B1. Автор: JUEZ Vicente Garcia,ARANDA Javier Gamo,BARBERO Miguel Angel Rodriguez,Fanego Juan Jos‚ Romero,Lozano Jos‚ Francisco Fernandez. Владелец: F?Brica Nac De Moneda Y Timbre Real Casa De La Moneda. Дата публикации: 2014-01-06.

Use of an aqueous coating composition for the manufacture of surface coatings of seals

Номер патента: EP1499691A1. Автор: Karl-Heinz Käsler,John Mitchell Huggins,Adrian-Malcolm Steedman. Владелец: GE Bayer Silicones GmbH and Co KG. Дата публикации: 2005-01-26.

Use of water as a catalyst for the polymerization of chlorocyclophosphazenes

Номер патента: US3937790A. Автор: Harry Rex Allcock,James Earl Gardner, deceased,Karen M. Smeltz. Владелец: Firestone Tire and Rubber Co. Дата публикации: 1976-02-10.

Use of a self-healing material for the formation of a film bag

Номер патента: EP4257345A1. Автор: Omer Ozkul. Владелец: Henkel AG and Co KGaA. Дата публикации: 2023-10-11.

Organic Electronic Component with Dopant, Use of a Dopant and Method for the Production of the Dopant

Номер патента: US20140264313A1. Автор: Guenter Schmid,Andreas Kanitz,Benedict Sandmann,Jan Hauke Wemken,Renate KELLERMANN. Владелец: OSRAM Opto Semiconductors GmbH. Дата публикации: 2014-09-18.

Use of radiation cross-linked polyethylene for the production of cartridges

Номер патента: CA1207185A. Автор: Axel Homburg,Hans Umbach,Kurt Ballreich,Horst Rammensee. Владелец: Dynamit Nobel AG. Дата публикации: 1986-07-08.

Systems and methods for the automated pre-treatment and processing of biological samples

Номер патента: US7584019B2. Автор: John A. Favuzzi,Marc E. Key,Gordon Alan Feingold,James B. Gilmartin,Mark Richard Holbrook. Владелец: Dako Denmark ApS. Дата публикации: 2009-09-01.

COMPOUNDS FOR THE TREATMENT OF ISCHEMIA-REPERFUSION-RELATED DISEASES

Номер патента: US20150080388A1. Автор: Guarna Antonio,Cozzolino Federico. Владелец: . Дата публикации: 2015-03-19.

COMPOUNDS FOR THE TREATMENT OF ISCHEMIA-REPERFUSION-RELATED DISEASES

Номер патента: US20180155363A1. Автор: Guarna Antonio,Cozzolino Federico. Владелец: . Дата публикации: 2018-06-07.

Common point authoring system for the complex sharing of hierarchically authored data objects in a distribution chain

Номер патента: US20170255602A1. Автор: Marvin L. Stone,Steven L. Holcombe. Владелец: Pardalis Inc. Дата публикации: 2017-09-07.

Common point authoring system for the complex sharing of hierarchically authored data objects in a distribution chain

Номер патента: US20190392030A1. Автор: Marvin L. Stone,Steven L. Holcombe. Владелец: Pardalis Inc. Дата публикации: 2019-12-26.

Agent for the treatment of cast iron melts, process for the production thereof and the use thereof for treating cast iron melts

Номер патента: CA2021451A1. Автор: Wolfgang Geiger,Friedrich Wolfsgruber,Detlef Missol. Владелец: SKW Trostberg AG. Дата публикации: 1991-01-26.

Dynamic use of a packet recovery mechanism to avoid congestion along a network path

Номер патента: US20230291679A1. Автор: Giovanna Carofiglio,Michele Papalini,Jacques Olivier Samain,Giulio Grassi. Владелец: Cisco Technology Inc. Дата публикации: 2023-09-14.

Common point authoring system for the complex sharing of hierarchically authored data objects in a distribution chain

Номер патента: US09690765B2. Автор: Marvin L. Stone,Steven L. Holcombe. Владелец: Pardalis Inc. Дата публикации: 2017-06-27.

GLYCOLIPID FOR TREATMENT OF ISCHEMIA REPERFUSION INJURY

Номер патента: US20130143828A1. Автор: Molteni Monica. Владелец: BLUEGREEN BIOTECH S.R.L.. Дата публикации: 2013-06-06.

SHORT PEPTIDES USEFUL FOR TREATMENT OF ISCHEMIA/REPERFUSION INJURY AND OTHER TISSUE DAMAGE CONDITIONS ASSOCIATED WITH NITRIC OXIDE AND ITS REACTIVE SPECIES

Номер патента: US20130150283A1. Автор: Nudler Evgeny A.,Rafikov Ruslan R.. Владелец: New York University. Дата публикации: 2013-06-13.

Use of stereoisomers of calendula glycosides for the treatment of psoriasis

Номер патента: ZA98584B. Автор: William Howard Stimson,Alexander Irvine Gray,Chaman Lal Anand,Peter George Waterman,Solomon Habtermariam. Владелец: Univ Strathclyde. Дата публикации: 1998-08-03.

Use of stereoisomers of calendula glycosides for the treatment of psoriasis

Номер патента: AU5771198A. Автор: William Howard Stimson,Alexander Irvine Gray,Chaman Lal Anand,Solomon Habtemariam,Peter George Waterman. Владелец: UNIVERSITY OF STRATHCLYDE. Дата публикации: 1998-08-18.

Conductive polymer material, use of same, and a method for the production of same

Номер патента: US09589698B2. Автор: Holger Reinhardt,Klaus-Peter Anhalt. Владелец: OTTO BOCK HEALTHCARE GMBH. Дата публикации: 2017-03-07.

Use of glass-resin composite fibres for the reinforcement of concrete

Номер патента: AU2021403916A9. Автор: Kevin Roos,Pierre PLOUZENNEC,Raphael Martinez. Владелец: Compagnie Generale des Etablissements Michelin SCA. Дата публикации: 2024-04-18.

Use of glass-resin composite fibres for the reinforcement of concrete

Номер патента: AU2021403916A1. Автор: Kevin Roos,Pierre PLOUZENNEC,Raphael Martinez. Владелец: Compagnie Generale des Etablissements Michelin SCA. Дата публикации: 2023-06-22.

Use of resonant microcavity display fed for the illumination of a light valve projector

Номер патента: EP1451638A1. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2004-09-01.

Use of resonant microcavity display fed for the illumination of a light valve projector

Номер патента: EP1451638A4. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2005-03-02.

Methods and systems for the use of photosynthetic microbes as mechanical transducers and sensors

Номер патента: US12012588B1. Автор: David Bortz,Jeffrey Carlyle Cameron,Kristin A. Moore,Evan B. Johnson,Jian Wei Tay,Janet B. Fox,Sabina Altus. Владелец: University of Colorado Boulder. Дата публикации: 2024-06-18.

Low-pressure process utilizing a stacked-bed system of specific catalysts for the hydrotreating of a gas oil feedstock

Номер патента: US09404053B2. Автор: John Anthony Smegal,Karl Marvin Krueger,Lawrence Stephen KRAUS. Владелец: Shell Oil Co. Дата публикации: 2016-08-02.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: EP1466474A2. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2004-10-13.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: WO2003061268A3. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Jr Estill Thone Hall. Дата публикации: 2003-10-16.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: EP1466474A4. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2005-09-28.

System for the management of loading and unloading operations of uav

Номер патента: WO2022190154A1. Автор: Francesco Ricci. Владелец: Francesco Ricci. Дата публикации: 2022-09-15.

Process for the depolymerization of polystyrene

Номер патента: US12116337B2. Автор: Norbert Niessner,Bianca WILHELMUS,Achim Schmidt-Rodenkirchen,Konstantin MIERDEL,Frank NEUNER. Владелец: INEOS STYROLUTION GROUP GMBH. Дата публикации: 2024-10-15.

Process for the carbonylation of epoxides

Номер патента: US20220204465A1. Автор: Christoph Guertler,Jens LANGANKE,Matthias LEVEN,Suresh Raju. Владелец: Covestro Intellectual Property GmbH and Co KG. Дата публикации: 2022-06-30.

Supported tantalum catalyst for the production of 1,3-butadiene

Номер патента: US12070738B2. Автор: Piotr Zapala,Ewelina JANKOWIAK,Szymon SKOWRONEK. Владелец: Synthos Dwory 7 Spolka Z Ograniczona Odpowiedzialnoscia. Дата публикации: 2024-08-27.

Biocompatible three dimensional matrix for the immobilization of biological substances

Номер патента: US09926383B2. Автор: Stefan Margraf,Martin Scholz. Владелец: Leukocare AG. Дата публикации: 2018-03-27.

Organofunctional siloxanes, process for preparing same and their use for the treatment of fillings and surfaces

Номер патента: US11773289B2. Автор: José Manuel Antelo Miguez,Benigno JANEIRO,Luis Angel ADRIO CASTIÑEIRA,Pablo BARREIRO GONZALEZ. Владелец: Abcr Laboratorios SL. Дата публикации: 2023-10-03.

Method for catalytic oxidation of a natural composition including unsaturated fatty acids and/or esters thereof and the use of a mixture obtained therefrom for the production of mono-, oligo- and/or polyesters

Номер патента: EP2785677A1. Автор: Jukka Tulisalo,Salme Koskimies,Pauliina PITKÄNEN,Minni Pirttimaa. Владелец: Valtion teknillinen tutkimuskeskus. Дата публикации: 2014-10-08.

Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer

Номер патента: WO2000079267A3. Автор: Dean Nizetic,Juergen Groet. Владелец: Univ London Pharmacy. Дата публикации: 2001-02-15.

System and method for detecting and preventing drowsiness

Номер патента: US20130328684A1. Автор: Hsuan Chang,Dennis A. Grahn,Horace Craig Heller. Владелец: Leland Stanford Junior University. Дата публикации: 2013-12-12.

Process for the hydrolysis of biomass

Номер патента: US09988658B2. Автор: Michael Zavrel,Markus Jakob,Marcus VERHUELSDONK,Danielle DENNEWALD,Sandra Schuetze. Владелец: CLARIANT INTERNATIONAL LTD. Дата публикации: 2018-06-05.

Aluminium oxide pastes and process for the use thereof

Номер патента: US09580610B2. Автор: Werner Stockum,Oliver Doll,Ingo Koehler,Sebastian Barth. Владелец: Merck Patent GmBH. Дата публикации: 2017-02-28.

Use of polyethylenoxide polymers for the preparation of lipids conjugated with poly(ethylene oxide) having c1 to c3-alkyloxymethyl side chains

Номер патента: EP4372027A1. Автор: Holger Frey,Philip Dreier,Rebecca MATTHES. Владелец: Johannes Gutenberg Universitaet Mainz. Дата публикации: 2024-05-22.

Use of an optimal control algorithm for the design of mri refocusing pulses with phase-free rotation axis

Номер патента: WO2015158814A1. Автор: Nicolas Boulant,Aurélien Massire. Владелец: Commissariat à l'énergie atomique et aux énergies alternatives. Дата публикации: 2015-10-22.

Method for the use of slurries in spray pyrolysis for the production of non-hollow, porous particles

Номер патента: US09748567B2. Автор: Richard Axelbaum,William Moller,Dror Elhassid,Miklos Lengyel,Gal Atlas. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2017-08-29.

Circulating micro-rnas as biomarkers for the diagnosis of celiac disease and for monitoring adherence to a gluten-free diet

Номер патента: WO2021124369A1. Автор: Andrea Masotti,Cristina FELLI. Владелец: Ospedale Pediatrico Bambino Gesu'. Дата публикации: 2021-06-24.

Use of substances binding to hat for the diagnosis and treatment of squamous carcinomas of the lung

Номер патента: AU2003289837A1. Автор: Thomas Brümmendorf,Esmeralda Heiden,Klaus Hermann,Henrik Kinnemann,Xinzhong Li,Stefan Röpcke,Bernd Hinzmann,André ROSENTHAL,Detlev Mennerich,Eicke Staub. Владелец: Individual. Дата публикации: 2004-06-30.

USE OF ELECTRIC OR HYBRID VEHICLES FOR THE TREATMENT OF AMBIENT AIR IN URBAN AREAS AND CONTROL CENTER FOR THE MANAGEMENT OF SUCH USE

Номер патента: FR3109099A1. Автор: Bruno Pintat,Denis Dumur,Karine Pajot,Gregory Blokkeel. Владелец: PSA Automobiles SA. Дата публикации: 2021-10-15.

USE OF ACID PROTEASE INHIBITOR PEPTIDES FOR THE PREPARATION OF MEDICINES USEFUL FOR THE TREATMENT OF VIRAL DISEASES

Номер патента: FR2646354B1. Автор: Dino Nisato,Jean-Claude Chermann,Sylvie Marchetto. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 1994-06-10.

USE OF ELECTRIC OR HYBRID VEHICLES FOR THE TREATMENT OF AMBIENT AIR IN URBAN ENVIRONMENTS AND CONTROL CENTER FOR THE MANAGEMENT OF SAID USE

Номер патента: FR3109099B1. Автор: Bruno Pintat,Denis Dumur,Karine Pajot,Gregory Blokkeel. Владелец: PSA Automobiles SA. Дата публикации: 2023-02-24.

Measurement, diagnosis, treatment and management of metabolic syndrome

Номер патента: WO2023161832A1. Автор: Eduardo GARCÍA ALANIS,Santos Eduardo Flores López,Sergio de Jesus Elizondo,Bernardo Dychter Cholow,Fernando Garcia Sada,Ivan Pacheco Espino,Alejandro Pulido Watts. Владелец: García Sada Fernando. Дата публикации: 2023-08-31.

Use of the single screw expander for the recovery of power from flashing fluids

Номер патента: GB9320959D0. Автор: . Владелец: TFC POWER SYST Ltd. Дата публикации: 1993-12-01.

Compositions for preliminary treatment, and also methods of applying coating on battery electrode

Номер патента: RU2620258C2. Автор: Стюарт Д. Хеллринг,Ричард Ф. КАРАБИН,Эдвард Ф. РАКИЕВИЧ,Натан Дж. СИЛВЕРНЕЙЛ,Ренди Е. ДОФЕНБО,Кейвин Томас СИЛЬВЕСТЕР. Владелец: Ппг Индастриз Огайо, Инк.. Дата публикации: 2017-05-24.

USE OF A QUATERNARY POLYAMONY POLYMER FOR THE CONTROL OF THE DEPOSITION OF ANIONIC AND RESIN IMPURITIES AND FOR THE TREATMENT OF STUCKED PAPER MANUFACTURING WASTE.

Номер патента: ES2210821T3. Автор: Jiansheng Tang,Jeffrey R. Cramm,Michael R. St. John,Laura M. Sherman. Владелец: Ondeo Nalco Co. Дата публикации: 2004-07-01.

Methods for the production of committed cardiac progenitor cells

Номер патента: US20230078230A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Kristin STACK,Ellen HEBRON. Владелец: Fujifilm Cellular Dynamics Inc. Дата публикации: 2023-03-16.

Methods for the production of committed cardiac progenitor cells

Номер патента: AU2022343749A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2024-03-28.

Methods for the production of committed cardiac progenitor cells

Номер патента: CA3231501A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2023-03-16.

USE OF AN ORGANIC REDUCING AGENT FOR THE TREATMENT OF WATER THROUGH THE ELIMINATION OF CHLORINE, CHLORINE AND OTHER COMPOUNDS OF ACTIVE CHLORINE OF MAINTENANCE WATER FOR AQUATIC ORGANISMS.

Номер патента: ES2340424T3. Автор: Gunter Ritter. Владелец: Tetra Gmbh. Дата публикации: 2010-06-02.

Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases

Номер патента: AU1395999A. Автор: Laszlo Nagy,Ronald M Evans,Richard J. Lin. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 1999-05-31.

Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome

Номер патента: US20230266340A1. Автор: Eduardo GARCÍA ALANIS,Santos Eduardo Flores López,Sergio de Jesus Elizondo,Bernardo Dychter Cholow,Fernando Garcia Sada,Ivan Pacheco Espino,Alejandro Pulido Watts. Владелец: Silta Ag. Дата публикации: 2023-08-24.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: AU2003207536A1. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2003-07-30.

Use of a self-insulating material for the current-dense transmission of electric power in fresh water or salt water

Номер патента: AU2003222745A1. Автор: Ingo Nowaczyc. Владелец: Individual. Дата публикации: 2004-08-30.

Use of a carbon-containing substitute for the production of yeast

Номер патента: DK2257619T3. Автор: Jean-Luc Fuentes,Anne-Dominique Quipourt-Isnard,Georges Rene Marcel Parasie,Emmanuel Poilpre,Gilles Georges Albert Stien. Владелец: Lesaffre & Cie. Дата публикации: 2016-03-07.

Use of resonant microcavity display fed for the illumination of a light valve projector

Номер патента: AU2002348260A1. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2003-06-23.

USE OF KYNURENIC ACID AMIDE DERIVATIVES FOR THE TREATMENT OF HUNTINGTON'S DISEASE

Номер патента: US20130172346A1. Автор: Fulop Ferenc,Szatmari Istvan,TOLDI József,VÉCSEI László,Zádori Dénes,Klivényi Péter,Freund Tamás,Nyiri Gábor,Szönyi András. Владелец: . Дата публикации: 2013-07-04.

USE OF PEGYLATED IGF-1 VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

Номер патента: US20140073567A1. Автор: Metzger Friedrich,Sendtner Michael,HOLTMAN BETTINA. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2014-03-13.

Method for producing a laminated glass pane free of optical obstruction caused by warping, use of a particular carrier film for the production of the laminated glass pane and carrier films particularly suitable for the method or the use

Номер патента: CA2226969C. Автор: Peter Costa. Владелец: Flachglas Automotive GmbH. Дата публикации: 2002-04-30.

USE OF ANTI-90K MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF TUMORS AND METASTASES THEREOF

Номер патента: US20120003157A1. Автор: Iacobelli Stefano. Владелец: . Дата публикации: 2012-01-05.

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

Номер патента: AU2015203865A1. Автор: Christine Fritsch,Sauveur-Michel Maira,Christian Rene Schnell,Carlos Garcia-Echeverria,Saskia Maria Brachmann. Владелец: NOVARTIS AG. Дата публикации: 2015-07-30.

Acylated enamide compounds, pharmaceutical compositions containing these, use of these compounds and process for the preparation of these compounds

Номер патента: CA1249999A. Автор: Heinz Viehe,Marcel Roberfroid,Francoise Hervens. Владелец: Biotec AB. Дата публикации: 1989-02-14.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A1. Автор: . Владелец: . Дата публикации: 2009-10-15.

USE OF HELIUM-OXYGEN GAS MIXTURES FOR TREATING PULMONARY ARTERIAL HYPERTENSION

Номер патента: US20120003325A1. Автор: . Владелец: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT. Дата публикации: 2012-01-05.

Use of Tiliacora Triandra in Cosmetics and Compositions Thereof

Номер патента: US20120003331A1. Автор: Ptchelintsev Dmitri S.. Владелец: AVON PRODUCTS, INC.. Дата публикации: 2012-01-05.

USE OF VAGINALLY-ADMINISTERED INSULIN SENSITIZING AGENTS

Номер патента: US20120004271A1. Автор: MOSCOSO DEL PRADO Jaime,Bandi Tosi Beatriz. Владелец: . Дата публикации: 2012-01-05.

Method for prevention of reperfusion injuries of donor organs

Номер патента: RU2487704C2. Автор: Владимир Юрьевич Ульянов,Антон Николаевич Россоловский,Валерий Владимирович Щуковский. Владелец: Государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ГБОУ ВПО "Саратовский ГМУ им. В.И. Разумовского" Минздрава России). Дата публикации: 2013-07-20.

Novel use of dpp-4 inhibitor in manufacture of drug for treatment of lupus nephritis

Номер патента: AU2023219870B1. Автор: Weiwei Li,Bin Yu,Chun Yao,Yongjun WANG,Ran Zhu,Zhifeng Gu,Zhanyun DA. Владелец: Affiliated Hospital of Nantong University. Дата публикации: 2024-02-08.

USE OF C1 INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY

Номер патента: US20120088728A1. Автор: . Владелец: PHARMING INTELLECTUAL PROPERTY B.V.. Дата публикации: 2012-04-12.

Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases

Номер патента: WO1998020864A9. Автор: . Владелец: . Дата публикации: 1998-08-27.

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome.

Номер патента: OA21483A. Автор: George GARIBALDI. Владелец: Noema Pharma Ag. Дата публикации: 2024-07-31.

METHOD FOR PRODUCING A RAT MODEL FOR THE STUDY AND CORRECTION OF ISCHEMIA-REPERFUSION

Номер патента: RU2013146210A. Автор: Мария Анатольевна Замкова,Анна Вячеславовна Баранова,Олег Николаевич Резник,Андрей Евгениевич Скворцов,Андрей Владимирович Марахонов,Михаил Юрьевич Скоблов,Анна Алексеевна Гуськова,Александр Олегович Резник,Денис Олегович Кузьмин,Александра Юрьевна Филатова. Владелец: Федеральное государственное бюджетное учреждение "Медико-генетический научный центр" Российской академии медицинских наук. Дата публикации: 2015-04-27.

Novel inhibitor of ischemia / reperfusion injury

Номер патента: JP4166851B2. Автор: 剛 渡邊,信男 櫻川,拓郎 三崎,泰弘 宇於崎. Владелец: Seikagaku Corp. Дата публикации: 2008-10-15.

Treatment Of Ischemia-Reperfusion Injury

Номер патента: US20120122870A1. Автор: . Владелец: . Дата публикации: 2012-05-17.

Use of ccn domain-containing proteins for the treatment of disease

Номер патента: GB202400055D0. Автор: . Владелец: Tribune Therapeutics AB. Дата публикации: 2024-02-14.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression

Номер патента: TW200808304A. Автор: Virginia L Smith-Swintosky. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2008-02-16.

Use of 1-hydroxy-2-pyridones for the treatment of skin diseases

Номер патента: MXPA99002865A. Автор: Bohn Manfred,Markus Astrid,Theodor Kraemer Karl. Владелец: Hoechst Ag 65929 Frankfurt De. Дата публикации: 1999-09-01.

Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases

Номер патента: AU2002362204A1. Автор: John Nieland,Christoph Rehfuess. Владелец: MEDIGENE AG. Дата публикации: 2003-05-19.

Therapeutic-and-preventive beverage production method

Номер патента: RU2537197C1. Автор: Яннис Сергеевич САМАРЧЕВ. Владелец: Яннис Сергеевич САМАРЧЕВ. Дата публикации: 2014-12-27.

Method for prevention of thermal burns of human skin

Номер патента: RU2429029C2. Автор: Павел Борисович Панов,Ольга Олеговна ВЛАДИМИРОВА,Наталья Александровна Миненко. Владелец: Государственное образовательное учреждение высшего профессионального образования Военно-Медицинская академия им. С.М. Кирова. Дата публикации: 2011-09-20.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment.

Номер патента: ZA96251B. Автор: Charles E Hart,Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard,Jan Ulrik Weis,Steven Bain. Владелец: Novo Nordisk AS. Дата публикации: 1997-02-20.

Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer

Номер патента: WO1994020080A9. Автор: . Владелец: . Дата публикации: 1994-10-27.

Use of the orbiting scroll expander for the recovery of power from flashing fluids

Номер патента: GB9409304D0. Автор: . Владелец: T F C POWER SYSTEMS Ltd. Дата публикации: 1994-06-29.

USE OF GYMNODIMINE, ANALOGUES AND DERIVATIVES FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES ASSOCIATED WITH TAU AND B-AMYLOID

Номер патента: US20120245223A1. Автор: Botana López Luis Miguel,Alonso López Eva,Vale González Carmen. Владелец: UNIVERSIDADE DE SANTIAGE DE COMPOSTELA. Дата публикации: 2012-09-27.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophy-laxis of atrophy of skin and/or mucous membranes

Номер патента: ZA97169B. Автор: Virender Mohan Labroo,Niels Korsgaard,James Robertson Piggott,Steven Bain. Владелец: Novo Nordisk AS. Дата публикации: 1997-07-21.

Uses of super-oxide dismutase supplements

Номер патента: WO2024220782A1. Автор: Liaquat HOSSAIN. Владелец: Advance Pharmaceutical, Inc.. Дата публикации: 2024-10-24.

Use of a 3-phenoxyazetidine carboxamide for the preparation of a pharmaceutical composition for the treatment of muscle tension and / or muscle plasticity

Номер патента: DK170270B1. Автор: Jr Chandler Roy Taylor,Jr Albert Duncal Cale,David Norseen Johnson,Jr Harold Fisher Stauffer. Владелец: Robins Co Inc A H. Дата публикации: 1995-07-24.

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

Номер патента: CA2507753A1. Автор: Rima Kaddurah-Daouk,Ghaleb Daouk,M. Flint Beal. Владелец: M. Flint Beal. Дата публикации: 1996-05-17.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...

Номер патента: TW370460B. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard,Jan Ulrik Weis,Steven Bain. Владелец: Novo Nordisk AS. Дата публикации: 1999-09-21.

Use of heterogeneous catalysts in methods for the production of polyamides

Номер патента: SI1141091T1. Автор: Volker Hildebrandt,Ralf Mohrschladt. Владелец: BASF AKTIENGESELLSCHAFT. Дата публикации: 2002-12-31.

USE OF WNT5-A PEPTIDE DERIVATES FOR THE TREATMENT OF MELANOMA AND GASTRIC CANCER

Номер патента: US20120010151A1. Автор: ANDERSSON Tommy. Владелец: . Дата публикации: 2012-01-12.

USE OF LNA APOB ANTISENSE OLIGOMERS FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES

Номер патента: US20120122955A1. Автор: Straarup Ellen Marie,Bagger Yu. Владелец: . Дата публикации: 2012-05-17.

USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS

Номер патента: US20120135961A1. Автор: Hubschwerlen Christian,SCHMITT Christine,SPECKLIN Jean-Luc,Baeschlin Daniel,Locher Hans. Владелец: Morphochem Aktiengesellschaft Fur Kombinatorische Chemie. Дата публикации: 2012-05-31.

Device and use of a pressure-sound-source for the treatment of fungal diseases

Номер патента: US20120172765A1. Автор: Esenwein Cornelia. Владелец: . Дата публикации: 2012-07-05.

USE OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

Номер патента: US20120295849A1. Автор: . Владелец: CEDARS- SINAI MEDICAL CENTER. Дата публикации: 2012-11-22.

USE OF CI-994 AND DINALINE FOR THE TREATMENT OF MEMORY/COGNITION AND ANXIETY DISORDERS

Номер патента: US20120322879A1. Автор: . Владелец: . Дата публикации: 2012-12-20.

USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

Номер патента: US20120329835A1. Автор: Kraemer Karl Theodor,Bohn Manfred,Markus Astrid. Владелец: MEDICIS PHARMACEUTICAL CORPORATION. Дата публикации: 2012-12-27.

Use of modified thymosin beta 4 for the treatment of diabetic peripheral neuropathy

Номер патента: CN109865127B. Автор: 马素永,聂李亚,许松山,马杉姗,汤晓闯. Владелец: Beijing Northland Biotech Co Ltd. Дата публикации: 2022-03-04.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.